[6-K] Barclays PLC Current Report (Foreign Issuer)
H1-25 results: Barclays reported income of £14.9bn (+12% YoY) and profit before tax of £5.2bn (+23%). Attributable profit rose 26% to £3.5bn, lifting EPS to 24.7p (18.6p). RoTE reached 13.2% versus 11.1%, while the cost-income ratio improved to 58% from 62%. Loan-loss rate edged up to 52 bps but stayed within the 50-60 bps target range.
Q2-25 snapshot: income £7.2bn (+14%), PBT £2.5bn (+28%), RoTE 12.3%; every division delivered double-digit returns.
Capital & liquidity: CET1 strengthened to 14.0% (13.6% Dec-24); TNAV per share increased to 384p; liquidity coverage ratio stood at 177.7% and UK leverage at 5.0%.
Shareholder returns: Board declared a 3.0p interim dividend and launched a new £1bn buyback, bringing H1 distributions to £1.4bn (+21% YoY).
Execution of three-year plan: £17bn of targeted £30bn UK RWA growth achieved, two-thirds of £2bn gross cost saves realised; FY25 guidance (RoTE c.11%, cost-income c.61%, CET1 13-14%) unchanged.
Other events: German consumer finance sale added ~10 bps to CET1; FCA AML settlements total £48m; Tesco Bank acquisition continues to support revenue and cost base.
Risultati H1-25: Barclays ha riportato un reddito di £14,9 miliardi (+12% su base annua) e un utile ante imposte di £5,2 miliardi (+23%). L'utile attribuibile è cresciuto del 26% a £3,5 miliardi, portando l'EPS a 24,7p (rispetto a 18,6p). Il RoTE ha raggiunto il 13,2% contro l'11,1%, mentre il rapporto costi/ricavi è migliorato al 58% dal 62%. Il tasso di perdite sui prestiti è salito a 52 bps ma è rimasto all'interno dell'intervallo obiettivo di 50-60 bps.
Riepilogo Q2-25: reddito £7,2 miliardi (+14%), utile ante imposte £2,5 miliardi (+28%), RoTE 12,3%; ogni divisione ha registrato ritorni a doppia cifra.
Capitale e liquidità: CET1 rafforzato al 14,0% (13,6% a dicembre 2024); TNAV per azione aumentato a 384p; il liquidity coverage ratio si è attestato al 177,7% e la leva finanziaria UK al 5,0%.
Rendimenti per gli azionisti: Il Consiglio ha dichiarato un dividendo intermedio di 3,0p e ha avviato un nuovo buyback da £1 miliardo, portando le distribuzioni del primo semestre a £1,4 miliardi (+21% su base annua).
Esecuzione del piano triennale: raggiunti £17 miliardi dei £30 miliardi target di crescita RWA UK, realizzati due terzi dei risparmi lordi sui costi di £2 miliardi; le previsioni per il FY25 (RoTE circa 11%, rapporto costi/ricavi circa 61%, CET1 13-14%) rimangono invariate.
Altri eventi: la vendita del finanziamento al consumo tedesco ha aggiunto circa 10 bps al CET1; le sanzioni FCA AML ammontano a £48 milioni; l'acquisizione di Tesco Bank continua a sostenere ricavi e base costi.
Resultados H1-25: Barclays reportó ingresos de £14.9 mil millones (+12% interanual) y beneficio antes de impuestos de £5.2 mil millones (+23%). El beneficio atribuible aumentó un 26% hasta £3.5 mil millones, elevando el BPA a 24.7p (18.6p). El RoTE alcanzó el 13.2% frente al 11.1%, mientras que la ratio coste-ingreso mejoró al 58% desde el 62%. La tasa de pérdidas por préstamos subió a 52 pbs pero se mantuvo dentro del rango objetivo de 50-60 pbs.
Resumen Q2-25: ingresos £7.2 mil millones (+14%), beneficio antes de impuestos £2.5 mil millones (+28%), RoTE 12.3%; todas las divisiones entregaron retornos de dos dígitos.
Capital y liquidez: CET1 fortalecido al 14.0% (13.6% en dic-24); TNAV por acción aumentó a 384p; el ratio de cobertura de liquidez fue de 177.7% y el apalancamiento en Reino Unido al 5.0%.
Retornos para accionistas: La Junta declaró un dividendo interino de 3.0p y lanzó una recompra de acciones de £1 mil millones, llevando las distribuciones del primer semestre a £1.4 mil millones (+21% interanual).
Ejecución del plan a tres años: se lograron £17 mil millones de los £30 mil millones objetivo de crecimiento RWA en Reino Unido, se realizaron dos tercios de los ahorros brutos en costos de £2 mil millones; la guía para el FY25 (RoTE aprox. 11%, ratio coste-ingreso aprox. 61%, CET1 13-14%) permanece sin cambios.
Otros eventos: la venta de financiación al consumidor en Alemania añadió ~10 pbs al CET1; acuerdos FCA AML por £48 millones; la adquisición de Tesco Bank sigue apoyando ingresos y base de costos.
H1-25 실적: 바클레이즈는 149억 파운드의 수익(+12% 전년 대비)과 52억 파운드의 세전 이익(+23%)을 보고했습니다. 귀속 이익은 26% 증가한 35억 파운드로 EPS는 24.7펜스(18.6펜스)로 상승했습니다. RoTE는 11.1%에서 13.2%로 올랐으며, 비용 대비 수익 비율은 62%에서 58%로 개선되었습니다. 대출 손실률은 52bps로 소폭 상승했으나 목표 범위인 50-60bps 내에 머물렀습니다.
Q2-25 요약: 수익 72억 파운드(+14%), 세전 이익 25억 파운드(+28%), RoTE 12.3%; 모든 부문에서 두 자릿수 수익률 달성.
자본 및 유동성: CET1 비율은 14.0%(2024년 12월 13.6%)로 강화되었으며, 주당 TNAV는 384펜스로 증가했습니다. 유동성 커버리지 비율은 177.7%, 영국 레버리지는 5.0%였습니다.
주주 환원: 이사회는 3.0펜스의 중간 배당을 선언하고 10억 파운드 규모의 자사주 매입을 시작하여 상반기 배당금을 14억 파운드(+21% 전년 대비)로 늘렸습니다.
3개년 계획 실행: 목표인 300억 파운드 중 170억 파운드의 영국 RWA 성장 달성, 20억 파운드의 총 비용 절감 중 3분의 2 실현; FY25 가이던스(RoTE 약 11%, 비용 대비 수익 약 61%, CET1 13-14%)는 변함없음.
기타 이벤트: 독일 소비자 금융 매각으로 CET1에 약 10bps 기여; FCA AML 합의금 총 4800만 파운드; 테스코 은행 인수는 수익 및 비용 기반 지원 지속.
Résultats H1-25 : Barclays a déclaré un revenu de 14,9 milliards de livres (+12% en glissement annuel) et un bénéfice avant impôts de 5,2 milliards de livres (+23%). Le bénéfice attribuable a augmenté de 26% pour atteindre 3,5 milliards de livres, portant le BPA à 24,7p (18,6p). Le RoTE a atteint 13,2% contre 11,1%, tandis que le ratio coûts/revenus s'est amélioré à 58% contre 62%. Le taux de pertes sur prêts a légèrement augmenté à 52 points de base mais est resté dans la fourchette cible de 50-60 points de base.
Résumé T2-25 : revenus de 7,2 milliards de livres (+14%), BAI de 2,5 milliards de livres (+28%), RoTE de 12,3%; chaque division a généré des rendements à deux chiffres.
Capital et liquidité : CET1 renforcé à 14,0% (13,6% en déc. 24); TNAV par action augmenté à 384p; ratio de couverture de liquidité à 177,7% et levier UK à 5,0%.
Retour aux actionnaires : Le conseil d'administration a déclaré un dividende intérimaire de 3,0p et lancé un nouveau rachat d'actions de 1 milliard de livres, portant les distributions du premier semestre à 1,4 milliard de livres (+21% en glissement annuel).
Exécution du plan triennal : 17 milliards de livres de croissance RWA UK ciblée sur 30 milliards atteints, deux tiers des économies brutes de coûts de 2 milliards réalisées; les prévisions pour l'exercice 25 (RoTE env. 11%, ratio coûts/revenus env. 61%, CET1 13-14%) restent inchangées.
Autres événements : la vente du financement à la consommation allemand a ajouté environ 10 points de base au CET1; les règlements FCA AML totalisent 48 millions de livres; l'acquisition de Tesco Bank continue de soutenir les revenus et la base de coûts.
H1-25 Ergebnisse: Barclays meldete Einnahmen von £14,9 Mrd. (+12% im Jahresvergleich) und einen Gewinn vor Steuern von £5,2 Mrd. (+23%). Der auf Anteilseigner entfallende Gewinn stieg um 26% auf £3,5 Mrd., was das Ergebnis je Aktie auf 24,7p (18,6p) anhob. Die RoTE erreichte 13,2% gegenüber 11,1%, während die Cost-Income-Ratio sich von 62% auf 58% verbesserte. Die Kreditverlustquote stieg leicht auf 52 Basispunkte, blieb jedoch im Zielbereich von 50-60 Basispunkten.
Q2-25 Überblick: Einnahmen £7,2 Mrd. (+14%), Gewinn vor Steuern £2,5 Mrd. (+28%), RoTE 12,3%; alle Geschäftsbereiche erzielten zweistellige Renditen.
Kapital & Liquidität: CET1 stieg auf 14,0% (13,6% Dez-24); TNAV je Aktie stieg auf 384p; die Liquiditätsdeckungsquote lag bei 177,7% und die UK-Leverage bei 5,0%.
Aktionärsrenditen: Der Vorstand erklärte eine Zwischen Dividende von 3,0p und startete ein neues Aktienrückkaufprogramm im Umfang von £1 Mrd., womit die Ausschüttungen im ersten Halbjahr auf £1,4 Mrd. (+21% im Jahresvergleich) stiegen.
Umsetzung des Dreijahresplans: Von den angestrebten £30 Mrd. RWA-Wachstum in Großbritannien wurden £17 Mrd. erreicht, zwei Drittel der £2 Mrd. Bruttokosteneinsparungen realisiert; die FY25-Prognose (RoTE ca. 11%, Cost-Income ca. 61%, CET1 13-14%) bleibt unverändert.
Sonstige Ereignisse: Der Verkauf der deutschen Konsumfinanzierung steuerte ca. 10 Basispunkte zum CET1 bei; FCA AML-Vergleiche summieren sich auf £48 Mio.; die Übernahme der Tesco Bank unterstützt weiterhin Umsatz und Kostenbasis.
- Income and PBT up 12-23% YoY, demonstrating strong operating momentum
- RoTE improved to 13.2%, exceeding FY25 target of ~11% midway through year
- CET1 ratio 14.0%, giving room for a £1bn share buyback and 3.0p dividend
- Cost-income ratio fell to 58%; £350m savings achieved toward £500m FY goal
- All business units recorded double-digit RoTE, indicating balanced franchise strength
- Loan-loss rate rose to 52 bps vs 45 bps YoY, highlighting credit cost pressure
- Regulatory settlements with FCA total £48m for AML deficiencies
- Operating expenses up 5% YoY due to inflation, integration of Tesco Bank and staff grants
- US Consumer Bank RoTE remains low at 7.3% with high 523 bps loss rate
Insights
TL;DR — Solid beat on income & capital, enhanced buyback supports equity story.
Top-line growth of 12% and CET1 at 14% deliver positive operating leverage, allowing a 21% larger capital return package. All major divisions generated double-digit RoTE, underlining business mix resilience. Cost control is on track with £350m saved, and guidance is reiterated, giving credibility to the 2024-26 strategic plan. Upside stems from continued markets strength and rising structural hedge income. Risks are higher impairments (LLR 52 bps) and regulatory fines, but these look manageable relative to earnings power. Net: results are equity-positive.
TL;DR — Capital buffer widened; credit costs rising but still contained.
CET1 ratio rose 40 bps QoQ to 14.0%, comfortably above the 13-14% target even after reserving for the new buyback. Liquidity metrics (LCR 178%, NSFR 136%) remain robust. Impairments increased to £1.1bn, mainly Tesco Bank consolidation and US macro overlays; yet coverage stays flat at 1.2% and arrears trends are stable. FCA AML settlements (£48m) are modest. Overall credit profile supportive; outlook neutral-to-positive barring a sharp macro downturn.
Risultati H1-25: Barclays ha riportato un reddito di £14,9 miliardi (+12% su base annua) e un utile ante imposte di £5,2 miliardi (+23%). L'utile attribuibile è cresciuto del 26% a £3,5 miliardi, portando l'EPS a 24,7p (rispetto a 18,6p). Il RoTE ha raggiunto il 13,2% contro l'11,1%, mentre il rapporto costi/ricavi è migliorato al 58% dal 62%. Il tasso di perdite sui prestiti è salito a 52 bps ma è rimasto all'interno dell'intervallo obiettivo di 50-60 bps.
Riepilogo Q2-25: reddito £7,2 miliardi (+14%), utile ante imposte £2,5 miliardi (+28%), RoTE 12,3%; ogni divisione ha registrato ritorni a doppia cifra.
Capitale e liquidità: CET1 rafforzato al 14,0% (13,6% a dicembre 2024); TNAV per azione aumentato a 384p; il liquidity coverage ratio si è attestato al 177,7% e la leva finanziaria UK al 5,0%.
Rendimenti per gli azionisti: Il Consiglio ha dichiarato un dividendo intermedio di 3,0p e ha avviato un nuovo buyback da £1 miliardo, portando le distribuzioni del primo semestre a £1,4 miliardi (+21% su base annua).
Esecuzione del piano triennale: raggiunti £17 miliardi dei £30 miliardi target di crescita RWA UK, realizzati due terzi dei risparmi lordi sui costi di £2 miliardi; le previsioni per il FY25 (RoTE circa 11%, rapporto costi/ricavi circa 61%, CET1 13-14%) rimangono invariate.
Altri eventi: la vendita del finanziamento al consumo tedesco ha aggiunto circa 10 bps al CET1; le sanzioni FCA AML ammontano a £48 milioni; l'acquisizione di Tesco Bank continua a sostenere ricavi e base costi.
Resultados H1-25: Barclays reportó ingresos de £14.9 mil millones (+12% interanual) y beneficio antes de impuestos de £5.2 mil millones (+23%). El beneficio atribuible aumentó un 26% hasta £3.5 mil millones, elevando el BPA a 24.7p (18.6p). El RoTE alcanzó el 13.2% frente al 11.1%, mientras que la ratio coste-ingreso mejoró al 58% desde el 62%. La tasa de pérdidas por préstamos subió a 52 pbs pero se mantuvo dentro del rango objetivo de 50-60 pbs.
Resumen Q2-25: ingresos £7.2 mil millones (+14%), beneficio antes de impuestos £2.5 mil millones (+28%), RoTE 12.3%; todas las divisiones entregaron retornos de dos dígitos.
Capital y liquidez: CET1 fortalecido al 14.0% (13.6% en dic-24); TNAV por acción aumentó a 384p; el ratio de cobertura de liquidez fue de 177.7% y el apalancamiento en Reino Unido al 5.0%.
Retornos para accionistas: La Junta declaró un dividendo interino de 3.0p y lanzó una recompra de acciones de £1 mil millones, llevando las distribuciones del primer semestre a £1.4 mil millones (+21% interanual).
Ejecución del plan a tres años: se lograron £17 mil millones de los £30 mil millones objetivo de crecimiento RWA en Reino Unido, se realizaron dos tercios de los ahorros brutos en costos de £2 mil millones; la guía para el FY25 (RoTE aprox. 11%, ratio coste-ingreso aprox. 61%, CET1 13-14%) permanece sin cambios.
Otros eventos: la venta de financiación al consumidor en Alemania añadió ~10 pbs al CET1; acuerdos FCA AML por £48 millones; la adquisición de Tesco Bank sigue apoyando ingresos y base de costos.
H1-25 실적: 바클레이즈는 149억 파운드의 수익(+12% 전년 대비)과 52억 파운드의 세전 이익(+23%)을 보고했습니다. 귀속 이익은 26% 증가한 35억 파운드로 EPS는 24.7펜스(18.6펜스)로 상승했습니다. RoTE는 11.1%에서 13.2%로 올랐으며, 비용 대비 수익 비율은 62%에서 58%로 개선되었습니다. 대출 손실률은 52bps로 소폭 상승했으나 목표 범위인 50-60bps 내에 머물렀습니다.
Q2-25 요약: 수익 72억 파운드(+14%), 세전 이익 25억 파운드(+28%), RoTE 12.3%; 모든 부문에서 두 자릿수 수익률 달성.
자본 및 유동성: CET1 비율은 14.0%(2024년 12월 13.6%)로 강화되었으며, 주당 TNAV는 384펜스로 증가했습니다. 유동성 커버리지 비율은 177.7%, 영국 레버리지는 5.0%였습니다.
주주 환원: 이사회는 3.0펜스의 중간 배당을 선언하고 10억 파운드 규모의 자사주 매입을 시작하여 상반기 배당금을 14억 파운드(+21% 전년 대비)로 늘렸습니다.
3개년 계획 실행: 목표인 300억 파운드 중 170억 파운드의 영국 RWA 성장 달성, 20억 파운드의 총 비용 절감 중 3분의 2 실현; FY25 가이던스(RoTE 약 11%, 비용 대비 수익 약 61%, CET1 13-14%)는 변함없음.
기타 이벤트: 독일 소비자 금융 매각으로 CET1에 약 10bps 기여; FCA AML 합의금 총 4800만 파운드; 테스코 은행 인수는 수익 및 비용 기반 지원 지속.
Résultats H1-25 : Barclays a déclaré un revenu de 14,9 milliards de livres (+12% en glissement annuel) et un bénéfice avant impôts de 5,2 milliards de livres (+23%). Le bénéfice attribuable a augmenté de 26% pour atteindre 3,5 milliards de livres, portant le BPA à 24,7p (18,6p). Le RoTE a atteint 13,2% contre 11,1%, tandis que le ratio coûts/revenus s'est amélioré à 58% contre 62%. Le taux de pertes sur prêts a légèrement augmenté à 52 points de base mais est resté dans la fourchette cible de 50-60 points de base.
Résumé T2-25 : revenus de 7,2 milliards de livres (+14%), BAI de 2,5 milliards de livres (+28%), RoTE de 12,3%; chaque division a généré des rendements à deux chiffres.
Capital et liquidité : CET1 renforcé à 14,0% (13,6% en déc. 24); TNAV par action augmenté à 384p; ratio de couverture de liquidité à 177,7% et levier UK à 5,0%.
Retour aux actionnaires : Le conseil d'administration a déclaré un dividende intérimaire de 3,0p et lancé un nouveau rachat d'actions de 1 milliard de livres, portant les distributions du premier semestre à 1,4 milliard de livres (+21% en glissement annuel).
Exécution du plan triennal : 17 milliards de livres de croissance RWA UK ciblée sur 30 milliards atteints, deux tiers des économies brutes de coûts de 2 milliards réalisées; les prévisions pour l'exercice 25 (RoTE env. 11%, ratio coûts/revenus env. 61%, CET1 13-14%) restent inchangées.
Autres événements : la vente du financement à la consommation allemand a ajouté environ 10 points de base au CET1; les règlements FCA AML totalisent 48 millions de livres; l'acquisition de Tesco Bank continue de soutenir les revenus et la base de coûts.
H1-25 Ergebnisse: Barclays meldete Einnahmen von £14,9 Mrd. (+12% im Jahresvergleich) und einen Gewinn vor Steuern von £5,2 Mrd. (+23%). Der auf Anteilseigner entfallende Gewinn stieg um 26% auf £3,5 Mrd., was das Ergebnis je Aktie auf 24,7p (18,6p) anhob. Die RoTE erreichte 13,2% gegenüber 11,1%, während die Cost-Income-Ratio sich von 62% auf 58% verbesserte. Die Kreditverlustquote stieg leicht auf 52 Basispunkte, blieb jedoch im Zielbereich von 50-60 Basispunkten.
Q2-25 Überblick: Einnahmen £7,2 Mrd. (+14%), Gewinn vor Steuern £2,5 Mrd. (+28%), RoTE 12,3%; alle Geschäftsbereiche erzielten zweistellige Renditen.
Kapital & Liquidität: CET1 stieg auf 14,0% (13,6% Dez-24); TNAV je Aktie stieg auf 384p; die Liquiditätsdeckungsquote lag bei 177,7% und die UK-Leverage bei 5,0%.
Aktionärsrenditen: Der Vorstand erklärte eine Zwischen Dividende von 3,0p und startete ein neues Aktienrückkaufprogramm im Umfang von £1 Mrd., womit die Ausschüttungen im ersten Halbjahr auf £1,4 Mrd. (+21% im Jahresvergleich) stiegen.
Umsetzung des Dreijahresplans: Von den angestrebten £30 Mrd. RWA-Wachstum in Großbritannien wurden £17 Mrd. erreicht, zwei Drittel der £2 Mrd. Bruttokosteneinsparungen realisiert; die FY25-Prognose (RoTE ca. 11%, Cost-Income ca. 61%, CET1 13-14%) bleibt unverändert.
Sonstige Ereignisse: Der Verkauf der deutschen Konsumfinanzierung steuerte ca. 10 Basispunkte zum CET1 bei; FCA AML-Vergleiche summieren sich auf £48 Mio.; die Übernahme der Tesco Bank unterstützt weiterhin Umsatz und Kostenbasis.
|
BARCLAYS
PLC
|
|
(Registrant)
|
|
By: /s/
Garth Wright
--------------------------------
|
|
Garth
Wright
|
|
Assistant
Secretary
|
|
Results Announcement
|
Page
|
|
|
Notes
|
1
|
|
|
Performance Highlights
|
2
|
|
|
Group Finance Director’s Review
|
5
|
|
|
Results by Business
|
|
|
|
● Barclays UK
|
7
|
|
|
● Barclays UK
Corporate
|
10
|
|
|
● Barclays Private Bank and Wealth
Management
|
11
|
|
|
● Barclays Investment
Bank
|
12
|
|
|
● Barclays US Consumer
Bank
|
14
|
|
|
● Head Office
|
16
|
|
|
Quarterly Results Summary
|
17
|
|
|
Quarterly Results by Business
|
18
|
|
|
Performance Management
|
|
|
|
● Margins and
Balances
|
25
|
|
|
Risk Management
|
|
|
|
● Risk Management and Principal
Risks
|
27
|
|
|
● Credit Risk
|
28
|
|
|
● Market Risk
|
49
|
|
|
● Treasury and Capital
Risk
|
50
|
|
|
Statement of Directors' Responsibilities
|
60
|
|
|
Independent Review Report to Barclays PLC
|
61
|
|
|
Condensed Consolidated Financial Statements
|
63
|
|
|
Financial Statement Notes
|
69
|
|
|
Appendix: Non-IFRS Performance Measures
|
90
|
|
|
Shareholder Information
|
981
|
|
Income
|
Profit before tax
|
Attributable profit
|
Cost: income ratio
|
LLR
|
RoTE
|
EPS
|
TNAV per share
|
CET1 ratio
|
Total capital return
|
Q225
|
£7.2bn
|
£2.5bn
|
£1.7bn
|
59%
|
44bps
|
12.3%
|
11.7p
|
384p
|
14.0%
|
£1.4bn
|
H125
|
£14.9bn
|
£5.2bn
|
£3.5bn
|
58%
|
52bps
|
13.2%
|
24.7p
|
1
|
Represents RWAs from business growth across Barclays UK, Private
Bank and Wealth Management, and UK Corporate Bank, excludes the
effects of securitisations, model updates and other methodological
changes. Also excludes additional Operational Risk RWAs related to
organic growth.
|
2
|
Q224 included a £220m loss on sale of the performing Italian
retail mortgage portfolio and a £20m loss on disposal from the
German consumer finance business.
|
1
|
H124 included a £220m loss on sale of the performing Italian
retail mortgage portfolio and a £20m loss on disposal from the
German consumer finance business.
|
2
|
Our targets and guidance are based on management's current
expectations as to the macroeconomic environment and the business
and may be subject to change.
|
Barclays Group results
|
Half year ended
|
|
Three months ended
|
||||
|
30.06.25
|
30.06.24
|
|
|
30.06.25
|
30.06.24
|
|
|
£m
|
£m
|
% Change
|
|
£m
|
£m
|
% Change
|
Barclays
UK
|
4,193
|
3,713
|
13
|
|
2,119
|
1,887
|
12
|
Barclays
UK Corporate Bank
|
1,003
|
877
|
14
|
|
519
|
443
|
17
|
Barclays
Private Bank and Wealth Management
|
697
|
632
|
10
|
|
348
|
320
|
9
|
Barclays
Investment Bank
|
7,180
|
6,347
|
13
|
|
3,307
|
3,019
|
10
|
Barclays
US Consumer Bank
|
1,687
|
1,678
|
1
|
|
823
|
819
|
—
|
Head
Office
|
136
|
30
|
|
|
71
|
(164)
|
|
Total income
|
14,896
|
13,277
|
12
|
|
7,187
|
6,324
|
14
|
Operating costs
|
(8,407)
|
(7,997)
|
(5)
|
|
(4,149)
|
(3,999)
|
(4)
|
UK regulatory levies
|
(96)
|
(120)
|
20
|
|
—
|
—
|
—
|
Litigation and conduct
|
(87)
|
(64)
|
(36)
|
|
(76)
|
(7)
|
|
Total operating expenses
|
(8,590)
|
(8,181)
|
(5)
|
|
(4,225)
|
(4,006)
|
(5)
|
Other net income/(expenses)
|
9
|
16
|
(44)
|
|
(9)
|
4
|
|
Profit before impairment
|
6,315
|
5,112
|
24
|
|
2,953
|
2,322
|
27
|
Credit impairment charges
|
(1,112)
|
(897)
|
(24)
|
|
(469)
|
(384)
|
(22)
|
Profit before tax
|
5,203
|
4,215
|
23
|
|
2,484
|
1,938
|
28
|
Tax charge
|
(1,173)
|
(892)
|
(32)
|
|
(552)
|
(427)
|
(29)
|
Profit after tax
|
4,030
|
3,323
|
21
|
|
1,932
|
1,511
|
28
|
Non-controlling interests
|
(23)
|
(26)
|
12
|
|
(21)
|
(23)
|
9
|
Other equity instrument holders
|
(484)
|
(510)
|
5
|
|
(252)
|
(251)
|
—
|
Attributable profit
|
3,523
|
2,787
|
26
|
|
1,659
|
1,237
|
34
|
|
|
|
|
|
|
|
|
Performance measures
|
|
|
|
|
|
|
|
Return on average tangible shareholders' equity
|
13.2%
|
11.1%
|
|
|
12.3%
|
9.9%
|
|
Average tangible shareholders' equity (£bn)
|
53.5
|
50.1
|
|
|
53.9
|
49.8
|
|
Cost: income ratio
|
58%
|
62%
|
|
|
59%
|
63%
|
|
Loan loss rate (bps)
|
52
|
45
|
|
|
44
|
38
|
|
Basic earnings per ordinary share
|
24.7p
|
18.6p
|
|
|
11.7p
|
8.3p
|
|
Dividend per share
|
3.0p
|
2.9p
|
3
|
|
|
|
|
Share buybacks announced (£m)
|
1,000
|
750
|
33
|
|
|
|
|
Total payout equivalent per share
|
c.10.1p
|
c.8.0p
|
26
|
|
|
|
|
Basic weighted average number of shares (m)
|
14,262
|
14,972
|
(5)
|
|
14,211
|
14,915
|
(5)
|
Period end number of shares (m)
|
14,180
|
14,826
|
(4)
|
|
|
|
|
Period end tangible shareholders' equity (£bn)
|
54.5
|
50.4
|
|
|
|
|
|
|
As at 30.06.25
|
As at 31.12.24
|
As at 30.06.24
|
Balance sheet and capital management1
|
£bn
|
£bn
|
£bn
|
Loans and advances at amortised cost
|
417.8
|
414.5
|
399.5
|
Loans and advances at amortised cost impairment coverage
ratio
|
1.2%
|
1.2%
|
1.4%
|
Total assets
|
1,598.7
|
1,518.2
|
1,576.6
|
Deposits at amortised cost
|
564.5
|
560.7
|
557.5
|
Tangible net asset value per share
|
384p
|
357p
|
340p
|
Common equity tier 1 ratio
|
14.0%
|
13.6%
|
13.6%
|
Common equity tier 1 capital
|
49.5
|
48.6
|
47.7
|
Risk weighted assets
|
353.0
|
358.1
|
351.4
|
UK leverage ratio
|
5.0%
|
5.0%
|
5.0%
|
UK leverage exposure
|
1,259.8
|
1,206.5
|
1,222.7
|
|
|
|
|
Funding and liquidity
|
|
|
|
Group liquidity pool (£bn)
|
333.7
|
296.9
|
328.7
|
Liquidity
coverage ratio2
|
177.7%
|
172.4%
|
167.0%
|
Net
stable funding ratio3
|
135.6%
|
134.9%
|
136.4%
|
Loan: deposit ratio
|
74%
|
74%
|
72%
|
1
|
Refer to pages 55 to 59 for further information on how capital,
RWAs and leverage are calculated.
|
2
|
Represents average of the last 12 spot month end ratios. From June
2025, Barclays is prospectively implementing a new methodology for
calculating net stress outflows related to secured financing
transactions in the liquidity coverage ratio (LCR), see page 50 for
additional information.
|
3
|
Represents average of the last four spot quarter end
positions.
|
1
|
Represents average of the last 12 spot month end ratios. From June
2025, Barclays is prospectively implementing a new methodology for
calculating net stress outflows related to secured financing
transactions in the liquidity coverage ratio, see page 50 for
additional information
|
2
|
Represents average of the last four spot quarter end
ratios.
|
Barclays UK
|
Half year ended
|
|
Three months ended
|
||||
|
30.06.25
|
30.06.24
|
|
|
30.06.25
|
30.06.24
|
|
Income statement information
|
£m
|
£m
|
% Change
|
|
£m
|
£m
|
% Change
|
Net interest income
|
3,677
|
3,146
|
17
|
|
1,855
|
1,597
|
16
|
Net fee, commission and other income
|
516
|
567
|
(9)
|
|
264
|
290
|
(9)
|
Total income
|
4,193
|
3,713
|
13
|
|
2,119
|
1,887
|
12
|
Operating costs
|
(2,283)
|
(2,048)
|
(11)
|
|
(1,168)
|
(1,041)
|
(12)
|
UK regulatory levies
|
(43)
|
(54)
|
20
|
|
—
|
—
|
|
Litigation and conduct
|
(29)
|
(6)
|
|
|
(27)
|
(4)
|
|
Total operating expenses
|
(2,355)
|
(2,108)
|
(12)
|
|
(1,195)
|
(1,045)
|
(14)
|
Other net income
|
—
|
—
|
|
|
—
|
—
|
#DIV/0!
|
Profit before impairment
|
1,838
|
1,605
|
15
|
|
924
|
842
|
10
|
Credit impairment charges
|
(237)
|
(66)
|
|
|
(79)
|
(8)
|
|
Profit before tax
|
1,601
|
1,539
|
4
|
|
845
|
834
|
1
|
Attributable profit
|
1,090
|
1,063
|
3
|
|
580
|
584
|
(1)
|
|
|
|
|
|
|
|
|
Performance measures
|
|
|
|
|
|
|
|
Return on average allocated tangible equity
|
18.6%
|
20.4%
|
|
|
19.7%
|
22.3%
|
|
Average allocated tangible equity (£bn)
|
11.7
|
10.4
|
|
|
11.8
|
10.5
|
|
Cost: income ratio
|
56%
|
57%
|
|
|
56%
|
55%
|
|
Loan loss rate (bps)
|
21
|
6
|
|
|
14
|
1
|
|
Net interest margin
|
3.55%
|
3.15%
|
|
|
3.55%
|
3.22%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Key facts
|
As at 30.06.25
|
As at 30.06.24
|
|
|
|
|
|
UK mortgage balances (£bn)
|
166.8
|
161.1
|
|
|
|
|
|
Mortgage gross lending flow (£bn)
|
15.4
|
9.2
|
|
|
|
|
|
Average
LTV of mortgage portfolio1
|
54%
|
53%
|
|
|
|
|
|
Average
LTV of new mortgage lending1
|
70%
|
63%
|
|
|
|
|
|
Number of branches
|
207
|
228
|
|
|
|
|
|
Digitally
active customers (m)2
|
13.7
|
13.2
|
|
|
|
|
|
30 day arrears rate - total UK cards
|
0.7%
|
0.8%
|
|
|
|
|
|
90 day arrears rate - total UK cards
|
0.2%
|
0.2%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As at 30.06.25
|
As at 31.12.24
|
As at 30.06.24
|
|
|
|
|
Balance sheet information
|
£bn
|
£bn
|
£bn
|
|
|
|
|
Loans and advances to customers at amortised cost
|
211.2
|
207.7
|
198.7
|
|
|
|
|
Total assets
|
299.7
|
299.8
|
293.0
|
|
|
|
|
Customer deposits at amortised cost
|
241.3
|
244.2
|
236.8
|
|
|
|
|
Loan: deposit ratio
|
94%
|
92%
|
91%
|
|
|
|
|
Risk weighted assets
|
86.1
|
84.5
|
76.5
|
|
|
|
|
Period end allocated tangible equity
|
11.8
|
11.6
|
10.6
|
|
|
|
|
1
|
Average loan to value (LTV) of mortgages is balance weighted and
reflects both residential and buy-to-let (BTL) mortgage portfolios
within the Home Loans portfolio.
|
2
|
Mobile active customers has been replaced by digitally active
customers as a more complete reflection of digital adoption by
Barclays UK customers. Excludes Tesco Bank.
|
Analysis of Barclays UK
|
Half year ended
|
|
Three months ended
|
||||
30.06.25
|
30.06.24
|
|
|
30.06.25
|
30.06.24
|
|
|
Analysis of total income
|
£m
|
£m
|
% Change
|
|
£m
|
£m
|
% Change
|
Personal
Banking
|
2,729
|
2,302
|
19
|
|
1,381
|
1,174
|
18
|
Barclaycard
Consumer UK
|
443
|
457
|
(3)
|
|
218
|
228
|
(4)
|
Retail
Banking1
|
3,172
|
2,759
|
15
|
|
1,599
|
1,402
|
14
|
Business Banking
|
1,021
|
954
|
7
|
|
520
|
485
|
7
|
Total income
|
4,193
|
3,713
|
13
|
|
2,119
|
1,887
|
12
|
|
|
|
|
|
|
|
|
Analysis of credit impairment charges
|
|
|
|
|
|
|
|
Personal
Banking
|
(162)
|
(40)
|
|
|
(55)
|
(26)
|
|
Barclaycard
Consumer UK
|
(42)
|
(63)
|
33
|
|
(4)
|
(25)
|
84
|
Retail
Banking1
|
(204)
|
(103)
|
(98)
|
|
(59)
|
(51)
|
(16)
|
Business Banking
|
(33)
|
37
|
|
|
(20)
|
43
|
|
Total credit impairment charges
|
(237)
|
(66)
|
|
|
(79)
|
(8)
|
|
|
|
|
|
|
|
|
|
|
As at 30.06.25
|
As at 31.12.24
|
As at 30.06.24
|
|
|
|
|
Analysis of loans and advances to customers at amortised
cost
|
£bn
|
£bn
|
£bn
|
|
|
|
|
Personal
Banking
|
180.7
|
177.0
|
167.3
|
|
|
|
|
Barclaycard
Consumer UK
|
11.7
|
11.0
|
10.2
|
|
|
|
|
Retail
Banking1
|
192.4
|
188.0
|
177.5
|
|
|
|
|
Business Banking
|
18.8
|
19.7
|
21.2
|
|
|
|
|
Total loans and advances to customers at amortised
cost
|
211.2
|
207.7
|
198.7
|
|
|
|
|
|
|
|
|
|
|
|
|
Analysis of customer deposits at amortised cost
|
|
|
|
|
|
|
|
Personal
Banking
|
189.3
|
191.4
|
183.3
|
|
|
|
|
Barclaycard
Consumer UK
|
—
|
—
|
—
|
|
|
|
|
Retail
Banking1
|
189.3
|
191.4
|
183.3
|
|
|
|
|
Business Banking
|
52.0
|
52.8
|
53.5
|
|
|
|
|
Total customer deposits at amortised cost
|
241.3
|
244.2
|
236.8
|
|
|
|
|
1
|
Following the completion of the acquisition on 1 November 2024,
Tesco Bank is reported in Retail Banking.
|
Barclays UK Corporate Bank
|
Half year ended
|
|
Three months ended
|
||||
|
30.06.25
|
30.06.24
|
|
|
30.06.25
|
30.06.24
|
|
Income statement information
|
£m
|
£m
|
% Change
|
|
£m
|
£m
|
% Change
|
Net interest income
|
701
|
573
|
22
|
|
359
|
296
|
21
|
Net fee, commission, trading and other income
|
302
|
304
|
(1)
|
|
160
|
147
|
9
|
Total income
|
1,003
|
877
|
14
|
|
519
|
443
|
17
|
Operating costs
|
(474)
|
(456)
|
(4)
|
|
(240)
|
(235)
|
(2)
|
UK regulatory levies
|
(24)
|
(30)
|
20
|
|
—
|
—
|
|
Litigation and conduct
|
(39)
|
—
|
|
|
(39)
|
—
|
|
Total operating expenses
|
(537)
|
(486)
|
(10)
|
|
(279)
|
(235)
|
(19)
|
Other net income
|
—
|
—
|
|
|
—
|
—
|
#DIV/0!
|
Profit before impairment
|
466
|
391
|
19
|
|
240
|
208
|
15
|
Credit impairment charges
|
(31)
|
(23)
|
(35)
|
|
(12)
|
(8)
|
(50)
|
Profit before tax
|
435
|
368
|
18
|
|
228
|
200
|
14
|
Attributable profit
|
284
|
248
|
15
|
|
142
|
135
|
5
|
|
|
|
|
|
|
|
|
Performance measures
|
|
|
|
|
|
|
|
Return on average allocated tangible equity
|
16.8%
|
16.6%
|
|
|
16.6%
|
18.0%
|
|
Average allocated tangible equity (£bn)
|
3.4
|
3.0
|
|
|
3.4
|
3.0
|
|
Cost: income ratio
|
54%
|
55%
|
|
|
54%
|
53%
|
|
Loan loss rate (bps)
|
22
|
18
|
|
|
17
|
12
|
|
|
|
|
|
|
|
|
|
|
As at 30.06.25
|
As at 31.12.24
|
As at 30.06.24
|
|
|
|
|
Balance sheet information
|
£bn
|
£bn
|
£bn
|
|
|
|
|
Loans and advances to customers at amortised cost
|
27.9
|
25.4
|
25.7
|
|
|
|
|
Deposits at amortised cost
|
85.3
|
83.1
|
84.9
|
|
|
|
|
Risk weighted assets
|
25.3
|
23.9
|
21.9
|
|
|
|
|
Period end allocated tangible equity
|
3.5
|
3.3
|
3.0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Half year ended
|
|
Three months ended
|
||||
|
30.06.25
|
30.06.24
|
|
|
30.06.25
|
30.06.24
|
|
Analysis of total income
|
£m
|
£m
|
% Change
|
|
£m
|
£m
|
% Change
|
Corporate lending
|
170
|
129
|
32
|
|
90
|
57
|
58
|
Transaction banking
|
833
|
748
|
11
|
|
429
|
386
|
11
|
Total income
|
1,003
|
877
|
14
|
|
519
|
443
|
17
|
Barclays Private Bank and Wealth Management
|
Half year ended
|
|
Three months ended
|
||||
|
30.06.25
|
30.06.24
|
|
|
30.06.25
|
30.06.24
|
|
Income statement information
|
£m
|
£m
|
% Change
|
|
£m
|
£m
|
% Change
|
Net interest income
|
407
|
362
|
12
|
|
203
|
187
|
9
|
Net fee, commission and other income
|
290
|
270
|
7
|
|
145
|
133
|
9
|
Total income
|
697
|
632
|
10
|
|
348
|
320
|
9
|
Operating costs
|
(472)
|
(434)
|
(9)
|
|
(238)
|
(220)
|
(8)
|
UK regulatory levies
|
(2)
|
(3)
|
33
|
|
—
|
—
|
|
Litigation and conduct
|
—
|
1
|
|
|
—
|
1
|
|
Total operating expenses
|
(474)
|
(436)
|
(9)
|
|
(238)
|
(219)
|
(9)
|
Other net income
|
—
|
—
|
#DIV/0!
|
`
|
—
|
—
|
#DIV/0!
|
Profit before impairment
|
223
|
196
|
14
|
|
110
|
101
|
9
|
Credit impairment releases
|
11
|
3
|
|
|
2
|
3
|
(33)
|
Profit before tax
|
234
|
199
|
18
|
|
112
|
104
|
8
|
Attributable profit
|
184
|
151
|
22
|
|
88
|
77
|
14
|
|
|
|
|
|
|
|
|
Performance measures
|
|
|
|
|
|
|
|
Return on average allocated tangible equity
|
33.2%
|
29.7%
|
|
|
31.9%
|
30.8%
|
|
Average allocated tangible equity (£bn)
|
1.1
|
1.0
|
|
|
1.1
|
1.0
|
|
Cost: income ratio
|
68%
|
69%
|
|
|
68%
|
68%
|
|
Loan loss rate (bps)
|
(15)
|
(4)
|
|
|
(5)
|
(9)
|
|
|
|
|
|
|
|
|
|
Key facts
|
£bn
|
£bn
|
|
|
£bn
|
£bn
|
|
Net new
assets under management1
|
1.9
|
1.7
|
|
|
0.9
|
1.5
|
|
|
|
|
|
|
|
|
|
|
As at 30.06.25
|
As at 31.12.24
|
As at 30.06.24
|
|
|
|
|
Balance sheet information
|
£bn
|
£bn
|
£bn
|
|
|
|
|
Loans and advances to customers at amortised cost
|
14.5
|
14.5
|
13.9
|
|
|
|
|
Deposits at amortised cost
|
66.7
|
69.5
|
64.6
|
|
|
|
|
Risk weighted assets
|
7.9
|
7.9
|
7.0
|
|
|
|
|
Period end allocated tangible equity
|
1.1
|
1.1
|
1.0
|
|
|
|
|
|
|
|
|
|
|
|
|
Invested
assets2
|
131.9
|
124.6
|
119.8
|
|
|
|
|
Clients
assets and liabilities3
|
213.4
|
208.9
|
198.5
|
|
|
|
|
1
|
Net new assets under management reflects the net inflows and
outflows of client balances within discretionary portfolio
management and advisory mandates. It excludes market performance
and foreign exchange translation, but includes reinvested dividend
payments.
|
2
|
Invested assets (held off-balance sheet) represent assets under
management and supervision. Uninvested cash held under an
investment mandate and reported within customer deposits is
excluded from invested assets.
|
3
|
Client assets and liabilities refers to customer deposits, lending
and invested assets.
|
Barclays Investment Bank
|
Half year ended
|
|
Three months ended
|
||||
|
30.06.25
|
30.06.24
|
|
|
30.06.25
|
30.06.24
|
|
Income statement information
|
£m
|
£m
|
% Change
|
|
£m
|
£m
|
% Change
|
Net interest income
|
631
|
465
|
36
|
|
334
|
268
|
25
|
Net trading income
|
4,322
|
3,467
|
25
|
|
1,906
|
1,485
|
28
|
Net fee, commission and other income
|
2,227
|
2,415
|
(8)
|
|
1,067
|
1,266
|
(16)
|
Total income
|
7,180
|
6,347
|
13
|
|
3,307
|
3,019
|
10
|
Operating costs
|
(3,993)
|
(3,858)
|
(3)
|
|
(1,932)
|
(1,900)
|
(2)
|
UK regulatory levies
|
(27)
|
(33)
|
18
|
|
—
|
—
|
|
Litigation and conduct
|
(11)
|
(11)
|
—
|
|
(8)
|
(3)
|
|
Total operating expenses
|
(4,031)
|
(3,902)
|
(3)
|
|
(1,940)
|
(1,903)
|
(2)
|
Other net income
|
—
|
—
|
#DIV/0!
|
|
—
|
—
|
#DIV/0!
|
Profit before impairment
|
3,149
|
2,445
|
29
|
|
1,367
|
1,116
|
22
|
Credit impairment charges
|
(139)
|
(34)
|
|
|
(67)
|
(44)
|
(52)
|
Profit before tax
|
3,010
|
2,411
|
25
|
|
1,300
|
1,072
|
21
|
Attributable profit
|
2,075
|
1,614
|
29
|
|
876
|
715
|
23
|
|
|
|
|
|
|
|
|
Performance measures
|
|
|
|
|
|
|
|
Return on average allocated tangible equity
|
14.2%
|
10.8%
|
|
|
12.2%
|
9.6%
|
|
Average allocated tangible equity (£bn)
|
29.2
|
30.0
|
|
|
28.7
|
29.9
|
|
Cost: income ratio
|
56%
|
61%
|
|
|
59%
|
63%
|
|
Loan loss rate (bps)
|
22
|
6
|
|
|
21
|
15
|
|
|
|
|
|
|
|
|
|
|
As at 30.06.25
|
As at 31.12.24
|
As at 30.06.24
|
|
|
|
|
Balance sheet information
|
£bn
|
£bn
|
£bn
|
|
|
|
|
Loans and advances to customers at amortised cost
|
66.8
|
69.7
|
66.6
|
|
|
|
|
Loans and advances to banks at amortised cost
|
7.1
|
6.8
|
6.6
|
|
|
|
|
Debt securities at amortised cost
|
52.4
|
47.9
|
41.7
|
|
|
|
|
Loans and advances at amortised cost
|
126.3
|
124.4
|
114.9
|
|
|
|
|
Trading portfolio assets
|
186.1
|
166.1
|
197.2
|
|
|
|
|
Derivative financial instrument assets
|
279.0
|
291.6
|
251.4
|
|
|
|
|
Financial assets at fair value through the income
statement
|
215.2
|
190.4
|
211.7
|
|
|
|
|
Cash collateral and settlement balances
|
145.0
|
111.1
|
139.8
|
|
|
|
|
|
|
|
|
|
|
|
|
Deposits at amortised cost
|
148.7
|
140.5
|
151.3
|
|
|
|
|
Derivative financial instrument liabilities
|
265.1
|
279.0
|
241.8
|
|
|
|
|
|
|
|
|
|
|
|
|
Risk weighted assets
|
196.4
|
198.8
|
203.3
|
|
|
|
|
Period end allocated tangible equity
|
28.7
|
29.3
|
29.7
|
|
|
|
|
|
Half year ended
|
|
Three months ended
|
||||
|
30.06.25
|
30.06.24
|
|
|
30.06.25
|
30.06.24
|
|
Analysis of total income
|
£m
|
£m
|
% Change
|
|
£m
|
£m
|
% Change
|
FICC
|
3,149
|
2,553
|
23
|
|
1,450
|
1,149
|
26
|
Equities
|
1,833
|
1,579
|
16
|
|
870
|
696
|
25
|
Global Markets
|
4,982
|
4,132
|
21
|
|
2,320
|
1,845
|
26
|
Advisory
|
266
|
286
|
(7)
|
|
123
|
138
|
(11)
|
Equity
capital markets
|
151
|
189
|
(20)
|
|
81
|
121
|
(33)
|
Debt
capital markets
|
795
|
821
|
(3)
|
|
364
|
420
|
(13)
|
Banking
fees and underwriting
|
1,212
|
1,296
|
(6)
|
|
568
|
679
|
(16)
|
Corporate
lending
|
152
|
129
|
18
|
|
(4)
|
87
|
|
Transaction
banking
|
834
|
790
|
6
|
|
423
|
408
|
4
|
International
Corporate Bank
|
986
|
919
|
7
|
|
419
|
495
|
(15)
|
Investment Banking
|
2,198
|
2,215
|
(1)
|
|
987
|
1,174
|
(16)
|
Total income
|
7,180
|
6,347
|
13
|
|
3,307
|
3,019
|
10
|
1
|
Data source: Dealogic as at 30 June 2025.
|
2
|
Q125 included c.£105m of fair value gains on leverage finance
lending. Q225 included c.£55m of fair value losses on
lending.
|
Barclays US Consumer Bank
|
Half year ended
|
|
Three months ended
|
||||
|
30.06.25
|
30.06.24
|
|
|
30.06.25
|
30.06.24
|
|
Income statement information
|
£m
|
£m
|
% Change
|
|
£m
|
£m
|
% Change
|
Net interest income
|
1,318
|
1,334
|
(1)
|
|
640
|
646
|
(1)
|
Net fee, commission and other income
|
369
|
344
|
7
|
|
183
|
173
|
6
|
Total income
|
1,687
|
1,678
|
1
|
|
823
|
819
|
—
|
Operating costs
|
(803)
|
(796)
|
(1)
|
|
(396)
|
(408)
|
3
|
UK regulatory levies
|
—
|
—
|
#DIV/0!
|
|
—
|
—
|
#DIV/0!
|
Litigation and conduct
|
(3)
|
(4)
|
25
|
|
—
|
(2)
|
|
Total operating expenses
|
(806)
|
(800)
|
(1)
|
|
(396)
|
(410)
|
3
|
Other net income
|
—
|
—
|
#DIV/0!
|
|
—
|
—
|
#DIV/0!
|
Profit before impairment
|
881
|
878
|
—
|
|
427
|
409
|
4
|
Credit impairment charges
|
(711)
|
(719)
|
1
|
|
(312)
|
(309)
|
(1)
|
Profit before tax
|
170
|
159
|
7
|
|
115
|
100
|
15
|
Attributable profit
|
128
|
119
|
8
|
|
87
|
75
|
16
|
|
|
|
|
|
|
|
|
Performance measures
|
|
|
|
|
|
|
|
Return on average allocated tangible equity
|
7.3%
|
7.2%
|
|
|
10.2%
|
9.2%
|
|
Average allocated tangible equity (£bn)
|
3.5
|
3.3
|
|
|
3.4
|
3.3
|
|
Cost: income ratio
|
48%
|
48%
|
|
|
48%
|
50%
|
|
Loan loss rate (bps)
|
523
|
509
|
|
|
456
|
438
|
|
Net interest margin
|
10.68%
|
10.78%
|
|
|
10.83%
|
10.43%
|
|
|
|
|
|
|
|
|
|
Key facts
|
|
|
|
|
|
|
|
US cards 30 day arrears rate
|
2.8%
|
2.9%
|
|
|
|
|
|
US cards 90 days arrears rate
|
1.6%
|
1.6%
|
|
|
|
|
|
US cards customer FICO score distribution
|
|
|
|
|
|
|
|
<660
|
12%
|
12%
|
|
|
|
|
|
>660
|
88%
|
88%
|
|
|
|
|
|
End net receivables (reported) ($bn)
|
32.9
|
31.2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As at 30.06.25
|
As at 31.12.24
|
As at 30.06.24
|
|
|
|
|
Balance sheet information
|
£bn
|
£bn
|
£bn
|
|
|
|
|
Loans and advances to customers at amortised cost
|
18.2
|
20.0
|
24.3
|
|
|
|
|
Deposits at amortised cost
|
22.5
|
23.3
|
20.0
|
|
|
|
|
Risk weighted assets
|
24.7
|
26.8
|
24.4
|
|
|
|
|
Period end allocated tangible equity
|
3.4
|
3.7
|
3.3
|
|
|
|
|
1
|
Including a co-branded cards portfolio classified as assets held
for sale.
|
Head Office
|
Half year ended
|
|
Three months ended
|
||||
|
30.06.25
|
30.06.24
|
|
|
30.06.25
|
30.06.24
|
|
Income statement information
|
£m
|
£m
|
% Change
|
|
£m
|
£m
|
% Change
|
Net interest income
|
288
|
248
|
16
|
|
114
|
62
|
84
|
Net fee, commission and other income
|
(152)
|
(218)
|
30
|
|
(43)
|
(226)
|
81
|
Total income
|
136
|
30
|
|
|
71
|
(164)
|
|
Operating costs
|
(382)
|
(406)
|
6
|
|
(175)
|
(195)
|
10
|
UK regulatory levies
|
—
|
—
|
|
|
—
|
—
|
#DIV/0!
|
Litigation and conduct
|
(5)
|
(43)
|
88
|
|
(2)
|
1
|
|
Total operating expenses
|
(387)
|
(449)
|
14
|
|
(177)
|
(194)
|
9
|
Other net income/(expenses)
|
9
|
16
|
(44)
|
|
(9)
|
4
|
|
Loss before impairment
|
(242)
|
(403)
|
40
|
|
(115)
|
(354)
|
68
|
Credit impairment charges
|
(5)
|
(58)
|
91
|
|
(1)
|
(18)
|
94
|
Loss before tax
|
(247)
|
(461)
|
46
|
|
(116)
|
(372)
|
69
|
Attributable loss
|
(238)
|
(408)
|
42
|
|
(114)
|
(349)
|
67
|
|
|
|
|
|
|
|
|
Performance measures
|
|
|
|
|
|
|
|
Average allocated tangible equity (£bn)
|
4.6
|
2.4
|
|
|
5.5
|
2.1
|
|
|
|
|
|
|
|
|
|
|
As at 30.06.25
|
As at 31.12.24
|
As at 30.06.24
|
|
|
|
|
Balance sheet information
|
£bn
|
£bn
|
£bn
|
|
|
|
|
Risk weighted assets
|
12.6
|
16.2
|
18.3
|
|
|
|
|
Period end allocated tangible equity
|
5.9
|
2.4
|
2.7
|
|
|
|
|
Barclays Group
|
|
|
|
|
|
|
|
|
|
|
|
Q225
|
Q125
|
|
Q424
|
Q324
|
Q224
|
Q124
|
|
Q423
|
Q323
|
Income statement information
|
£m
|
£m
|
|
£m
|
£m
|
£m
|
£m
|
|
£m
|
£m
|
Net interest income
|
3,505
|
3,517
|
|
3,500
|
3,308
|
3,056
|
3,072
|
|
3,139
|
3,247
|
Net fee, commission and other income
|
3,682
|
4,192
|
|
3,464
|
3,239
|
3,268
|
3,881
|
|
2,459
|
3,011
|
Total income
|
7,187
|
7,709
|
|
6,964
|
6,547
|
6,324
|
6,953
|
|
5,598
|
6,258
|
Operating costs
|
(4,149)
|
(4,258)
|
|
(4,244)
|
(3,954)
|
(3,999)
|
(3,998)
|
|
(4,735)
|
(3,949)
|
UK regulatory levies
|
—
|
(96)
|
|
(227)
|
27
|
—
|
(120)
|
|
(180)
|
—
|
Litigation and conduct
|
(76)
|
(11)
|
|
(121)
|
(35)
|
(7)
|
(57)
|
|
(5)
|
—
|
Total operating expenses
|
(4,225)
|
(4,365)
|
|
(4,592)
|
(3,962)
|
(4,006)
|
(4,175)
|
|
(4,920)
|
(3,949)
|
Other net (expenses)/income
|
(9)
|
18
|
|
—
|
21
|
4
|
12
|
|
(16)
|
9
|
Profit before impairment
|
2,953
|
3,362
|
|
2,372
|
2,606
|
2,322
|
2,790
|
|
662
|
2,318
|
Credit impairment charges
|
(469)
|
(643)
|
|
(711)
|
(374)
|
(384)
|
(513)
|
|
(552)
|
(433)
|
Profit before tax
|
2,484
|
2,719
|
|
1,661
|
2,232
|
1,938
|
2,277
|
|
110
|
1,885
|
Tax (charges)/credit
|
(552)
|
(621)
|
|
(448)
|
(412)
|
(427)
|
(465)
|
|
23
|
(343)
|
Profit after tax
|
1,932
|
2,098
|
|
1,213
|
1,820
|
1,511
|
1,812
|
|
133
|
1,542
|
Non-controlling interests
|
(21)
|
(2)
|
|
(20)
|
(3)
|
(23)
|
(3)
|
|
(25)
|
(9)
|
Other equity instrument holders
|
(252)
|
(232)
|
|
(228)
|
(253)
|
(251)
|
(259)
|
|
(219)
|
(259)
|
Attributable profit/(loss)
|
1,659
|
1,864
|
|
965
|
1,564
|
1,237
|
1,550
|
|
(111)
|
1,274
|
|
|
|
|
|
|
|
|
|
|
|
Performance measures
|
|
|
|
|
|
|
|
|
|
|
Return on average tangible shareholders' equity
|
12.3%
|
14.0%
|
|
7.5%
|
12.3%
|
9.9%
|
12.3%
|
|
(0.9)%
|
11.0%
|
Average tangible shareholders' equity (£bn)
|
53.9
|
53.1
|
|
51.5
|
51.0
|
49.8
|
50.5
|
|
48.9
|
46.5
|
Cost: income ratio
|
59%
|
57%
|
|
66%
|
61%
|
63%
|
60%
|
|
88%
|
63%
|
Loan loss rate (bps)
|
44
|
61
|
|
66
|
37
|
38
|
51
|
|
54
|
42
|
Basic earnings per ordinary share
|
11.7p
|
13.0p
|
|
6.7p
|
10.7p
|
8.3p
|
10.3p
|
|
(0.7)p
|
8.3p
|
Basic weighted average number of shares (m)
|
14,211
|
14,314
|
|
14,432
|
14,648
|
14,915
|
14,983
|
|
15,092
|
15,405
|
Period end number of shares (m)
|
14,180
|
14,336
|
|
14,420
|
14,571
|
14,826
|
15,091
|
|
15,155
|
15,239
|
Period end tangible shareholders' equity (£bn)
|
54.5
|
53.4
|
|
51.5
|
51.1
|
50.4
|
50.6
|
|
50.2
|
48.2
|
|
|
|
|
|
|
|
|
|
|
|
Balance sheet and capital
management1
|
£bn
|
£bn
|
|
£bn
|
£bn
|
£bn
|
£bn
|
|
£bn
|
£bn
|
Loans and advances to customers at amortised cost
|
339.2
|
338.6
|
|
337.9
|
326.5
|
329.8
|
332.1
|
|
333.3
|
339.6
|
Loans and advances to banks at amortised cost
|
8.7
|
9.4
|
|
8.3
|
8.1
|
8.0
|
8.5
|
|
9.5
|
11.5
|
Debt securities at amortised cost
|
69.9
|
71.4
|
|
68.2
|
64.6
|
61.7
|
57.4
|
|
56.7
|
54.3
|
Loans and advances at amortised cost
|
417.8
|
419.4
|
|
414.5
|
399.2
|
399.5
|
397.9
|
|
399.5
|
405.4
|
Loans and advances at amortised cost impairment coverage
ratio
|
1.2%
|
1.2%
|
|
1.2%
|
1.3%
|
1.4%
|
1.4%
|
|
1.4%
|
1.4%
|
Total assets
|
1,598.7
|
1,593.5
|
|
1,518.2
|
1,531.1
|
1,576.6
|
1,577.1
|
|
1,477.5
|
1,591.7
|
Deposits at amortised cost
|
564.5
|
574.3
|
|
560.7
|
542.8
|
557.5
|
552.3
|
|
538.8
|
561.3
|
Tangible net asset value per share
|
384p
|
372p
|
|
357p
|
351p
|
340p
|
335p
|
|
331p
|
316p
|
Common equity tier 1 ratio
|
14.0%
|
13.9%
|
|
13.6%
|
13.8%
|
13.6%
|
13.5%
|
|
13.8%
|
14.0%
|
Common equity tier 1 capital
|
49.5
|
48.8
|
|
48.6
|
47.0
|
47.7
|
47.1
|
|
47.3
|
48.0
|
Risk weighted assets
|
353.0
|
351.3
|
|
358.1
|
340.4
|
351.4
|
349.6
|
|
342.7
|
341.9
|
UK leverage ratio
|
5.0%
|
5.0%
|
|
5.0%
|
4.9%
|
5.0%
|
4.9%
|
|
5.2%
|
5.0%
|
UK leverage exposure
|
1,259.8
|
1,252.8
|
|
1,206.5
|
1,197.4
|
1,222.7
|
1,226.5
|
|
1,168.3
|
1,202.4
|
|
|
|
|
|
|
|
|
|
|
|
Funding and liquidity
|
|
|
|
|
|
|
|
|
|
|
Group liquidity pool (£bn)
|
333.7
|
336.3
|
|
296.9
|
311.7
|
328.7
|
323.5
|
|
298.1
|
335.0
|
Liquidity coverage ratio
|
177.7%
|
175.3%
|
|
172.4%
|
170.1%
|
167.0%
|
163.2%
|
|
161.4%
|
158.7%
|
Net stable funding ratio
|
135.6%
|
136.2%
|
|
134.9%
|
135.6%
|
136.4%
|
135.7%
|
|
138.0%
|
138.2%
|
Loan: deposit ratio
|
74%
|
73%
|
|
74%
|
74%
|
72%
|
72%
|
|
74%
|
72%
|
1
|
Refer to pages 55 to 59 for further information on how capital,
RWAs and leverage are calculated.
|
Barclays UK
|
|
|
|
|
|
|
|
|
|
|
|
Q225
|
Q125
|
|
Q4241
|
Q324
|
Q224
|
Q124
|
|
Q423
|
Q323
|
Income statement information
|
£m
|
£m
|
|
£m
|
£m
|
£m
|
£m
|
|
£m
|
£m
|
Net interest income
|
1,855
|
1,822
|
|
1,815
|
1,666
|
1,597
|
1,549
|
|
1,575
|
1,578
|
Net fee, commission and other income
|
264
|
252
|
|
800
|
280
|
290
|
277
|
|
217
|
295
|
Total income
|
2,119
|
2,074
|
|
2,615
|
1,946
|
1,887
|
1,826
|
|
1,792
|
1,873
|
Operating costs
|
(1,168)
|
(1,115)
|
|
(1,170)
|
(1,017)
|
(1,041)
|
(1,007)
|
|
(1,153)
|
(1,058)
|
UK regulatory levies
|
—
|
(43)
|
|
(36)
|
12
|
—
|
(54)
|
|
(30)
|
—
|
Litigation and conduct
|
(27)
|
(2)
|
|
(9)
|
(1)
|
(4)
|
(2)
|
|
(4)
|
9
|
Total operating expenses
|
(1,195)
|
(1,160)
|
|
(1,215)
|
(1,006)
|
(1,045)
|
(1,063)
|
|
(1,187)
|
(1,049)
|
Other net income
|
—
|
—
|
|
—
|
—
|
—
|
—
|
|
—
|
—
|
Profit before impairment
|
924
|
914
|
|
1,400
|
940
|
842
|
763
|
|
605
|
824
|
Credit impairment charges
|
(79)
|
(158)
|
|
(283)
|
(16)
|
(8)
|
(58)
|
|
(37)
|
(59)
|
Profit before tax
|
845
|
756
|
|
1,117
|
924
|
834
|
705
|
|
568
|
765
|
Attributable profit
|
580
|
510
|
|
781
|
621
|
584
|
479
|
|
382
|
531
|
|
|
|
|
|
|
|
|
|
|
|
Balance sheet information
|
£bn
|
£bn
|
|
£bn
|
£bn
|
£bn
|
£bn
|
|
£bn
|
£bn
|
Loans and advances to customers at amortised cost
|
211.2
|
209.6
|
|
207.7
|
199.3
|
198.7
|
200.8
|
|
202.8
|
204.9
|
Customer deposits at amortised cost
|
241.3
|
243.1
|
|
244.2
|
236.3
|
236.8
|
237.2
|
|
241.1
|
243.2
|
Loan: deposit ratio
|
94%
|
93%
|
|
92%
|
92%
|
91%
|
92%
|
|
92%
|
92%
|
Risk weighted assets
|
86.1
|
85.0
|
|
84.5
|
77.5
|
76.5
|
76.5
|
|
73.5
|
73.2
|
Period end allocated tangible equity
|
11.8
|
11.8
|
|
11.6
|
10.7
|
10.6
|
10.7
|
|
10.2
|
10.1
|
|
|
|
|
|
|
|
|
|
|
|
Performance measures
|
|
|
|
|
|
|
|
|
|
|
Return on average allocated tangible equity
|
19.7%
|
17.4%
|
|
28.0%
|
23.4%
|
22.3%
|
18.5%
|
|
14.9%
|
21.0%
|
Average allocated tangible equity (£bn)
|
11.8
|
11.7
|
|
11.2
|
10.6
|
10.5
|
10.4
|
|
10.2
|
10.1
|
Cost: income ratio
|
56%
|
56%
|
|
46%
|
52%
|
55%
|
58%
|
|
66%
|
56%
|
Loan loss rate (bps)
|
14
|
28
|
|
49
|
3
|
1
|
11
|
|
7
|
10
|
Net interest margin
|
3.55%
|
3.55%
|
|
3.53%
|
3.34%
|
3.22%
|
3.09%
|
|
3.07%
|
3.04%
|
|
|
|
|
|
|
|
|
|
|
|
1
|
Q424 includes the Day 1 impacts from the acquisition of Tesco Bank:
total Income includes a £556m gain, and credit impairment
charges includes a £209m charge.
|
Analysis of Barclays UK
|
Q225
|
Q125
|
|
Q424
|
Q324
|
Q224
|
Q124
|
|
Q423
|
Q323
|
Analysis of total income
|
£m
|
£m
|
|
£m
|
£m
|
£m
|
£m
|
|
£m
|
£m
|
Personal
Banking
|
1,381
|
1,348
|
|
1,847
|
1,184
|
1,174
|
1,128
|
|
1,067
|
1,165
|
Barclaycard
Consumer UK
|
218
|
225
|
|
231
|
249
|
228
|
229
|
|
242
|
238
|
Retail
Banking1
|
1,599
|
1,573
|
|
2,078
|
1,433
|
1,402
|
1,357
|
|
1,309
|
1,403
|
Business Banking
|
520
|
501
|
|
537
|
513
|
485
|
469
|
|
483
|
470
|
Total income
|
2,119
|
2,074
|
|
2,615
|
1,946
|
1,887
|
1,826
|
|
1,792
|
1,873
|
|
|
|
|
|
|
|
|
|
|
|
Analysis of credit impairment (charges)/releases
|
|
|
|
|
|
|
|
|
|
|
Personal
Banking
|
(55)
|
(107)
|
|
(244)
|
3
|
(26)
|
(14)
|
|
35
|
(85)
|
Barclaycard
Consumer UK
|
(4)
|
(38)
|
|
(35)
|
(15)
|
(25)
|
(38)
|
|
(73)
|
29
|
Retail
Banking1
|
(59)
|
(145)
|
|
(279)
|
(12)
|
(51)
|
(52)
|
|
(38)
|
(56)
|
Business Banking
|
(20)
|
(13)
|
|
(4)
|
(4)
|
43
|
(6)
|
|
1
|
(3)
|
Total credit impairment charges
|
(79)
|
(158)
|
|
(283)
|
(16)
|
(8)
|
(58)
|
|
(37)
|
(59)
|
|
|
|
|
|
|
|
|
|
|
|
Analysis of loans and advances to customers at amortised
cost
|
£bn
|
£bn
|
|
£bn
|
£bn
|
£bn
|
£bn
|
|
£bn
|
£bn
|
Personal
Banking
|
180.7
|
179.3
|
|
177.0
|
168.1
|
167.3
|
169.0
|
|
170.1
|
172.3
|
Barclaycard
Consumer UK
|
11.7
|
11.1
|
|
11.0
|
10.6
|
10.2
|
9.8
|
|
9.7
|
9.6
|
Retail
Banking1
|
192.4
|
190.4
|
|
188.0
|
178.7
|
177.5
|
178.8
|
|
179.8
|
181.9
|
Business Banking
|
18.8
|
19.2
|
|
19.7
|
20.6
|
21.2
|
22.0
|
|
23.0
|
23.0
|
Total loans and advances to customers at amortised
cost
|
211.2
|
209.6
|
|
207.7
|
199.3
|
198.7
|
200.8
|
|
202.8
|
204.9
|
|
|
|
|
|
|
|
|
|
|
|
Analysis of customer deposits at amortised cost
|
|
|
|
|
|
|
|
|
|
|
Personal
Banking
|
189.3
|
190.8
|
|
191.4
|
182.9
|
183.3
|
183.4
|
|
185.4
|
186.1
|
Barclaycard
Consumer UK
|
—
|
—
|
|
—
|
—
|
—
|
—
|
|
—
|
—
|
Retail
Banking1
|
189.3
|
190.8
|
|
191.4
|
182.9
|
183.3
|
183.4
|
|
185.4
|
186.1
|
Business Banking
|
52.0
|
52.3
|
|
52.8
|
53.4
|
53.5
|
53.8
|
|
55.7
|
57.1
|
Total customer deposits at amortised cost
|
241.3
|
243.1
|
|
244.2
|
236.3
|
236.8
|
237.2
|
|
241.1
|
243.2
|
Barclays UK Corporate Bank
|
|
|
|
|
|
|
|
|
|
|
|
Q225
|
Q125
|
|
Q424
|
Q324
|
Q224
|
Q124
|
|
Q423
|
Q323
|
Income statement information
|
£m
|
£m
|
|
£m
|
£m
|
£m
|
£m
|
|
£m
|
£m
|
Net interest income
|
359
|
342
|
|
324
|
309
|
296
|
277
|
|
247
|
304
|
Net fee, commission, trading and other income
|
160
|
142
|
|
134
|
136
|
147
|
157
|
|
148
|
136
|
Total income
|
519
|
484
|
|
458
|
445
|
443
|
434
|
|
395
|
440
|
Operating costs
|
(240)
|
(234)
|
|
(250)
|
(229)
|
(235)
|
(221)
|
|
(258)
|
(224)
|
UK regulatory levies
|
—
|
(24)
|
|
(14)
|
7
|
—
|
(30)
|
|
(8)
|
—
|
Litigation and conduct
|
(39)
|
—
|
|
(1)
|
—
|
—
|
—
|
|
(1)
|
2
|
Total operating expenses
|
(279)
|
(258)
|
|
(265)
|
(222)
|
(235)
|
(251)
|
|
(267)
|
(222)
|
Other net expenses
|
—
|
—
|
|
—
|
—
|
—
|
—
|
|
(5)
|
—
|
Profit before impairment
|
240
|
226
|
|
193
|
223
|
208
|
183
|
|
123
|
218
|
Credit impairment charges
|
(12)
|
(19)
|
|
(40)
|
(13)
|
(8)
|
(15)
|
|
(18)
|
(15)
|
Profit before tax
|
228
|
207
|
|
153
|
210
|
200
|
168
|
|
105
|
203
|
Attributable profit
|
142
|
142
|
|
98
|
144
|
135
|
113
|
|
59
|
129
|
|
|
|
|
|
|
|
|
|
|
|
Balance sheet information
|
£bn
|
£bn
|
|
£bn
|
£bn
|
£bn
|
£bn
|
|
£bn
|
£bn
|
Loans and advances to customers at amortised cost
|
27.9
|
26.7
|
|
25.4
|
24.8
|
25.7
|
25.7
|
|
26.4
|
26.9
|
Deposits at amortised cost
|
85.3
|
85.3
|
|
83.1
|
82.3
|
84.9
|
81.7
|
|
84.9
|
82.7
|
Risk weighted assets
|
25.3
|
24.2
|
|
23.9
|
22.1
|
21.9
|
21.4
|
|
20.9
|
19.5
|
Period end allocated tangible equity
|
3.5
|
3.4
|
|
3.3
|
3.0
|
3.0
|
3.0
|
|
3.0
|
2.8
|
|
|
|
|
|
|
|
|
|
|
|
Performance measures
|
|
|
|
|
|
|
|
|
|
|
Return on average allocated tangible equity
|
16.6%
|
17.1%
|
|
12.3%
|
18.8%
|
18.0%
|
15.2%
|
|
8.4%
|
18.3%
|
Average allocated tangible equity (£bn)
|
3.4
|
3.3
|
|
3.2
|
3.1
|
3.0
|
3.0
|
|
2.8
|
2.8
|
Cost: income ratio
|
54%
|
53%
|
|
58%
|
50%
|
53%
|
58%
|
|
68%
|
50%
|
Loan loss rate (bps)
|
17
|
28
|
|
62
|
21
|
12
|
23
|
|
27
|
21
|
|
|
|
|
|
|
|
|
|
|
|
Analysis of total income
|
£m
|
£m
|
|
£m
|
£m
|
£m
|
£m
|
|
£m
|
£m
|
Corporate lending
|
90
|
80
|
|
71
|
67
|
57
|
72
|
|
64
|
69
|
Transaction banking
|
429
|
404
|
|
387
|
378
|
386
|
362
|
|
331
|
371
|
Total income
|
519
|
484
|
|
458
|
445
|
443
|
434
|
|
395
|
440
|
Barclays Private Bank and Wealth Management
|
|
|
|
|
|
|
|
|
|
|
|
Q225
|
Q125
|
|
Q424
|
Q324
|
Q224
|
Q124
|
|
Q423
|
Q323
|
Income statement information
|
£m
|
£m
|
|
£m
|
£m
|
£m
|
£m
|
|
£m
|
£m
|
Net interest income
|
203
|
204
|
|
216
|
189
|
187
|
175
|
|
182
|
219
|
Net fee, commission and other income
|
145
|
145
|
|
135
|
137
|
133
|
137
|
|
131
|
118
|
Total income
|
348
|
349
|
|
351
|
326
|
320
|
312
|
|
313
|
337
|
Operating costs
|
(238)
|
(234)
|
|
(255)
|
(222)
|
(220)
|
(214)
|
|
(255)
|
(214)
|
UK regulatory levies
|
—
|
(2)
|
|
(7)
|
1
|
—
|
(3)
|
|
(4)
|
—
|
Litigation and conduct
|
—
|
—
|
|
(1)
|
—
|
1
|
—
|
|
2
|
—
|
Total operating expenses
|
(238)
|
(236)
|
|
(263)
|
(221)
|
(219)
|
(217)
|
|
(257)
|
(214)
|
Other net income
|
—
|
—
|
|
—
|
—
|
—
|
—
|
|
—
|
—
|
Profit before impairment
|
110
|
113
|
|
88
|
105
|
101
|
95
|
|
56
|
123
|
Credit impairment releases/(charges)
|
2
|
9
|
|
(2)
|
(7)
|
3
|
—
|
|
4
|
2
|
Profit before tax
|
112
|
122
|
|
86
|
98
|
104
|
95
|
|
60
|
125
|
Attributable profit
|
88
|
96
|
|
63
|
74
|
77
|
74
|
|
47
|
102
|
|
|
|
|
|
|
|
|
|
|
|
Balance sheet information
|
£bn
|
£bn
|
|
£bn
|
£bn
|
£bn
|
£bn
|
|
£bn
|
£bn
|
Loans and advances to customers at amortised cost
|
14.5
|
14.5
|
|
14.5
|
14.0
|
13.9
|
13.7
|
|
13.6
|
13.4
|
Deposits at amortised cost
|
66.7
|
73.1
|
|
69.5
|
64.8
|
64.6
|
61.9
|
|
60.3
|
59.7
|
Risk weighted assets
|
7.9
|
8.0
|
|
7.9
|
7.3
|
7.0
|
7.2
|
|
7.2
|
7.2
|
Period end allocated tangible equity
|
1.1
|
1.1
|
|
1.1
|
1.0
|
1.0
|
1.0
|
|
1.0
|
1.0
|
Client assets and liabilities1
|
213.4
|
212.4
|
|
208.9
|
201.5
|
198.5
|
189.1
|
|
182.9
|
178.7
|
|
|
|
|
|
|
|
|
|
|
|
Performance measures
|
|
|
|
|
|
|
|
|
|
|
Return on average allocated tangible equity
|
31.9%
|
34.5%
|
|
23.9%
|
29.0%
|
30.8%
|
28.7%
|
|
19.1%
|
41.2%
|
Average allocated tangible equity (£bn)
|
1.1
|
1.1
|
|
1.1
|
1.0
|
1.0
|
1.0
|
|
1.0
|
1.0
|
Cost: income ratio
|
68%
|
68%
|
|
75%
|
68%
|
68%
|
70%
|
|
82%
|
63%
|
Loan loss rate (bps)
|
(5)
|
(25)
|
|
5
|
19
|
(9)
|
—
|
|
(10)
|
(7)
|
1
|
Client assets and liabilities refers to customer deposits, lending
and invested assets.
|
Barclays Investment Bank
|
|
|
|
|
|
|
|
|
|
|
|
Q225
|
Q125
|
|
Q424
|
Q324
|
Q224
|
Q124
|
|
Q423
|
Q323
|
Income statement information
|
£m
|
£m
|
|
£m
|
£m
|
£m
|
£m
|
|
£m
|
£m
|
Net interest income
|
334
|
297
|
|
284
|
282
|
268
|
197
|
|
282
|
397
|
Net trading income
|
1,906
|
2,416
|
|
1,262
|
1,512
|
1,485
|
1,982
|
|
757
|
1,497
|
Net fee, commission and other income
|
1,067
|
1,160
|
|
1,061
|
1,057
|
1,266
|
1,149
|
|
998
|
792
|
Total income
|
3,307
|
3,873
|
|
2,607
|
2,851
|
3,019
|
3,328
|
|
2,037
|
2,686
|
Operating costs
|
(1,932)
|
(2,061)
|
|
(1,903)
|
(1,906)
|
(1,900)
|
(1,957)
|
|
(1,934)
|
(1,840)
|
UK regulatory levies
|
—
|
(27)
|
|
(161)
|
7
|
—
|
(33)
|
|
(123)
|
—
|
Litigation and conduct
|
(8)
|
(3)
|
|
(26)
|
(17)
|
(3)
|
(9)
|
|
(2)
|
6
|
Total operating expenses
|
(1,940)
|
(2,091)
|
|
(2,090)
|
(1,916)
|
(1,903)
|
(1,999)
|
|
(2,059)
|
(1,834)
|
Other net (expenses)/income
|
—
|
—
|
|
—
|
—
|
—
|
—
|
|
(1)
|
2
|
Profit/(loss) before impairment
|
1,367
|
1,782
|
|
517
|
935
|
1,116
|
1,329
|
|
(23)
|
854
|
Credit impairment (charges)/releases
|
(67)
|
(72)
|
|
(46)
|
(43)
|
(44)
|
10
|
|
(23)
|
23
|
Profit/(loss) before tax
|
1,300
|
1,710
|
|
471
|
892
|
1,072
|
1,339
|
|
(46)
|
877
|
Attributable profit/(loss)
|
876
|
1,199
|
|
247
|
652
|
715
|
899
|
|
(149)
|
580
|
|
|
|
|
|
|
|
|
|
|
|
Balance sheet information
|
£bn
|
£bn
|
|
£bn
|
£bn
|
£bn
|
£bn
|
|
£bn
|
£bn
|
Loans and advances to customers at amortised cost
|
66.8
|
68.6
|
|
69.7
|
64.5
|
66.6
|
64.6
|
|
62.7
|
62.3
|
Loans and advances to banks at amortised cost
|
7.1
|
7.4
|
|
6.8
|
6.7
|
6.6
|
7.6
|
|
7.3
|
9.5
|
Debt securities at amortised cost
|
52.4
|
53.1
|
|
47.9
|
44.8
|
41.7
|
40.4
|
|
38.9
|
36.3
|
Loans and advances at amortised cost
|
126.3
|
129.1
|
|
124.4
|
116.0
|
114.9
|
112.6
|
|
108.9
|
108.1
|
Trading portfolio assets
|
186.1
|
185.5
|
|
166.1
|
185.8
|
197.2
|
195.3
|
|
174.5
|
155.3
|
Derivative financial instrument assets
|
279.0
|
253.6
|
|
291.6
|
256.7
|
251.4
|
248.9
|
|
255.1
|
280.4
|
Financial assets at fair value through the income
statement
|
215.2
|
209.5
|
|
190.4
|
210.8
|
211.7
|
225.1
|
|
202.5
|
237.2
|
Cash collateral and settlement balances
|
145.0
|
148.8
|
|
111.1
|
134.7
|
139.8
|
129.8
|
|
102.3
|
134.6
|
|
|
|
|
|
|
|
|
|
|
|
Deposits at amortised cost
|
148.7
|
148.9
|
|
140.5
|
139.8
|
151.3
|
151.1
|
|
132.7
|
154.2
|
Derivative financial instrument liabilities
|
265.1
|
245.1
|
|
279.0
|
249.4
|
241.8
|
241.5
|
|
249.7
|
268.3
|
|
|
|
|
|
|
|
|
|
|
|
Risk weighted assets
|
196.4
|
195.9
|
|
198.8
|
194.2
|
203.3
|
200.4
|
|
197.3
|
201.1
|
Period end allocated tangible equity
|
28.7
|
28.9
|
|
29.3
|
28.4
|
29.7
|
29.6
|
|
29.0
|
29.0
|
|
|
|
|
|
|
|
|
|
|
|
Performance measures
|
|
|
|
|
|
|
|
|
|
|
Return on average allocated tangible equity
|
12.2%
|
16.2 %
|
|
3.4 %
|
8.8 %
|
9.6%
|
12.0 %
|
|
(2.1)%
|
8.0%
|
Average allocated tangible equity (£bn)
|
28.7
|
29.6
|
|
29.3
|
29.5
|
29.9
|
30.0
|
|
28.9
|
28.8
|
Cost: income ratio
|
59%
|
54%
|
|
80%
|
67%
|
63%
|
60%
|
|
101%
|
68%
|
Loan loss rate (bps)
|
21
|
23
|
|
15
|
15
|
15
|
(4)
|
|
8
|
(8)
|
|
|
|
|
|
|
|
|
|
|
|
Analysis of total income
|
£m
|
£m
|
|
£m
|
£m
|
£m
|
£m
|
|
£m
|
£m
|
FICC
|
1,450
|
1,699
|
|
934
|
1,180
|
1,149
|
1,404
|
|
724
|
1,147
|
Equities
|
870
|
963
|
|
604
|
692
|
696
|
883
|
|
431
|
675
|
Global Markets
|
2,320
|
2,662
|
|
1,538
|
1,872
|
1,845
|
2,287
|
|
1,155
|
1,822
|
Advisory
|
123
|
143
|
|
189
|
186
|
138
|
148
|
|
171
|
80
|
Equity
capital markets
|
81
|
70
|
|
98
|
64
|
121
|
68
|
|
38
|
62
|
Debt
capital markets
|
364
|
431
|
|
327
|
344
|
420
|
401
|
|
301
|
233
|
Banking
Fees and Underwriting
|
568
|
644
|
|
614
|
594
|
679
|
617
|
|
510
|
375
|
Corporate
lending
|
(4)
|
156
|
|
45
|
(21)
|
87
|
42
|
|
(23)
|
103
|
Transaction
banking
|
423
|
411
|
|
410
|
406
|
408
|
382
|
|
395
|
386
|
International
Corporate Banking
|
419
|
567
|
|
455
|
385
|
495
|
424
|
|
372
|
489
|
Investment Banking
|
987
|
1,211
|
|
1,069
|
979
|
1,174
|
1,041
|
|
882
|
864
|
Total income
|
3,307
|
3,873
|
|
2,607
|
2,851
|
3,019
|
3,328
|
|
2,037
|
2,686
|
Barclays US Consumer Bank
|
|
|
|
|
|
|
|
|
|
|
|
Q225
|
Q125
|
|
Q424
|
Q324
|
Q224
|
Q124
|
|
Q423
|
Q323
|
Income statement information
|
£m
|
£m
|
|
£m
|
£m
|
£m
|
£m
|
|
£m
|
£m
|
Net interest income
|
640
|
678
|
|
678
|
647
|
646
|
688
|
|
686
|
662
|
Net fee, commission, trading and other income
|
183
|
186
|
|
179
|
144
|
173
|
171
|
|
180
|
147
|
Total income
|
823
|
864
|
|
857
|
791
|
819
|
859
|
|
866
|
809
|
Operating costs
|
(396)
|
(407)
|
|
(433)
|
(384)
|
(408)
|
(387)
|
|
(418)
|
(404)
|
UK regulatory levies
|
—
|
—
|
|
—
|
—
|
—
|
—
|
|
—
|
—
|
Litigation and conduct
|
—
|
(3)
|
|
—
|
(9)
|
(2)
|
(3)
|
|
(2)
|
—
|
Total operating expenses
|
(396)
|
(410)
|
|
(433)
|
(393)
|
(410)
|
(390)
|
|
(420)
|
(404)
|
Other net income
|
—
|
—
|
|
—
|
—
|
—
|
—
|
|
—
|
—
|
Profit before impairment
|
427
|
454
|
|
424
|
398
|
409
|
469
|
|
446
|
405
|
Credit impairment charges
|
(312)
|
(399)
|
|
(298)
|
(276)
|
(309)
|
(410)
|
|
(449)
|
(404)
|
Profit/(loss) before tax
|
115
|
55
|
|
126
|
122
|
100
|
59
|
|
(3)
|
1
|
Attributable profit/(loss)
|
87
|
41
|
|
94
|
89
|
75
|
44
|
|
(3)
|
3
|
|
|
|
|
|
|
|
|
|
|
|
Balance sheet information
|
£bn
|
£bn
|
|
£bn
|
£bn
|
£bn
|
£bn
|
|
£bn
|
£bn
|
Loans and advances to customers at amortised cost
|
18.2
|
18.8
|
|
20.0
|
23.2
|
24.3
|
23.6
|
|
24.2
|
24.3
|
Deposits at amortised cost
|
22.5
|
23.8
|
|
23.3
|
19.4
|
20.0
|
20.3
|
|
19.7
|
19.3
|
Risk weighted assets
|
24.7
|
25.6
|
|
26.8
|
23.2
|
24.4
|
23.9
|
|
24.8
|
24.1
|
Period end allocated tangible equity
|
3.4
|
3.5
|
|
3.7
|
3.2
|
3.3
|
3.3
|
|
3.4
|
3.3
|
|
|
|
|
|
|
|
|
|
|
|
Performance measures
|
|
|
|
|
|
|
|
|
|
|
Return on average allocated tangible equity
|
10.2%
|
4.5%
|
|
11.2%
|
10.9%
|
9.2%
|
5.3%
|
|
(0.3)%
|
0.4%
|
Average allocated tangible equity (£bn)
|
3.4
|
3.6
|
|
3.4
|
3.3
|
3.3
|
3.3
|
|
3.3
|
3.1
|
Cost: income ratio
|
48%
|
47%
|
|
51%
|
50%
|
50%
|
46%
|
|
48%
|
50%
|
Loan loss rate (bps)1
|
456
|
562
|
|
395
|
411
|
438
|
610
|
|
636
|
582
|
Net interest margin
|
10.83%
|
10.53%
|
|
10.66%
|
10.38%
|
10.43%
|
11.12%
|
|
10.88%
|
10.88%
|
1
|
LLR includes held for sale portfolios to remain consistent with the
treatment of impairment.
|
Head Office
|
|
|
|
|
|
|
|
|
|
|
|
Q225
|
Q125
|
|
Q424
|
Q324
|
Q224
|
Q124
|
|
Q423
|
Q323
|
Income statement information
|
£m
|
£m
|
|
£m
|
£m
|
£m
|
£m
|
|
£m
|
£m
|
Net interest income
|
114
|
174
|
|
183
|
215
|
62
|
186
|
|
167
|
87
|
Net fee, commission and other income
|
(43)
|
(109)
|
|
(107)
|
(27)
|
(226)
|
8
|
|
28
|
26
|
Total income
|
71
|
65
|
|
76
|
188
|
(164)
|
194
|
|
195
|
113
|
Operating costs
|
(175)
|
(207)
|
|
(233)
|
(197)
|
(195)
|
(211)
|
|
(717)
|
(210)
|
UK regulatory levies
|
—
|
—
|
|
(9)
|
—
|
—
|
—
|
|
(14)
|
—
|
Litigation and conduct
|
(2)
|
(3)
|
|
(84)
|
(7)
|
1
|
(44)
|
|
1
|
(16)
|
Total operating expenses
|
(177)
|
(210)
|
|
(326)
|
(204)
|
(194)
|
(255)
|
|
(730)
|
(226)
|
Other net (expenses)/income
|
(9)
|
18
|
|
—
|
21
|
4
|
12
|
|
(10)
|
7
|
(Loss)/profit before impairment
|
(115)
|
(127)
|
|
(250)
|
5
|
(354)
|
(49)
|
|
(545)
|
(106)
|
Credit impairment (charges)/releases
|
(1)
|
(4)
|
|
(42)
|
(19)
|
(18)
|
(40)
|
|
(29)
|
20
|
Loss before tax
|
(116)
|
(131)
|
|
(292)
|
(14)
|
(372)
|
(89)
|
|
(574)
|
(86)
|
Attributable loss
|
(114)
|
(124)
|
|
(318)
|
(16)
|
(349)
|
(59)
|
|
(447)
|
(71)
|
|
|
|
|
|
|
|
|
|
|
|
Balance sheet information
|
£bn
|
£bn
|
|
£bn
|
£bn
|
£bn
|
£bn
|
|
£bn
|
£bn
|
Risk weighted assets
|
12.6
|
12.7
|
|
16.2
|
16.1
|
18.3
|
20.2
|
|
19.0
|
16.8
|
Period end allocated tangible equity
|
5.9
|
4.7
|
|
2.4
|
4.9
|
2.7
|
3.0
|
|
3.6
|
2.0
|
|
|
|
|
|
|
|
|
|
|
|
Performance measures
|
|
|
|
|
|
|
|
|
|
|
Average allocated tangible equity (£bn)
|
5.5
|
3.8
|
|
3.4
|
3.5
|
2.1
|
2.8
|
|
2.7
|
0.7
|
Margins and balances
|
|
|
|
|
|
|
|
Half year ended 30.06.25
|
Half year ended 30.06.24
|
||||
|
Net interest income
|
Average customer assets
|
Net interest margin
|
Net interest income
|
Average customer assets
|
Net interest margin
|
|
£m
|
£m
|
%
|
£m
|
£m
|
%
|
Barclays UK
|
3,677
|
208,977
|
3.55
|
3,146
|
200,599
|
3.15
|
Barclays UK Corporate Bank
|
701
|
25,044
|
5.64
|
573
|
22,454
|
5.13
|
Barclays Private Bank and Wealth Management
|
407
|
14,701
|
5.58
|
362
|
13,762
|
5.29
|
Barclays US Consumer Bank1
|
1,318
|
24,897
|
10.68
|
1,334
|
24,890
|
10.78
|
Group excluding IB and Head
Office1
|
6,103
|
273,619
|
4.50
|
5,415
|
261,705
|
4.16
|
Barclays Investment Bank
|
631
|
|
|
465
|
|
|
Head Office
|
288
|
|
|
248
|
|
|
Barclays Group Net interest income
|
7,022
|
|
|
6,128
|
|
|
Quarterly analysis
|
|
|
|||
|
Q225
|
Q125
|
Q424
|
Q324
|
Q224
|
Net interest income
|
£m
|
£m
|
£m
|
£m
|
£m
|
Barclays UK
|
1,855
|
1,822
|
1,815
|
1,666
|
1,597
|
Barclays UK Corporate Bank
|
359
|
342
|
324
|
309
|
296
|
Barclays Private Bank and Wealth Management
|
203
|
204
|
216
|
189
|
187
|
Barclays US Consumer Bank
|
640
|
678
|
678
|
647
|
646
|
Group excluding IB and Head Office
|
3,057
|
3,046
|
3,033
|
2,811
|
2,726
|
|
|
|
|
|
|
Average customer assets
|
£m
|
£m
|
£m
|
£m
|
£m
|
Barclays UK
|
209,649
|
208,305
|
204,793
|
198,616
|
199,529
|
Barclays UK Corporate Bank
|
25,478
|
24,605
|
23,450
|
23,049
|
22,474
|
Barclays Private Bank and Wealth Management
|
14,729
|
14,674
|
14,381
|
14,061
|
13,931
|
Barclays US Consumer Bank1
|
23,713
|
26,106
|
25,314
|
24,798
|
24,899
|
Group excluding IB and Head Office
|
273,569
|
273,690
|
267,938
|
260,524
|
260,833
|
|
|
|
|
|
|
Net interest margin
|
%
|
%
|
%
|
%
|
%
|
Barclays UK
|
3.55
|
3.55
|
3.53
|
3.34
|
3.22
|
Barclays UK Corporate Bank
|
5.65
|
5.64
|
5.50
|
5.33
|
5.30
|
Barclays Private Bank and Wealth Management
|
5.53
|
5.64
|
5.98
|
5.35
|
5.40
|
Barclays US Consumer Bank
|
10.83
|
10.53
|
10.66
|
10.38
|
10.43
|
Group excluding IB and Head Office
|
4.48
|
4.51
|
4.50
|
4.29
|
4.20
|
1
|
Includes average customer asset balances classified as held for
sale.
|
|
Gross exposure
|
|
Impairment allowance
|
||||||||
|
Stage 1
|
Stage 2
|
Stage 3 excluding POCI
|
Stage 3 POCI
|
Total
|
|
Stage 1
|
Stage 2
|
Stage 3 excluding POCI
|
Stage 3 POCI
|
Total
|
As at 30.06.25
|
£m
|
£m
|
£m
|
£m
|
£m
|
|
£m
|
£m
|
£m
|
£m
|
£m
|
Retail mortgages
|
151,153
|
17,151
|
1,721
|
—
|
170,025
|
|
35
|
59
|
64
|
—
|
158
|
Retail credit cards
|
13,793
|
2,401
|
233
|
28
|
16,455
|
|
160
|
441
|
136
|
—
|
737
|
Retail other
|
10,001
|
1,433
|
272
|
14
|
11,720
|
|
99
|
151
|
182
|
—
|
432
|
Corporate loans1
|
53,565
|
7,247
|
1,723
|
—
|
62,535
|
|
135
|
215
|
418
|
—
|
768
|
Total UK
|
228,512
|
28,232
|
3,949
|
42
|
260,735
|
|
429
|
866
|
800
|
—
|
2,095
|
Retail mortgages
|
1,708
|
74
|
163
|
—
|
1,945
|
|
2
|
—
|
20
|
—
|
22
|
Retail credit cards
|
15,975
|
2,663
|
1,615
|
—
|
20,253
|
|
297
|
751
|
1,323
|
—
|
2,371
|
Retail other
|
2,244
|
167
|
130
|
—
|
2,541
|
|
4
|
2
|
17
|
—
|
23
|
Corporate loans
|
62,334
|
3,704
|
1,262
|
—
|
67,300
|
|
81
|
141
|
213
|
—
|
435
|
Total Rest of the World
|
82,261
|
6,608
|
3,170
|
—
|
92,039
|
|
384
|
894
|
1,573
|
—
|
2,851
|
Total loans and advances at amortised cost
|
310,773
|
34,840
|
7,119
|
42
|
352,774
|
|
813
|
1,760
|
2,373
|
—
|
4,946
|
Debt securities at amortised cost
|
69,252
|
708
|
—
|
—
|
69,960
|
|
12
|
12
|
—
|
—
|
24
|
Total loans and advances at amortised cost including debt
securities
|
380,025
|
35,548
|
7,119
|
42
|
422,734
|
|
825
|
1,772
|
2,373
|
—
|
4,970
|
Off-balance sheet loan commitments and financial guarantee
contracts2
|
398,675
|
17,054
|
943
|
5
|
416,677
|
|
164
|
239
|
22
|
—
|
425
|
Total3,4
|
778,700
|
52,602
|
8,062
|
47
|
839,411
|
|
989
|
2,011
|
2,395
|
—
|
5,395
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net exposure
|
|
Coverage ratio
|
||||||||
|
Stage 1
|
Stage 2
|
Stage 3 excluding POCI
|
Stage 3 POCI
|
Total
|
|
Stage 1
|
Stage 2
|
Stage 3 excluding POCI
|
Stage 3 POCI
|
Total
|
As at 30.06.25
|
£m
|
£m
|
£m
|
£m
|
£m
|
|
%
|
%
|
%
|
%
|
%
|
Retail mortgages
|
151,118
|
17,092
|
1,657
|
—
|
169,867
|
|
—
|
0.3
|
3.7
|
—
|
0.1
|
Retail credit cards
|
13,633
|
1,960
|
97
|
28
|
15,718
|
|
1.2
|
18.4
|
58.4
|
—
|
4.5
|
Retail other
|
9,902
|
1,282
|
90
|
14
|
11,288
|
|
1.0
|
10.5
|
66.9
|
—
|
3.7
|
Corporate loans1
|
53,430
|
7,032
|
1,305
|
—
|
61,767
|
|
0.3
|
3.0
|
24.3
|
—
|
1.2
|
Total UK
|
228,083
|
27,366
|
3,149
|
42
|
258,640
|
|
0.2
|
3.1
|
20.3
|
—
|
0.8
|
Retail mortgages
|
1,706
|
74
|
143
|
—
|
1,923
|
|
0.1
|
—
|
12.3
|
—
|
1.1
|
Retail credit cards
|
15,678
|
1,912
|
292
|
—
|
17,882
|
|
1.9
|
28.2
|
81.9
|
—
|
11.7
|
Retail other
|
2,240
|
165
|
113
|
—
|
2,518
|
|
0.2
|
1.2
|
13.1
|
—
|
0.9
|
Corporate loans
|
62,253
|
3,563
|
1,049
|
—
|
66,865
|
|
0.1
|
3.8
|
16.9
|
—
|
0.6
|
Total Rest of the World
|
81,877
|
5,714
|
1,597
|
—
|
89,188
|
|
0.5
|
13.5
|
49.6
|
—
|
3.1
|
Total loans and advances at amortised cost
|
309,960
|
33,080
|
4,746
|
42
|
347,828
|
|
0.3
|
5.1
|
33.3
|
—
|
1.4
|
Debt securities at amortised cost
|
69,240
|
696
|
—
|
—
|
69,936
|
|
—
|
1.7
|
—
|
—
|
—
|
Total loans and advances at amortised cost including debt
securities
|
379,200
|
33,776
|
4,746
|
42
|
417,764
|
|
0.2
|
5.0
|
33.3
|
—
|
1.2
|
Off-balance sheet loan commitments and financial guarantee
contracts2
|
398,511
|
16,815
|
921
|
5
|
416,252
|
|
—
|
1.4
|
2.3
|
—
|
0.1
|
Total3,4
|
777,711
|
50,591
|
5,667
|
47
|
834,016
|
|
0.1
|
3.8
|
29.7
|
—
|
0.6
|
1
|
Includes Business Banking, which has a gross exposure of
£12.7bn and an impairment allowance of £346m. This
comprises £61m impairment allowance on £8.8bn Stage 1
exposure, £62m on £2.8bn Stage 2 exposure and £223m
on £1.1bn Stage 3 exposure. Excluding this, total coverage for
corporate loans in UK is 0.8%.
|
2
|
Excludes loan commitments and financial guarantees of £18.8bn
carried at fair value.
|
3
|
Other financial assets subject to impairment excluded in the table
above include cash collateral and settlement balances, reverse
repurchase agreements and other similar secured lending, financial
assets at fair value through other comprehensive income and other
assets. These have a total gross exposure of £239.2bn and an
impairment allowance of £150m. This comprises £23m
impairment allowance on £238.2bn Stage 1 exposure, £4m on
£0.9bn Stage 2 exposure and £123m on £128m Stage 3
exposure.
|
4
|
The annualised loan loss rate is 52bps after applying the total
impairment charge of £1,112m.
|
|
Gross exposure
|
|
Impairment allowance
|
||||||||
|
Stage 1
|
Stage 2
|
Stage 3 excluding POCI
|
Stage 3 POCI
|
Total
|
|
Stage 1
|
Stage 2
|
Stage 3 excluding POCI
|
Stage 3 POCI
|
Total
|
As at 31.12.24
|
£m
|
£m
|
£m
|
£m
|
£m
|
|
£m
|
£m
|
£m
|
£m
|
£m
|
Retail mortgages
|
145,039
|
19,507
|
1,793
|
—
|
166,339
|
|
36
|
61
|
61
|
—
|
158
|
Retail credit cards
|
13,497
|
2,064
|
179
|
40
|
15,780
|
|
219
|
440
|
91
|
—
|
750
|
Retail other
|
10,606
|
1,218
|
257
|
17
|
12,098
|
|
135
|
110
|
138
|
—
|
383
|
Corporate loans1
|
52,284
|
7,266
|
2,171
|
—
|
61,721
|
|
133
|
196
|
420
|
—
|
749
|
Total UK
|
221,426
|
30,055
|
4,400
|
57
|
255,938
|
|
523
|
807
|
710
|
—
|
2,040
|
Retail mortgages
|
1,651
|
89
|
169
|
—
|
1,909
|
|
2
|
1
|
26
|
—
|
29
|
Retail credit cards
|
17,629
|
2,953
|
1,724
|
—
|
22,306
|
|
334
|
807
|
1,416
|
—
|
2,557
|
Retail other
|
1,844
|
155
|
121
|
—
|
2,120
|
|
3
|
1
|
23
|
—
|
27
|
Corporate loans
|
64,224
|
3,901
|
945
|
—
|
69,070
|
|
76
|
135
|
206
|
—
|
417
|
Total Rest of the World
|
85,348
|
7,098
|
2,959
|
—
|
95,405
|
|
415
|
944
|
1,671
|
—
|
3,030
|
Total loans and advances at amortised cost
|
306,774
|
37,153
|
7,359
|
57
|
351,343
|
|
938
|
1,751
|
2,381
|
—
|
5,070
|
Debt securities at amortised cost
|
64,988
|
3,245
|
—
|
—
|
68,233
|
|
12
|
11
|
—
|
—
|
23
|
Total loans and advances at amortised cost including debt
securities
|
371,762
|
40,398
|
7,359
|
57
|
419,576
|
|
950
|
1,762
|
2,381
|
—
|
5,093
|
Off-balance sheet loan commitments and financial guarantee
contracts2
|
412,255
|
18,728
|
1,168
|
6
|
432,157
|
|
164
|
250
|
25
|
—
|
439
|
Total3,4
|
784,017
|
59,126
|
8,527
|
63
|
851,733
|
|
1,114
|
2,012
|
2,406
|
—
|
5,532
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net exposure
|
|
Coverage ratio
|
||||||||
|
Stage 1
|
Stage 2
|
Stage 3 excluding POCI
|
Stage 3 POCI
|
Total
|
|
Stage 1
|
Stage 2
|
Stage 3 excluding POCI
|
Stage 3 POCI
|
Total
|
As at 31.12.24
|
£m
|
£m
|
£m
|
£m
|
£m
|
|
%
|
%
|
%
|
%
|
%
|
Retail mortgages
|
145,003
|
19,446
|
1,732
|
—
|
166,181
|
|
—
|
0.3
|
3.4
|
—
|
0.1
|
Retail credit cards
|
13,278
|
1,624
|
88
|
40
|
15,030
|
|
1.6
|
21.3
|
50.8
|
—
|
4.8
|
Retail other
|
10,471
|
1,108
|
119
|
17
|
11,715
|
|
1.3
|
9.0
|
53.7
|
—
|
3.2
|
Corporate loans1
|
52,151
|
7,070
|
1,751
|
—
|
60,972
|
|
0.3
|
2.7
|
19.3
|
—
|
1.2
|
Total UK
|
220,903
|
29,248
|
3,690
|
57
|
253,898
|
|
0.2
|
2.7
|
16.1
|
—
|
0.8
|
Retail mortgages
|
1,649
|
88
|
143
|
—
|
1,880
|
|
0.1
|
1.1
|
15.4
|
—
|
1.5
|
Retail credit cards
|
17,295
|
2,146
|
308
|
—
|
19,749
|
|
1.9
|
27.3
|
82.1
|
—
|
11.5
|
Retail other
|
1,841
|
154
|
98
|
—
|
2,093
|
|
0.2
|
0.6
|
19.0
|
—
|
1.3
|
Corporate loans
|
64,148
|
3,766
|
739
|
—
|
68,653
|
|
0.1
|
3.5
|
21.8
|
—
|
0.6
|
Total Rest of the World
|
84,933
|
6,154
|
1,288
|
—
|
92,375
|
|
0.5
|
13.3
|
56.5
|
—
|
3.2
|
Total loans and advances at amortised cost
|
305,836
|
35,402
|
4,978
|
57
|
346,273
|
|
0.3
|
4.7
|
32.4
|
—
|
1.4
|
Debt securities at amortised cost
|
64,976
|
3,234
|
—
|
—
|
68,210
|
|
—
|
0.3
|
—
|
—
|
—
|
Total loans and advances at amortised cost including debt
securities
|
370,812
|
38,636
|
4,978
|
57
|
414,483
|
|
0.3
|
4.4
|
32.4
|
—
|
1.2
|
Off-balance sheet loan commitments and financial guarantee
contracts2
|
412,091
|
18,478
|
1,143
|
6
|
431,718
|
|
—
|
1.3
|
2.1
|
—
|
0.1
|
Total3,4
|
782,903
|
57,114
|
6,121
|
63
|
846,201
|
|
0.1
|
3.4
|
28.2
|
—
|
0.6
|
1
|
Includes Business Banking, which has a gross exposure of
£13.1bn and an impairment allowance of £356m. This
comprises £60m impairment allowance on £8.9bn Stage 1
exposure, £60m on £2.8bn Stage 2 exposure and £236m
on £1.5bn Stage 3 exposure. Excluding this, total coverage for
corporate loans in UK is 0.8%.
|
2
|
Excludes loan commitments and financial guarantees of £16.3bn
carried at fair value and includes exposures relating to financial
assets classified as assets held for sale.
|
3
|
Other financial assets subject to impairment excluded in the table
above include cash collateral and settlement balances, reverse
repurchase agreements and other similar secured lending, financial
assets at fair value through other comprehensive income and other
assets. These have a total gross exposure of £204.2bn and an
impairment allowance of £156m. This comprises £19m
impairment allowance on £202.7bn Stage 1 exposure, £7m on
£1.3bn Stage 2 exposure and £130m on £139m Stage 3
exposure.
|
4
|
The annualised loan loss rate is 46bps after applying the total
impairment charge of £1,982m.
|
|
|
Stage 2
|
|
|
|
|||
As at 30.06.25
|
Stage 1
|
Not past due
|
<=30 days past due
|
>30 days past due
|
Total
|
Stage 3 excluding POCI
|
Stage 3 POCI
|
Total
|
Gross exposure
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
Retail mortgages
|
152,861
|
14,293
|
2,149
|
783
|
17,225
|
1,884
|
—
|
171,970
|
Retail credit cards
|
29,768
|
4,518
|
292
|
254
|
5,064
|
1,848
|
28
|
36,708
|
Retail other
|
12,245
|
1,337
|
187
|
76
|
1,600
|
402
|
14
|
14,261
|
Corporate loans
|
115,899
|
10,778
|
79
|
94
|
10,951
|
2,985
|
—
|
129,835
|
Total
|
310,773
|
30,926
|
2,707
|
1,207
|
34,840
|
7,119
|
42
|
352,774
|
|
|
|
|
|
|
|
|
|
Impairment allowance
|
|
|
|
|
|
|
|
|
Retail mortgages
|
37
|
29
|
17
|
13
|
59
|
84
|
—
|
180
|
Retail credit cards
|
457
|
940
|
111
|
141
|
1,192
|
1,459
|
—
|
3,108
|
Retail other
|
103
|
104
|
24
|
25
|
153
|
199
|
—
|
455
|
Corporate loans
|
216
|
343
|
5
|
8
|
356
|
631
|
—
|
1,203
|
Total
|
813
|
1,416
|
157
|
187
|
1,760
|
2,373
|
—
|
4,946
|
|
|
|
|
|
|
|
|
|
Net exposure
|
|
|
|
|
|
|
|
|
Retail mortgages
|
152,824
|
14,264
|
2,132
|
770
|
17,166
|
1,800
|
—
|
171,790
|
Retail credit cards
|
29,311
|
3,578
|
181
|
113
|
3,872
|
389
|
28
|
33,600
|
Retail other
|
12,142
|
1,233
|
163
|
51
|
1,447
|
203
|
14
|
13,806
|
Corporate loans
|
115,683
|
10,435
|
74
|
86
|
10,595
|
2,354
|
—
|
128,632
|
Total
|
309,960
|
29,510
|
2,550
|
1,020
|
33,080
|
4,746
|
42
|
347,828
|
|
|
|
|
|
|
|
|
|
Coverage ratio
|
%
|
%
|
%
|
%
|
%
|
%
|
%
|
%
|
Retail mortgages
|
—
|
0.2
|
0.8
|
1.7
|
0.3
|
4.5
|
—
|
0.1
|
Retail credit cards
|
1.5
|
20.8
|
38.0
|
55.5
|
23.5
|
79.0
|
—
|
8.5
|
Retail other
|
0.8
|
7.8
|
12.8
|
32.9
|
9.6
|
49.5
|
—
|
3.2
|
Corporate loans
|
0.2
|
3.2
|
6.3
|
8.5
|
3.3
|
21.1
|
—
|
0.9
|
Total
|
0.3
|
4.6
|
5.8
|
15.5
|
5.1
|
33.3
|
—
|
1.4
|
As at 31.12.24
|
|
|
|
|
|
|
|
|
Gross exposure
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
Retail mortgages
|
146,690
|
16,790
|
2,034
|
772
|
19,596
|
1,962
|
—
|
168,248
|
Retail credit cards
|
31,126
|
4,435
|
303
|
279
|
5,017
|
1,903
|
40
|
38,086
|
Retail other
|
12,450
|
1,056
|
211
|
106
|
1,373
|
378
|
17
|
14,218
|
Corporate loans
|
116,508
|
10,849
|
144
|
174
|
11,167
|
3,116
|
—
|
130,791
|
Total
|
306,774
|
33,130
|
2,692
|
1,331
|
37,153
|
7,359
|
57
|
351,343
|
|
|
|
|
|
|
|
|
|
Impairment allowance
|
|
|
|
|
|
|
|
|
Retail mortgages
|
38
|
42
|
13
|
7
|
62
|
87
|
—
|
187
|
Retail credit cards
|
553
|
959
|
122
|
166
|
1,247
|
1,507
|
—
|
3,307
|
Retail other
|
138
|
76
|
17
|
18
|
111
|
161
|
—
|
410
|
Corporate loans
|
209
|
316
|
7
|
8
|
331
|
626
|
—
|
1,166
|
Total
|
938
|
1,393
|
159
|
199
|
1,751
|
2,381
|
—
|
5,070
|
|
|
|
|
|
|
|
|
|
Net exposure
|
|
|
|
|
|
|
|
|
Retail mortgages
|
146,652
|
16,748
|
2,021
|
765
|
19,534
|
1,875
|
—
|
168,061
|
Retail credit cards
|
30,573
|
3,476
|
181
|
113
|
3,770
|
396
|
40
|
34,779
|
Retail other
|
12,312
|
980
|
194
|
88
|
1,262
|
217
|
17
|
13,808
|
Corporate loans
|
116,299
|
10,533
|
137
|
166
|
10,836
|
2,490
|
—
|
129,625
|
Total
|
305,836
|
31,737
|
2,533
|
1,132
|
35,402
|
4,978
|
57
|
346,273
|
|
|
|
|
|
|
|
|
|
Coverage ratio
|
%
|
%
|
%
|
%
|
%
|
%
|
%
|
%
|
Retail mortgages
|
—
|
0.3
|
0.6
|
0.9
|
0.3
|
4.4
|
—
|
0.1
|
Retail credit cards
|
1.8
|
21.6
|
40.3
|
59.5
|
24.9
|
79.2
|
—
|
8.7
|
Retail other
|
1.1
|
7.2
|
8.1
|
17.0
|
8.1
|
42.6
|
—
|
2.9
|
Corporate loans
|
0.2
|
2.9
|
4.9
|
4.6
|
3.0
|
20.1
|
—
|
0.9
|
Total
|
0.3
|
4.2
|
5.9
|
15.0
|
4.7
|
32.4
|
—
|
1.4
|
|
Stage 1
|
Stage 2
|
Stage 3 excluding POCI
|
Stage 3 POCI
|
Total
|
|||||
|
Gross exposure
|
ECL
|
Gross exposure
|
ECL
|
Gross exposure
|
ECL
|
Gross exposure
|
ECL
|
Gross exposure
|
ECL
|
Retail mortgages
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
As at 1 January 2025
|
146,690
|
38
|
19,596
|
62
|
1,962
|
87
|
—
|
—
|
168,248
|
187
|
Transfers from Stage 1 to Stage 2
|
(5,409)
|
(2)
|
5,409
|
2
|
—
|
—
|
—
|
—
|
—
|
—
|
Transfers from Stage 2 to Stage 1
|
6,592
|
21
|
(6,592)
|
(21)
|
—
|
—
|
—
|
—
|
—
|
—
|
Transfers to Stage 3
|
(153)
|
—
|
(255)
|
(4)
|
408
|
4
|
—
|
—
|
—
|
—
|
Transfers from Stage 3
|
79
|
2
|
155
|
1
|
(234)
|
(3)
|
—
|
—
|
—
|
—
|
Business activity in the period
|
15,180
|
6
|
385
|
2
|
26
|
—
|
—
|
—
|
15,591
|
8
|
Refinements to models used for calculation
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
Net drawdowns, repayments, net re-measurement and movement due to
exposure and risk parameter changes
|
(3,839)
|
(26)
|
(563)
|
21
|
(63)
|
23
|
—
|
—
|
(4,465)
|
18
|
Final repayments
|
(6,279)
|
(2)
|
(909)
|
(3)
|
(193)
|
(9)
|
—
|
—
|
(7,381)
|
(14)
|
Disposals1s
|
—
|
—
|
(1)
|
(1)
|
(9)
|
(5)
|
—
|
—
|
(10)
|
(6)
|
Write-offs
|
—
|
—
|
—
|
—
|
(13)
|
(13)
|
—
|
—
|
(13)
|
(13)
|
As at 30 June 2025
|
152,861
|
37
|
17,225
|
59
|
1,884
|
84
|
—
|
—
|
171,970
|
180
|
|
|
|
|
|
|
|
|
|
|
|
Retail credit cards
|
|
|
|
|
|
|
|
|
|
|
As at 1 January 2025
|
31,126
|
553
|
5,017
|
1,247
|
1,903
|
1,507
|
40
|
—
|
38,086
|
3,307
|
Transfers from Stage 1 to Stage 2
|
(2,065)
|
(59)
|
2,065
|
59
|
—
|
—
|
—
|
—
|
—
|
—
|
Transfers from Stage 2 to Stage 1
|
1,488
|
306
|
(1,488)
|
(306)
|
—
|
—
|
—
|
—
|
—
|
—
|
Transfers to Stage 3
|
(298)
|
(12)
|
(636)
|
(272)
|
934
|
284
|
—
|
—
|
—
|
—
|
Transfers from Stage 3
|
12
|
6
|
15
|
6
|
(27)
|
(12)
|
—
|
—
|
—
|
—
|
Business activity in the period
|
1,951
|
31
|
171
|
38
|
1
|
1
|
—
|
—
|
2,123
|
70
|
Refinements to models used for calculation2
|
—
|
14
|
—
|
(47)
|
—
|
1
|
—
|
—
|
—
|
(32)
|
Net drawdowns, repayments, net re-measurement and movement due to
exposure and risk parameter changes
|
(2,310)
|
(377)
|
(69)
|
469
|
(200)
|
385
|
(12)
|
—
|
(2,591)
|
477
|
Final repayments
|
(136)
|
(5)
|
(11)
|
(2)
|
(2)
|
(1)
|
—
|
—
|
(149)
|
(8)
|
Disposals1
|
—
|
—
|
—
|
—
|
(245)
|
(190)
|
—
|
—
|
(245)
|
(190)
|
Write-offs
|
—
|
—
|
—
|
—
|
(516)
|
(516)
|
—
|
—
|
(516)
|
(516)
|
As at 30 June 2025
|
29,768
|
457
|
5,064
|
1,192
|
1,848
|
1,459
|
28
|
—
|
36,708
|
3,108
|
1
|
The £10m of gross disposals reported within Retail mortgages
relate to sale of the Italian mortgage loans. The £245m of
gross disposals reported within Retail credit cards relate to debt
sales undertaken during the period.
|
2
|
Refinements to models used for calculation reported within Retail
credit cards include a £(32)m movement in the calculated ECL
for the US Cards portfolio. These reflect model enhancements made
during the period. Barclays continually reviews the output of
models to determine accuracy of the ECL calculation including
review of model monitoring, external benchmarking and experience of
model operation over an extended period of time. This helps to
ensure that the models used continue to reflect the risks inherent
across the businesses.
|
Loans and advances at amortised cost
|
|
|
|
|
|
|||||
|
Stage 1
|
Stage 2
|
Stage 3 excluding POCI
|
Stage 3 POCI
|
Total
|
|||||
|
Gross exposure
|
ECL
|
Gross exposure
|
ECL
|
Gross exposure
|
ECL
|
Gross exposure
|
ECL
|
Gross exposure
|
ECL
|
Retail other
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
As at 1 January 2025
|
12,450
|
138
|
1,373
|
111
|
378
|
161
|
17
|
—
|
14,218
|
410
|
Transfers from Stage 1 to Stage 2
|
(757)
|
(12)
|
757
|
12
|
—
|
—
|
—
|
—
|
—
|
—
|
Transfers from Stage 2 to Stage 1
|
309
|
20
|
(309)
|
(20)
|
—
|
—
|
—
|
—
|
—
|
—
|
Transfers to Stage 3
|
(85)
|
(1)
|
(84)
|
(22)
|
169
|
23
|
—
|
—
|
—
|
—
|
Transfers from Stage 3
|
23
|
1
|
3
|
2
|
(26)
|
(3)
|
—
|
—
|
—
|
—
|
Business activity in the period
|
2,969
|
23
|
180
|
19
|
11
|
4
|
—
|
—
|
3,160
|
46
|
Refinements to models used for calculation
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
Net drawdowns, repayments, net re-measurement and movement due to
exposure and risk parameter changes
|
(615)
|
(54)
|
(30)
|
54
|
67
|
98
|
(3)
|
—
|
(581)
|
98
|
Final repayments
|
(2,049)
|
(12)
|
(290)
|
(3)
|
(119)
|
(12)
|
—
|
—
|
(2,458)
|
(27)
|
Disposals1
|
—
|
—
|
—
|
—
|
(21)
|
(15)
|
—
|
—
|
(21)
|
(15)
|
Write-offs
|
—
|
—
|
—
|
—
|
(57)
|
(57)
|
—
|
—
|
(57)
|
(57)
|
As at 30 June 2025
|
12,245
|
103
|
1,600
|
153
|
402
|
199
|
14
|
—
|
14,261
|
455
|
|
|
|
|
|
|
|
|
|
|
|
Corporate loans
|
|
|
|
|
|
|
|
|
|
|
As at 1 January 2025
|
116,508
|
209
|
11,167
|
331
|
3,116
|
626
|
—
|
—
|
130,791
|
1,166
|
Transfers from Stage 1 to Stage 2
|
(3,210)
|
(17)
|
3,210
|
17
|
—
|
—
|
—
|
—
|
—
|
—
|
Transfers from Stage 2 to Stage 1
|
2,156
|
46
|
(2,156)
|
(46)
|
—
|
—
|
—
|
—
|
—
|
—
|
Transfers to Stage 3
|
(374)
|
(2)
|
(461)
|
(25)
|
835
|
27
|
—
|
—
|
—
|
—
|
Transfers from Stage 3
|
207
|
10
|
220
|
10
|
(427)
|
(20)
|
—
|
—
|
—
|
—
|
Business activity in the period
|
16,320
|
26
|
1,290
|
27
|
373
|
25
|
—
|
—
|
17,983
|
78
|
Refinements to models used for calculation2
|
—
|
(8)
|
—
|
(6)
|
—
|
—
|
—
|
—
|
—
|
(14)
|
Net drawdowns, repayments, net re-measurement and movement due to
exposure and risk parameter changes3
|
181
|
(33)
|
(732)
|
86
|
(370)
|
199
|
—
|
—
|
(921)
|
252
|
Final repayments
|
(15,888)
|
(14)
|
(1,585)
|
(36)
|
(260)
|
(44)
|
—
|
—
|
(17,733)
|
(94)
|
Disposals1
|
(1)
|
(1)
|
(2)
|
(2)
|
(121)
|
(21)
|
—
|
—
|
(124)
|
(24)
|
Write-offs
|
—
|
—
|
—
|
—
|
(161)
|
(161)
|
—
|
—
|
(161)
|
(161)
|
As at 30 June 2025
|
115,899
|
216
|
10,951
|
356
|
2,985
|
631
|
—
|
—
|
129,835
|
1,203
|
1
|
The £21m of gross disposals reported within Retail other and
£124m of gross disposals reported within Corporate loans
relate to debt sales undertaken during the period.
|
2
|
Refinements to models used for calculation reported within
Corporate loans include a £(14)m movement in the calculated
ECL for the IB portfolio. These reflect model enhancements made
during the period. Barclays continually reviews the output of
models to determine accuracy of the ECL calculation including
review of model monitoring, external benchmarking and experience of
model operation over an extended period of time. This helps to
ensure that the models used continue to reflect the risks inherent
across the businesses.
|
3
|
'Net drawdowns, repayments, net re-measurement and movements due to
exposure and risk parameter changes' reported within Corporate
loans includes assets of £0.2bn de-recognised due to payment
received on defaulted loans from government guarantees issued under
the Government’s Bounce Back Loan Scheme.
|
Reconciliation of ECL movement to impairment charge/(release) for
the period
|
|
|
||||||
|
|
|
|
Stage 1
|
Stage 2
|
Stage 3 excluding POCI
|
Stage 3 POCI
|
Total
|
|
|
|
|
£m
|
£m
|
£m
|
£m
|
£m
|
Retail mortgages
|
(1)
|
(2)
|
15
|
—
|
12
|
|||
Retail credit cards
|
(96)
|
(55)
|
658
|
—
|
507
|
|||
Retail other
|
(35)
|
42
|
110
|
—
|
117
|
|||
Corporate loans
|
8
|
27
|
187
|
—
|
222
|
|||
ECL movements excluding disposals and
write-offs1
|
(124)
|
12
|
970
|
—
|
858
|
|||
ECL movement on
loan commitments and other financial guarantees
|
—
|
(11)
|
(3)
|
—
|
(14)
|
|||
ECL movement on other financial assets
|
4
|
(3)
|
(7)
|
—
|
(6)
|
|||
ECL movement on debt securities at amortised cost
|
—
|
1
|
—
|
—
|
1
|
|||
Recoveries and reimbursements2
|
(4)
|
(20)
|
(77)
|
—
|
(101)
|
|||
ECL charge on assets held for sale3
|
|
|
|
|
105
|
|||
Total exchange and other adjustments
|
|
|
|
|
269
|
|||
Total income statement charge for the period
|
|
|
|
|
1,112
|
1
|
In H125, gross write-offs amounted to £747m (H124: £760m)
and post write-off recoveries amounted to £43m (H124:
£38m). Net write-offs represent gross write-offs less post
write-off recoveries and amounted to £704m (H124:
£722m).
|
2
|
Recoveries and reimbursements include £58m (H124: £18m)
for reimbursements expected to be received under the arrangement
where Group has entered into financial guarantee contracts which
provide credit protection over certain assets with third parties
and cash recoveries of previously written off amounts of
£43m(H124: £38m).
|
3
|
ECL charge on assets held for sale relate to the charges on a
co-branded card portfolio in USCB and the German consumer finance
business.
|
Loan commitments and financial
guarantees1
|
||||||||||
|
Stage 1
|
Stage 2
|
Stage 3 excluding POCI
|
Stage 3 POCI
|
Total
|
|||||
|
Gross
exposure
|
ECL
|
Gross
exposure
|
ECL
|
Gross
exposure
|
ECL
|
Gross
exposure
|
ECL
|
Gross
exposure
|
ECL
|
Retail mortgages
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
As at 1 January 2025
|
11,093
|
—
|
340
|
—
|
2
|
—
|
—
|
—
|
11,435
|
—
|
Net transfers between stages
|
(22)
|
—
|
20
|
—
|
2
|
—
|
—
|
—
|
—
|
—
|
Business activity in the period
|
10,082
|
—
|
—
|
—
|
6
|
—
|
—
|
—
|
10,088
|
—
|
Net drawdowns, repayments, net re-measurement and movement due to
exposure and risk parameter changes
|
(8,050)
|
—
|
(27)
|
—
|
(2)
|
—
|
—
|
—
|
(8,079)
|
—
|
Limit management and final repayments
|
(171)
|
—
|
(19)
|
—
|
(1)
|
—
|
—
|
—
|
(191)
|
—
|
As at 30 June 2025
|
12,932
|
—
|
314
|
—
|
7
|
—
|
—
|
—
|
13,253
|
—
|
Retail credit cards
|
|
|
|
|
|
|
|
|
|
|
As at 1 January 2025
|
162,471
|
53
|
2,515
|
13
|
122
|
—
|
6
|
—
|
165,114
|
66
|
Net transfers between stages
|
(2,001)
|
10
|
1,977
|
(10)
|
24
|
—
|
—
|
—
|
—
|
—
|
Business activity in the period
|
9,162
|
11
|
136
|
2
|
—
|
—
|
—
|
—
|
9,298
|
13
|
Net drawdowns, repayments, net re-measurement and movement due to
exposure and risk parameter changes
|
(7,840)
|
(16)
|
(1,284)
|
14
|
(26)
|
—
|
(1)
|
—
|
(9,151)
|
(2)
|
Limit management and final repayments
|
(6,172)
|
(5)
|
(122)
|
(5)
|
(11)
|
—
|
—
|
—
|
(6,305)
|
(10)
|
Disposals2
|
(5,203)
|
—
|
(217)
|
—
|
(10)
|
—
|
—
|
—
|
(5,430)
|
—
|
As at 30 June 2025
|
150,417
|
53
|
3,005
|
14
|
99
|
—
|
5
|
—
|
153,526
|
67
|
Retail other
|
|
|
|
|
|
|
|
|
|
|
As at 1 January 2025
|
8,416
|
6
|
440
|
—
|
25
|
—
|
—
|
—
|
8,881
|
6
|
Net transfers between stages
|
(10)
|
—
|
10
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
Business activity in the period
|
364
|
—
|
—
|
—
|
6
|
—
|
—
|
—
|
370
|
—
|
Net drawdowns, repayments, net re-measurement and movement due to
exposure and risk parameter changes
|
(126)
|
(3)
|
(14)
|
—
|
(7)
|
—
|
—
|
—
|
(147)
|
(3)
|
Limit management and final repayments
|
(573)
|
—
|
(25)
|
—
|
(3)
|
—
|
—
|
—
|
(601)
|
—
|
Disposals2
|
(743)
|
—
|
(30)
|
—
|
(1)
|
—
|
—
|
—
|
(774)
|
—
|
As at 30 June 2025
|
7,328
|
3
|
381
|
—
|
20
|
—
|
—
|
—
|
7,729
|
3
|
Corporate loans
|
|
|
|
|
|
|
|
|
|
|
As at 1 January 2025
|
230,275
|
105
|
15,433
|
237
|
1,019
|
25
|
—
|
—
|
246,727
|
367
|
Net transfers between stages
|
(77)
|
23
|
(77)
|
(22)
|
154
|
(1)
|
—
|
—
|
—
|
—
|
Business activity in the period
|
52,278
|
23
|
1,166
|
31
|
68
|
—
|
—
|
—
|
53,512
|
54
|
Net drawdowns, repayments, net re-measurement and movement due to
exposure and risk parameter changes
|
(4,520)
|
(29)
|
(1,182)
|
17
|
(261)
|
—
|
—
|
—
|
(5,963)
|
(12)
|
Limit management and final repayments
|
(49,958)
|
(14)
|
(1,986)
|
(38)
|
(163)
|
(2)
|
—
|
—
|
(52,107)
|
(54)
|
As at 30 June 2025
|
227,998
|
108
|
13,354
|
225
|
817
|
22
|
—
|
—
|
242,169
|
355
|
1
|
Loan commitments reported also include financial assets classified
as held for sale.
|
2
|
The gross disposals reported within Retail credit card and Retail
other relate to the German consumer finance business; sale of which
was completed in Q125.
|
|
Impairment allowance pre management
adjustments2
|
Economic uncertainty adjustments
|
Other adjustments
|
Management
adjustments3
|
Total impairment
allowance4
|
Proportion of Management adjustments to Total impairment
allowance
|
|
|
(a)
|
(b)
|
(a+b)
|
|
|
As at 30.06.25
|
£m
|
£m
|
£m
|
£m
|
£m
|
%
|
Retail mortgages
|
50
|
36
|
72
|
108
|
158
|
68.4
|
Retail credit cards
|
883
|
—
|
(127)
|
(127)
|
756
|
(16.8)
|
Retail other
|
350
|
—
|
84
|
84
|
434
|
19.4
|
Corporate loans
|
767
|
43
|
40
|
83
|
850
|
9.8
|
Total UK
|
2,050
|
79
|
69
|
148
|
2,198
|
6.7
|
Retail mortgages
|
22
|
—
|
—
|
—
|
22
|
—
|
Retail credit cards5
|
2,389
|
30
|
—
|
30
|
2,419
|
1.2
|
Retail other
|
24
|
—
|
—
|
—
|
24
|
—
|
Corporate loans5
|
719
|
44
|
(55)
|
(11)
|
708
|
(1.6)
|
Total Rest of the World
|
3,154
|
74
|
(55)
|
19
|
3,173
|
0.6
|
Total
|
5,204
|
153
|
14
|
167
|
5,371
|
3.1
|
Debt securities at amortised cost
|
23
|
1
|
—
|
1
|
24
|
4.2
|
Total including debt securities at amortised cost
|
5,227
|
154
|
14
|
168
|
5,395
|
3.1
|
|
|
|
|
|
|
|
As at 31.12.24
|
£m
|
£m
|
£m
|
£m
|
£m
|
%
|
Retail mortgages
|
51
|
36
|
71
|
107
|
158
|
67.7
|
Retail credit cards
|
787
|
—
|
(22)
|
(22)
|
765
|
(2.9)
|
Retail other
|
298
|
—
|
90
|
90
|
388
|
23.2
|
Corporate loans
|
759
|
42
|
39
|
81
|
840
|
9.6
|
Total UK
|
1,895
|
78
|
178
|
256
|
2,151
|
11.9
|
Retail mortgages
|
29
|
—
|
—
|
—
|
29
|
—
|
Retail credit cards
|
2,631
|
—
|
(23)
|
(23)
|
2,608
|
(0.9)
|
Retail other
|
24
|
—
|
4
|
4
|
28
|
14.3
|
Corporate loans
|
695
|
—
|
(2)
|
(2)
|
693
|
(0.3)
|
Total Rest of the World
|
3,379
|
—
|
(21)
|
(21)
|
3,358
|
(0.6)
|
Total
|
5,274
|
78
|
157
|
235
|
5,509
|
4.3
|
Debt securities at amortised cost
|
30
|
—
|
(7)
|
(7)
|
23
|
(30.4)
|
Total including debt securities at amortised cost
|
5,304
|
78
|
150
|
228
|
5,532
|
4.1
|
|
Stage 1
|
Stage 2
|
Stage 3
|
Total
|
As at 30.06.25
|
£m
|
£m
|
£m
|
£m
|
Retail mortgages
|
7
|
18
|
11
|
36
|
Retail credit cards
|
—
|
—
|
—
|
—
|
Retail other
|
—
|
—
|
—
|
—
|
Corporate loans
|
25
|
12
|
6
|
43
|
Total UK
|
32
|
30
|
17
|
79
|
Retail mortgages
|
—
|
—
|
—
|
—
|
Retail credit cards
|
—
|
30
|
—
|
30
|
Retail other
|
—
|
—
|
—
|
—
|
Corporate loans
|
13
|
31
|
—
|
44
|
Total Rest of the World
|
13
|
61
|
—
|
74
|
Total
|
45
|
91
|
17
|
153
|
Debt securities at amortised cost
|
1
|
—
|
—
|
1
|
Total including debt securities at amortised cost
|
46
|
91
|
17
|
154
|
As at 31.12.24
|
£m
|
£m
|
£m
|
£m
|
Retail mortgages
|
7
|
18
|
11
|
36
|
Retail credit cards
|
—
|
—
|
—
|
—
|
Retail other
|
—
|
—
|
—
|
—
|
Corporate loans
|
26
|
10
|
6
|
42
|
Total UK
|
33
|
28
|
17
|
78
|
Retail mortgages
|
—
|
—
|
—
|
—
|
Retail credit cards
|
—
|
—
|
—
|
—
|
Retail other
|
—
|
—
|
—
|
—
|
Corporate loans
|
—
|
—
|
—
|
—
|
Total Rest of the World
|
—
|
—
|
—
|
—
|
Total
|
33
|
28
|
17
|
78
|
Debt securities at amortised cost
|
—
|
—
|
—
|
—
|
Total including debt securities at amortised cost
|
33
|
28
|
17
|
78
|
1
|
Positive values reflect an increase in impairment allowance and
negative values reflect a reduction in the impairment
allowance.
|
2
|
Includes £4.5bn (December 2024: £4.7bn) of modelled ECL,
£0.5bn (December 2024: £0.5bn) of individually assessed
impairments, £(0.2)bn (December 2024: £(0.3)bn) of ECL
from assets held for sale (co-branded card portfolio) and
£0.4bn (December 2024: £0.4bn) of ECL from non-modelled
exposures and debt securities.
|
3
|
Management adjustments related to other financial assets subject to
impairment not included in the table above include cash collateral
and settlement balances £nil (December 2024: £(1)m),
reverse repurchase agreements £1m (December 2024: £(2)m)
and financial assets at fair value through other comprehensive
income £nil (December 2024: £(2)m) within the IB
portfolio.
|
4
|
Total impairment allowance consists of ECL stock on drawn and
undrawn exposure.
|
5
|
Economic uncertainty adjustment of £87m is split £36m in
USCB (including £6m in HFS) and £51m in IB, primarily
reported within Corporate loans (ROW).
|
1
|
Significant Risk Transfer (SRT) represents risk transfer
transactions used to enhance risk management
capabilities.
|
Macroeconomic variables used in the calculation of ECL
|
|||||
As at 30.06.25
|
2025
|
2026
|
2027
|
2028
|
2029
|
Baseline
|
%
|
%
|
%
|
%
|
%
|
UK GDP1
|
0.7
|
1.2
|
1.5
|
1.6
|
1.7
|
UK unemployment2
|
4.6
|
4.7
|
4.7
|
4.6
|
4.6
|
UK HPI3
|
2.1
|
2.3
|
2.3
|
3.5
|
3.9
|
UK bank rate6
|
4.1
|
3.8
|
3.8
|
3.8
|
3.9
|
US GDP1
|
1.9
|
1.4
|
2.0
|
2.0
|
2.0
|
US unemployment4
|
4.4
|
4.6
|
4.6
|
4.6
|
4.6
|
US HPI5
|
2.8
|
2.0
|
2.0
|
2.0
|
2.0
|
US federal funds rate6
|
4.3
|
3.6
|
3.6
|
3.8
|
3.8
|
|
|
|
|
|
|
Downside 2
|
|
|
|
|
|
UK GDP1
|
(0.2)
|
(3.4)
|
1.7
|
2.6
|
1.8
|
UK unemployment2
|
4.9
|
7.6
|
7.5
|
5.9
|
5.3
|
UK HPI3
|
(9.4)
|
(20.6)
|
1.2
|
18.1
|
10.0
|
UK bank rate6
|
4.0
|
1.4
|
0.2
|
0.8
|
1.5
|
US GDP1
|
0.9
|
(4.7)
|
(0.2)
|
2.3
|
2.3
|
US unemployment4
|
4.6
|
7.3
|
7.8
|
6.4
|
5.8
|
US HPI5
|
(1.6)
|
(6.6)
|
3.6
|
9.1
|
4.7
|
US federal funds rate6
|
4.5
|
4.1
|
2.4
|
1.4
|
1.2
|
|
|
|
|
|
|
Downside 1
|
|
|
|
|
|
UK GDP1
|
0.2
|
(1.1)
|
1.6
|
2.1
|
1.8
|
UK unemployment2
|
4.8
|
6.2
|
6.1
|
5.2
|
4.9
|
UK HPI3
|
(3.7)
|
(9.6)
|
1.7
|
10.7
|
7.0
|
UK bank rate6
|
4.1
|
3.1
|
2.2
|
2.3
|
2.7
|
US GDP1
|
1.4
|
(1.6)
|
0.9
|
2.1
|
2.1
|
US unemployment4
|
4.5
|
5.9
|
6.2
|
5.5
|
5.2
|
US HPI5
|
0.5
|
(2.4)
|
2.8
|
5.5
|
3.4
|
US federal funds rate6
|
4.3
|
3.9
|
2.9
|
2.6
|
2.6
|
|
|
|
|
|
|
Upside 2
|
|
|
|
|
|
UK GDP1
|
1.1
|
3.9
|
3.2
|
2.6
|
2.3
|
UK unemployment2
|
4.4
|
4.0
|
3.8
|
3.7
|
3.7
|
UK HPI3
|
4.4
|
14.2
|
6.8
|
2.7
|
3.8
|
UK bank rate6
|
4.1
|
3.1
|
2.5
|
2.6
|
2.9
|
US GDP1
|
2.3
|
3.1
|
2.9
|
2.8
|
2.8
|
US unemployment4
|
4.2
|
3.9
|
3.9
|
3.9
|
3.9
|
US HPI5
|
5.2
|
4.3
|
5.3
|
4.9
|
4.9
|
US federal funds rate6
|
4.1
|
2.9
|
2.8
|
2.8
|
2.8
|
|
|
|
|
|
|
Upside 1
|
|
|
|
|
|
UK GDP1
|
0.9
|
2.5
|
2.4
|
2.1
|
2.0
|
UK unemployment2
|
4.5
|
4.3
|
4.3
|
4.2
|
4.2
|
UK HPI3
|
3.2
|
8.1
|
4.5
|
3.1
|
3.9
|
UK bank rate6
|
4.1
|
3.4
|
3.3
|
3.3
|
3.4
|
US GDP1
|
2.1
|
2.3
|
2.4
|
2.4
|
2.4
|
US unemployment4
|
4.3
|
4.2
|
4.2
|
4.2
|
4.2
|
US HPI5
|
4.0
|
3.1
|
3.7
|
3.4
|
3.4
|
US federal funds rate6
|
4.3
|
3.3
|
3.3
|
3.5
|
3.5
|
1
|
Average Real GDP seasonally adjusted change in year.
|
2
|
Average UK unemployment rate 16-year+.
|
3
|
Change in year end UK HPI = Halifax HPI Meth2 All Houses, All
Buyers index.
|
4
|
Average US civilian unemployment rate 16-year+.
|
5
|
Change in year end US HPI = FHFA House Price Index, relative to
prior year end.
|
6
|
Average rate.
|
As at 31.12.24
|
2024
|
2025
|
2026
|
2027
|
2028
|
Baseline
|
%
|
%
|
%
|
%
|
%
|
UK GDP1
|
1.0
|
1.4
|
1.5
|
1.6
|
1.5
|
UK unemployment2
|
4.3
|
4.4
|
4.5
|
4.4
|
4.4
|
UK HPI3
|
2.8
|
3.3
|
1.6
|
4.5
|
3.0
|
UK bank rate6
|
5.1
|
4.3
|
4.0
|
4.0
|
3.8
|
US GDP1
|
2.7
|
2.0
|
2.0
|
2.0
|
2.0
|
US unemployment4
|
4.1
|
4.3
|
4.2
|
4.2
|
4.2
|
US HPI5
|
6.5
|
2.6
|
2.7
|
3.0
|
3.0
|
US federal funds rate6
|
5.1
|
4.1
|
4.0
|
3.8
|
3.8
|
|
|
|
|
|
|
Downside 2
|
|
|
|
|
|
UK GDP1
|
1.0
|
(2.3)
|
(1.3)
|
2.6
|
2.3
|
UK unemployment2
|
4.3
|
6.2
|
8.1
|
6.6
|
5.5
|
UK HPI3
|
2.8
|
(24.8)
|
(5.2)
|
10.0
|
14.6
|
UK bank rate6
|
5.1
|
3.5
|
1.7
|
0.6
|
1.1
|
US GDP1
|
2.7
|
(1.3)
|
(1.3)
|
3.3
|
2.9
|
US unemployment4
|
4.1
|
5.8
|
7.2
|
6.2
|
5.5
|
US HPI5
|
6.5
|
(8.0)
|
(0.7)
|
5.2
|
4.0
|
US federal funds rate6
|
5.1
|
2.5
|
0.6
|
0.8
|
1.5
|
|
|
|
|
|
|
Downside 1
|
|
|
|
|
|
UK GDP1
|
1.0
|
(0.5)
|
0.1
|
2.1
|
1.9
|
UK unemployment2
|
4.3
|
5.3
|
6.3
|
5.5
|
5.0
|
UK HPI3
|
2.8
|
(11.6)
|
(1.8)
|
7.2
|
8.7
|
UK bank rate6
|
5.1
|
3.9
|
2.9
|
2.3
|
2.4
|
US GDP1
|
2.7
|
0.3
|
0.4
|
2.7
|
2.4
|
US unemployment4
|
4.1
|
5.1
|
5.7
|
5.2
|
4.9
|
US HPI5
|
6.5
|
(2.7)
|
1.0
|
4.1
|
3.5
|
US federal funds rate6
|
5.1
|
3.4
|
2.3
|
2.3
|
2.7
|
|
|
|
|
|
|
Upside 2
|
|
|
|
|
|
UK GDP1
|
1.0
|
3.0
|
3.7
|
2.9
|
2.4
|
UK unemployment2
|
4.3
|
3.8
|
3.4
|
3.5
|
3.5
|
UK HPI3
|
2.8
|
11.9
|
8.4
|
5.1
|
4.1
|
UK bank rate6
|
5.1
|
3.9
|
2.9
|
2.8
|
2.8
|
US GDP1
|
2.7
|
2.8
|
3.1
|
2.8
|
2.8
|
US unemployment4
|
4.1
|
3.8
|
3.5
|
3.5
|
3.5
|
US HPI5
|
6.5
|
6.2
|
4.7
|
4.8
|
4.9
|
US federal funds rate6
|
5.1
|
3.7
|
3.3
|
3.1
|
2.8
|
|
|
|
|
|
|
Upside 1
|
|
|
|
|
|
UK GDP1
|
1.0
|
2.2
|
2.6
|
2.2
|
2.0
|
UK unemployment2
|
4.3
|
4.1
|
4.0
|
4.0
|
4.0
|
UK HPI3
|
2.8
|
7.6
|
4.9
|
4.8
|
3.5
|
UK bank rate6
|
5.1
|
4.1
|
3.5
|
3.4
|
3.3
|
US GDP1
|
2.7
|
2.4
|
2.6
|
2.4
|
2.4
|
US unemployment4
|
4.1
|
4.0
|
3.9
|
3.9
|
3.9
|
US HPI5
|
6.5
|
4.4
|
3.7
|
3.9
|
3.9
|
US federal funds rate6
|
5.1
|
4.0
|
3.8
|
3.6
|
3.3
|
1
|
Average Real GDP seasonally adjusted change in year.
|
2
|
Average UK unemployment rate 16-year+.
|
3
|
Change in year end UK HPI = Halifax All Houses, All Buyers index,
relative to prior year end.
|
4
|
Average US civilian unemployment rate 16-year+.
|
5
|
Change in year end US HPI = FHFA House Price Index, relative to
prior year end.
|
6
|
Average rate.
|
Scenario weighting
|
Upside 2
|
Upside 1
|
Baseline
|
Downside 1
|
Downside 2
|
|
%
|
%
|
%
|
%
|
%
|
As at 30.06.25
|
|
|
|
|
|
Scenario weighting
|
15.5
|
26.4
|
34.4
|
15.2
|
8.5
|
As at 31.12.24
|
|
|
|
|
|
Scenario weighting
|
17.4
|
26.8
|
32.5
|
14.7
|
8.6
|
Macroeconomic variables (specific
bases)1
|
|||||
|
Upside 2
|
Upside 1
|
Baseline
|
Downside 1
|
Downside 2
|
As at 30.06.25
|
%
|
%
|
%
|
%
|
%
|
UK GDP2
|
14.5
|
10.9
|
1.3
|
(1.3)
|
(4.0)
|
UK unemployment3
|
3.7
|
4.2
|
4.6
|
6.5
|
8.4
|
UK HPI4
|
35.8
|
25.0
|
2.8
|
(13.2)
|
(28.1)
|
UK bank rate3
|
2.5
|
3.3
|
3.9
|
4.6
|
4.6
|
US GDP2
|
14.8
|
12.0
|
1.8
|
(1.4)
|
(5.3)
|
US unemployment3
|
3.9
|
4.1
|
4.5
|
6.5
|
8.4
|
US HPI4
|
27.1
|
19.0
|
2.2
|
(2.2)
|
(8.4)
|
US federal funds rate3
|
2.8
|
3.3
|
3.8
|
4.5
|
4.5
|
As at 31.12.24
|
%
|
%
|
%
|
%
|
%
|
UK GDP2
|
15.0
|
11.6
|
1.4
|
0.2
|
(2.9)
|
UK unemployment3
|
3.4
|
3.9
|
4.4
|
6.5
|
8.4
|
UK HPI4
|
36.3
|
25.9
|
3.0
|
(11.3)
|
(26.8)
|
UK bank rate3
|
2.8
|
3.3
|
4.2
|
5.3
|
5.3
|
US GDP2
|
14.9
|
12.8
|
2.2
|
0.4
|
(2.1)
|
US unemployment3
|
3.5
|
3.8
|
4.2
|
5.9
|
7.5
|
US HPI4
|
30.1
|
24.4
|
3.5
|
1.1
|
(4.0)
|
US federal funds rate3
|
2.8
|
3.3
|
4.2
|
5.3
|
5.3
|
1
|
UK GDP = Real GDP growth seasonally adjusted; UK unemployment = UK
unemployment rate 16-year+; UK HPI (31.12.24) = Halifax All Houses,
All Buyers Index; UK HPI (30.06.25) = Halifax HPI Meth2 All Houses,
All Buyers index; US GDP = Real GDP growth seasonally adjusted; US
unemployment = US civilian unemployment rate 16-year+; US HPI =
FHFA House Price Index. 20 quarter period starts from Q125 (2024:
Q124).
|
2
|
Maximum growth relative to Q424 (2024: Q423), based on 20 quarter
period in Upside scenarios; 5-year yearly average Compound Annual
Growth Rate(CAGR) in Baseline; minimum growth relative to Q424
(2024: Q423), based on 20 quarter period in Downside
scenarios.
|
3
|
Lowest quarter in 20 quarter period in Upside scenarios; 5-year
average in Baseline; highest quarter 20 quarter period in Downside
scenarios.
|
4
|
Maximum growth relative to Q424 (2024: Q423), based on 20 quarter
period in Upside scenarios; 5-year quarter end CAGR in Baseline;
minimum growth relative to Q424 (2024: Q423), based on 20 quarter
period in Downside scenarios.
|
Macroeconomic variables (5-year
averages)1
|
|||||
|
Upside 2
|
Upside 1
|
Baseline
|
Downside 1
|
Downside 2
|
As at 30.06.25
|
%
|
%
|
%
|
%
|
%
|
UK GDP2
|
2.6
|
2.0
|
1.3
|
0.9
|
0.5
|
UK unemployment3
|
3.9
|
4.3
|
4.6
|
5.4
|
6.2
|
UK HPI4
|
6.3
|
4.6
|
2.8
|
0.9
|
(1.1)
|
UK bank rate3
|
3.0
|
3.5
|
3.9
|
2.9
|
1.6
|
US GDP2
|
2.8
|
2.3
|
1.8
|
1.0
|
0.1
|
US unemployment3
|
3.9
|
4.2
|
4.5
|
5.4
|
6.4
|
US HPI4
|
4.9
|
3.5
|
2.2
|
1.9
|
1.7
|
US federal funds rate3
|
3.1
|
3.6
|
3.8
|
3.3
|
2.7
|
As at 31.12.24
|
%
|
%
|
%
|
%
|
%
|
UK GDP2
|
2.6
|
2.0
|
1.4
|
0.9
|
0.5
|
UK unemployment3
|
3.7
|
4.0
|
4.4
|
5.3
|
6.1
|
UK HPI4
|
6.4
|
4.7
|
3.0
|
0.8
|
(1.6)
|
UK bank rate3
|
3.5
|
3.9
|
4.2
|
3.3
|
2.4
|
US GDP2
|
2.9
|
2.5
|
2.2
|
1.7
|
1.2
|
US unemployment3
|
3.7
|
3.9
|
4.2
|
5.0
|
5.8
|
US HPI4
|
5.4
|
4.5
|
3.5
|
2.4
|
1.2
|
US federal funds rate3
|
3.6
|
4.0
|
4.2
|
3.2
|
2.1
|
1
|
UK GDP = Real GDP growth seasonally adjusted; UK unemployment = UK
unemployment rate 16-year+; UK HPI (31.12.24) = Halifax All Houses,
All Buyers Index; UK HPI (30.06.25) = Halifax HPI Meth2 All Houses,
All Buyers index; US GDP = Real GDP growth seasonally adjusted; US
unemployment = US civilian unemployment rate 16-year+; US HPI =
FHFA House Price Index. 20 quarter period starts from Q125 (2024:
Q124).
|
2
|
5-year yearly average CAGR, starting 2024 (2024:
2023).
|
3
|
5-year average. Period based on 20 quarters from Q125 (2024:
Q124).
|
4
|
5-year quarter end CAGR, starting Q424 (2024: Q423).
|
|
Scenarios
|
|||||
As at 30.06.25
|
Weighted1
|
Upside 2
|
Upside 1
|
Baseline
|
Downside 1
|
Downside 2
|
Stage 1 Model Exposure (£m)
|
|
|
|
|
|
|
Retail mortgages
|
143,893
|
144,499
|
144,220
|
143,894
|
142,404
|
140,285
|
Retail credit cards2
|
61,346
|
61,301
|
61,334
|
61,364
|
61,389
|
61,315
|
Retail other
|
6,361
|
6,488
|
6,436
|
6,375
|
6,217
|
6,047
|
Corporate loans2
|
206,132
|
208,928
|
208,025
|
206,540
|
204,086
|
197,488
|
Stage 1 Model ECL (£m)
|
|
|
|
|
|
|
Retail mortgages
|
2
|
1
|
1
|
1
|
3
|
5
|
Retail credit cards2
|
514
|
493
|
503
|
513
|
533
|
551
|
Retail other
|
31
|
28
|
29
|
30
|
33
|
35
|
Corporate loans2
|
288
|
251
|
264
|
274
|
332
|
385
|
Stage 1 Coverage (%)
|
|
|
|
|
|
|
Retail mortgages
|
—
|
—
|
—
|
—
|
—
|
—
|
Retail credit cards
|
0.8
|
0.8
|
0.8
|
0.8
|
0.9
|
0.9
|
Retail other
|
0.5
|
0.4
|
0.5
|
0.5
|
0.5
|
0.6
|
Corporate loans
|
0.1
|
0.1
|
0.1
|
0.1
|
0.2
|
0.2
|
Stage 2 Model Exposure (£m)
|
|
|
|
|
|
|
Retail mortgages
|
17,837
|
16,768
|
17,185
|
17,673
|
19,831
|
23,057
|
Retail credit cards2
|
6,381
|
6,216
|
6,288
|
6,363
|
6,525
|
6,794
|
Retail other
|
1,181
|
1,054
|
1,106
|
1,167
|
1,325
|
1,495
|
Corporate loans2
|
20,327
|
17,378
|
18,338
|
19,936
|
22,509
|
29,237
|
Stage 2 Model ECL (£m)
|
|
|
|
|
|
|
Retail mortgages
|
3
|
1
|
2
|
2
|
5
|
9
|
Retail credit cards2
|
1,353
|
1,268
|
1,302
|
1,337
|
1,440
|
1,584
|
Retail other
|
79
|
66
|
70
|
75
|
98
|
127
|
Corporate loans2
|
550
|
418
|
462
|
517
|
693
|
1,045
|
Stage 2 Coverage (%)
|
|
|
|
|
|
|
Retail mortgages
|
—
|
—
|
—
|
—
|
—
|
—
|
Retail credit cards
|
21.2
|
20.4
|
20.7
|
21.0
|
22.1
|
23.3
|
Retail other
|
6.7
|
6.3
|
6.3
|
6.4
|
7.4
|
8.5
|
Corporate loans
|
2.7
|
2.4
|
2.5
|
2.6
|
3.1
|
3.6
|
Stage 3 Model Exposure
(£m)3
|
|
|
|
|
|
|
Retail mortgages
|
1,128
|
1,128
|
1,128
|
1,128
|
1,128
|
1,128
|
Retail credit cards2
|
2,050
|
2,050
|
2,050
|
2,050
|
2,050
|
2,050
|
Retail other
|
133
|
133
|
133
|
133
|
133
|
133
|
Corporate loans2
|
3,858
|
3,858
|
3,858
|
3,858
|
3,858
|
3,858
|
Stage 3 Model ECL (£m)
|
|
|
|
|
|
|
Retail mortgages
|
18
|
11
|
14
|
16
|
27
|
35
|
Retail credit cards2
|
1,525
|
1,486
|
1,507
|
1,527
|
1,558
|
1,586
|
Retail other
|
75
|
73
|
73
|
74
|
78
|
82
|
Corporate loans2,4
|
61
|
58
|
58
|
60
|
66
|
72
|
Stage 3 Coverage (%)
|
|
|
|
|
|
|
Retail mortgages
|
1.6
|
1.0
|
1.2
|
1.4
|
2.4
|
3.1
|
Retail credit cards
|
74.4
|
72.5
|
73.5
|
74.5
|
76.0
|
77.4
|
Retail other
|
56.4
|
54.9
|
54.9
|
55.6
|
58.6
|
61.7
|
Corporate loans4
|
1.6
|
1.5
|
1.5
|
1.6
|
1.7
|
1.9
|
Total Model ECL (£m)
|
|
|
|
|
|
|
Retail mortgages
|
23
|
13
|
17
|
19
|
35
|
49
|
Retail credit cards2
|
3,392
|
3,247
|
3,312
|
3,377
|
3,531
|
3,721
|
Retail other
|
185
|
167
|
172
|
179
|
209
|
244
|
Corporate loans2,
|
899
|
727
|
784
|
851
|
1,091
|
1,502
|
Total Model ECL
|
4,499
|
4,154
|
4,285
|
4,426
|
4,866
|
5,516
|
Reconciliation to total ECL
|
£m
|
Total weighted model ECL
|
4,499
|
ECL from individually assessed exposures4
|
485
|
ECL from non-modelled exposures and others5
|
459
|
ECL from debt securities at amortised cost
|
24
|
ECL from held for sale assets (co-branded card
portfolio)
|
(239)
|
ECL from post model management adjustments
|
167
|
Of which: ECL from economic uncertainty adjustments
|
153
|
Total ECL
|
5,395
|
1
|
Model exposures are allocated to a stage based on an individual
scenario rather than a probability-weighted approach as required
for Barclays reported impairment allowances. As a result, it is not
possible to back solve the final reported weighted ECL from
individual scenarios given balances may be assigned to a different
stage dependent on the scenario.
|
2
|
Model exposure and ECL reported within Retail credit cards and
Corporate loans continues to include a co-branded card portfolio,
as its sale is expected to close in 2026.
|
3
|
Model exposures allocated to Stage 3 does not change in any of the
scenarios as the transition criteria relies only on an observable
evidence of default as at 30 June 2025 and not on macroeconomic
scenario.
|
4
|
Material corporate loan defaults are individually assessed across
different recovery strategies. As a result, ECL of £485m is
reported as an individually assessed impairment in the
reconciliation table.
|
5
|
ECL from non-modelled exposures and
others includes ECL on Tesco Bank's retail banking business of
£295m calculated using a
benchmarked approach based on UK cards and UK retail loans. The
sensitivity of the non-modelled exposures would materially reflect
the sensitivity of the benchmarked model.
|
|
Scenarios1
|
|||||
As at 31.12.24
|
Weighted2
|
Upside 2
|
Upside 1
|
Baseline
|
Downside 1
|
Downside 2
|
Stage 1 Model Exposure (£m)
|
|
|
|
|
|
|
Retail mortgages
|
139,086
|
140,828
|
140,079
|
139,188
|
136,671
|
134,861
|
Retail credit cards
|
63,937
|
63,821
|
63,859
|
63,894
|
63,980
|
63,975
|
Retail other
|
7,952
|
8,074
|
8,025
|
7,968
|
7,804
|
7,614
|
Corporate loans
|
213,905
|
216,064
|
215,215
|
214,293
|
212,007
|
207,062
|
Stage 1 Model ECL (£m)
|
|
|
|
|
|
|
Retail mortgages
|
1
|
—
|
1
|
1
|
3
|
6
|
Retail credit cards
|
535
|
512
|
523
|
534
|
560
|
586
|
Retail other
|
34
|
32
|
32
|
33
|
36
|
40
|
Corporate loans
|
270
|
235
|
247
|
258
|
311
|
363
|
Stage 1 Coverage (%)
|
|
|
|
|
|
|
Retail mortgages
|
—
|
—
|
—
|
—
|
—
|
—
|
Retail credit card
|
0.8
|
0.8
|
0.8
|
0.8
|
0.9
|
0.9
|
Retail other
|
0.4
|
0.4
|
0.4
|
0.4
|
0.5
|
0.5
|
Corporate loans
|
0.1
|
0.1
|
0.1
|
0.1
|
0.1
|
0.2
|
Stage 2 Model Exposure (£m)
|
|
|
|
|
|
|
Retail mortgages
|
20,401
|
18,178
|
19,072
|
20,134
|
23,359
|
26,339
|
Retail credit cards
|
6,904
|
6,747
|
6,817
|
6,889
|
7,052
|
7,310
|
Retail other
|
1,232
|
1,110
|
1,159
|
1,215
|
1,380
|
1,570
|
Corporate loans
|
21,197
|
18,889
|
19,793
|
20,827
|
23,238
|
28,340
|
Stage 2 Model ECL (£m)
|
|
|
|
|
|
|
Retail mortgages
|
4
|
1
|
2
|
3
|
8
|
16
|
Retail credit cards
|
1,473
|
1,387
|
1,422
|
1,459
|
1,567
|
1,714
|
Retail other
|
81
|
68
|
72
|
77
|
101
|
134
|
Corporate loans
|
532
|
424
|
461
|
505
|
655
|
932
|
Stage 2 Coverage (%)
|
|
|
|
|
|
|
Retail mortgages
|
—
|
—
|
—
|
—
|
—
|
0.1
|
Retail credit cards
|
21.3
|
20.6
|
20.9
|
21.2
|
22.2
|
23.4
|
Retail other
|
6.6
|
6.1
|
6.2
|
6.3
|
7.3
|
8.5
|
Corporate loans
|
2.5
|
2.2
|
2.3
|
2.4
|
2.8
|
3.3
|
Stage 3 Model Exposure
(£m)3
|
|
|
|
|
|
|
Retail mortgages
|
1,062
|
1,062
|
1,062
|
1,062
|
1,062
|
1,062
|
Retail credit cards
|
2,197
|
2,197
|
2,197
|
2,197
|
2,197
|
2,197
|
Retail other
|
158
|
158
|
158
|
158
|
158
|
158
|
Corporate loans
|
4,051
|
4,051
|
4,051
|
4,051
|
4,051
|
4,051
|
Stage 3 Model ECL (£m)
|
|
|
|
|
|
|
Retail mortgages
|
19
|
12
|
14
|
17
|
29
|
41
|
Retail credit cards
|
1,625
|
1,585
|
1,606
|
1,627
|
1,663
|
1,695
|
Retail other
|
92
|
90
|
91
|
92
|
95
|
97
|
Corporate loans4
|
71
|
66
|
67
|
69
|
79
|
89
|
Stage 3 Coverage (%)
|
|
|
|
|
|
|
Retail mortgages
|
1.8
|
1.1
|
1.3
|
1.6
|
2.7
|
3.9
|
Retail credit cards
|
74.0
|
72.1
|
73.1
|
74.1
|
75.7
|
77.2
|
Retail other
|
58.2
|
57.0
|
57.6
|
58.2
|
60.1
|
61.4
|
Corporate loans4
|
1.8
|
1.6
|
1.7
|
1.7
|
2.0
|
2.2
|
Total Model ECL (£m)
|
|
|
|
|
|
|
Retail mortgages
|
24
|
13
|
17
|
21
|
40
|
63
|
Retail credit cards
|
3,633
|
3,484
|
3,551
|
3,620
|
3,790
|
3,995
|
Retail other
|
207
|
190
|
195
|
202
|
232
|
271
|
Corporate loans4
|
873
|
725
|
775
|
832
|
1,045
|
1,384
|
Total Model ECL
|
4,737
|
4,412
|
4,538
|
4,675
|
5,107
|
5,713
|
Reconciliation to total ECL
|
£m
|
Total weighted model ECL
|
4,737
|
ECL from individually assessed exposures4
|
461
|
ECL from non-modelled exposures and others5
|
358
|
ECL from debt securities at amortised cost
|
23
|
ECL from held for sale assets (co-branded card
portfolio)
|
(282)
|
ECL from post model management adjustments
|
235
|
Of which: ECL from economic uncertainty adjustments
|
78
|
Total ECL
|
5,532
|
1
|
Model exposure and ECL reported within Retail credit cards and
Retail Other excludes the German consumer finance business, sale of
which completed after the balance sheet date. Model exposure and
ECL reported within Retail credit cards and Corporate loans
continues to include a co-branded card portfolio, as its sale is
expected to close in 2026.
|
2
|
Model exposures are allocated to a stage based on an individual
scenario rather than a probability-weighted approach as required
for Barclays reported impairment allowances. As a result, it is not
possible to back solve the final reported weighted ECL from
individual scenarios given balances may be assigned to a different
stage dependent on the scenario.
|
3
|
Model exposures allocated to Stage 3 does not change in any of the
scenarios as the transition criteria relies only on an observable
evidence of default as at 31 December 2024 and not on macroeconomic
scenario.
|
4
|
Material corporate loan defaults are individually assessed across
different recovery strategies. As a result, ECL of £461m is
reported as an individually assessed impairment in the
reconciliation table.
|
5
|
ECL from non-modelled exposures and
others includes ECL on Tesco Bank's retail banking business of
£209m calculated using a
benchmarked approach based on UK cards and UK retail loans. The
sensitivity of the non-modelled exposures would materially reflect
the sensitivity of the benchmarked model.
|
|
Barclays UK
|
|
Home loans principal portfolios
|
As at 30.06.25
|
As at 31.12.24
|
Gross loans and advances (£m)
|
166,960
|
163,197
|
90 day arrears rate, excluding recovery book (%)
|
0.2
|
0.2
|
Annualised gross charge-off rates - 180 days past due
(%)
|
0.5
|
0.5
|
Recovery book proportion of outstanding balances (%)
|
0.6
|
0.6
|
Recovery book impairment coverage ratio (%)1
|
4.1
|
3.7
|
|
|
|
Average marked to market LTV
|
|
|
Balance weighted %
|
53.8
|
53.0
|
Valuation weighted %
|
40.4
|
39.7
|
|
|
|
New lending
|
Half year ended 30.06.25
|
Half year ended 30.06.24
|
New home loan bookings (£m)
|
15,448
|
9,239
|
New home loan proportion > 90% LTV (%)
|
1.6
|
0.8
|
Average LTV on new home loans: balance weighted (%)
|
69.5
|
63.4
|
Average LTV on new home loans: valuation weighted (%)
|
60.7
|
54.1
|
1
|
Recovery Book Impairment Coverage Ratio excludes Kensington
Mortgages Company.
|
|
Distribution of balances
|
Distribution of impairment allowance
|
Coverage ratio
|
||||||||||
|
Stage 1
|
Stage 2
|
Stage 3
|
Total
|
Stage 1
|
Stage 2
|
Stage 3
|
Total
|
Stage 1
|
Stage 2
|
Stage 3
|
Total
|
|
|
Barclays UK
|
%
|
%
|
%
|
%
|
%
|
%
|
%
|
%
|
%
|
%
|
%
|
%
|
|
As at 30.06.25
|
|
|
|
|
|
|
|
|
|
|
|
|
|
<=75%
|
74.3
|
9.1
|
0.9
|
84.3
|
7.9
|
14.3
|
19.2
|
41.4
|
—
|
0.1
|
2.0
|
—
|
|
>75% and <=90%
|
13.6
|
1.1
|
0.1
|
14.8
|
11.6
|
22.4
|
10.5
|
44.5
|
0.1
|
1.8
|
12.7
|
0.3
|
|
>90% and <=100%
|
0.9
|
—
|
—
|
0.9
|
1.3
|
1.8
|
4.2
|
7.3
|
0.1
|
4.4
|
35.7
|
0.7
|
|
>100%
|
—
|
—
|
—
|
—
|
0.3
|
2.1
|
4.4
|
6.8
|
1.7
|
75.7
|
78.0
|
27.8
|
|
As at 31.12.24
|
|
|
|
|
|
|
|
|
|
|
|
|
|
<=75%
|
74.5
|
10.7
|
0.9
|
86.1
|
8.3
|
15.8
|
18.7
|
42.8
|
—
|
0.1
|
1.8
|
—
|
|
>75% and <=90%
|
11.8
|
1.2
|
0.1
|
13.1
|
10.2
|
24.2
|
9.7
|
44.1
|
0.1
|
1.7
|
13.0
|
0.3
|
|
>90% and <=100%
|
0.8
|
—
|
—
|
0.8
|
1.3
|
2.3
|
4.0
|
7.6
|
0.1
|
4.9
|
35.8
|
0.8
|
|
>100%
|
—
|
—
|
—
|
—
|
0.2
|
1.4
|
3.9
|
5.5
|
1.6
|
45.9
|
68.7
|
24.8
|
1
|
Portfolio marked to market based on the most updated valuation
including recovery book balances. Updated valuations reflect the
application of the latest HPI available as at 30 June
2025.
|
Principal portfolios
|
Gross exposure
|
30 day arrears rate, excluding recovery book
|
90 day arrears rate, excluding recovery book
|
Annualised gross write-off rate
|
Annualised net write-off rate
|
As at 30.06.25
|
£m
|
%
|
%
|
%
|
%
|
Barclays UK
|
|
|
|
|
|
UK cards1
|
16,455
|
0.7
|
0.2
|
0.9
|
0.8
|
UK personal loans1
|
8,389
|
1.0
|
0.4
|
0.8
|
0.7
|
Barclays Partner Finance
|
1,258
|
0.8
|
0.4
|
1.2
|
1.2
|
Barclays US Consumer Bank
|
|
|
|
|
|
US cards2
|
25,906
|
2.8
|
1.6
|
3.8
|
3.7
|
|
|
|
|
|
|
As at 31.12.24
|
|
|
|
|
|
Barclays UK
|
|
|
|
|
|
UK cards1
|
15,781
|
0.7
|
0.2
|
1.1
|
0.9
|
UK personal loans1
|
8,051
|
1.0
|
0.4
|
0.7
|
0.5
|
Barclays Partner Finance
|
1,609
|
0.6
|
0.3
|
1.0
|
1.0
|
Barclays US Consumer Bank
|
|
|
|
|
|
US cards2
|
28,548
|
3.0
|
1.6
|
3.8
|
3.7
|
1
|
Includes Tesco Bank. Tesco Bank arrears rates are calculated using
POCI balances adjusted to fair value.
|
2
|
Includes a co-branded card portfolio in USCB, classified as held
for sale (see table below).
|
Retail Credit Cards and Retail Other held for sale
|
Gross exposure
|
30 day arrears rate, excluding recovery book
|
90 day arrears rate, excluding recovery book
|
Annualised gross write-off rate
|
Annualised net write-off rate
|
As at 30.06.25
|
£m
|
%
|
%
|
%
|
%
|
Barclays US Consumer Bank
|
5,653
|
1.7
|
0.9
|
1.9
|
1.8
|
|
|
|
|
|
|
As at 31.12.24
|
|
|
|
|
|
Barclays US Consumer Bank
|
6,241
|
1.3
|
0.5
|
2.0
|
2.0
|
Head Office - German consumer finance business
|
3,733
|
1.8
|
0.9
|
1.3
|
1.2
|
Loans and advances to customers classified as assets held for
sale
|
|||||||||||||||
|
Stage 1
|
|
Stage 2
|
|
Stage 3
|
|
Total
|
||||||||
|
Gross
|
ECL
|
Coverage
|
|
Gross
|
ECL
|
Coverage
|
|
Gross
|
ECL
|
Coverage
|
|
Gross
|
ECL
|
Coverage
|
As at 30.06.25
|
£m
|
£m
|
%
|
|
£m
|
£m
|
%
|
|
£m
|
£m
|
%
|
|
£m
|
£m
|
%
|
Retail credit cards - US
|
4,988
|
55
|
1.1
|
|
613
|
139
|
22.7
|
|
52
|
42
|
80.8
|
|
5,653
|
236
|
4.2
|
Retail credit cards - Germany
|
—
|
—
|
—
|
|
—
|
—
|
—
|
|
—
|
—
|
—
|
|
—
|
—
|
—
|
Retail other - Germany
|
—
|
—
|
—
|
|
—
|
—
|
—
|
|
—
|
—
|
—
|
|
—
|
—
|
—
|
Corporate loans - US
|
43
|
1
|
2.3
|
|
7
|
2
|
28.6
|
|
1
|
1
|
100.0
|
|
51
|
4
|
7.8
|
Total Rest of the World
|
5,031
|
56
|
1.1
|
|
620
|
141
|
22.7
|
|
53
|
43
|
81.1
|
|
5,704
|
240
|
4.2
|
As at 31.12.24
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Retail credit cards - US
|
5,495
|
64
|
1.2
|
|
689
|
161
|
23.4
|
|
57
|
46
|
80.7
|
|
6,241
|
271
|
4.3
|
Retail credit cards - Germany
|
1,908
|
18
|
0.9
|
|
307
|
29
|
9.4
|
|
93
|
69
|
74.2
|
|
2,308
|
116
|
5.0
|
Retail other - Germany
|
1,134
|
16
|
1.4
|
|
220
|
33
|
15.0
|
|
71
|
48
|
67.6
|
|
1,425
|
97
|
6.8
|
Corporate loans - US
|
49
|
1
|
2.0
|
|
9
|
3
|
33.3
|
|
1
|
1
|
100.0
|
|
59
|
5
|
8.5
|
Total Rest of the World
|
8,586
|
99
|
1.2
|
|
1,225
|
226
|
18.4
|
|
222
|
164
|
73.9
|
|
10,033
|
489
|
4.9
|
Management adjustments to models for impairment allowance presented
by product
|
||||||
|
Impairment allowance pre management adjustments
|
Economic uncertainty
adjustments1
|
Other adjustments
|
Management adjustments
|
Total impairment allowance
|
Proportion of Management adjustments to Total impairment
allowance
|
|
|
|
|
|
|
|
As at 30.06.25
|
£m
|
£m
|
£m
|
£m
|
£m
|
%
|
Retail credit cards - US
|
235
|
6
|
—
|
6
|
241
|
2.5
|
Retail credit cards - Germany
|
—
|
—
|
—
|
—
|
—
|
—
|
Retail other - Germany
|
—
|
—
|
—
|
—
|
—
|
—
|
Corporate loans - US
|
4
|
—
|
—
|
—
|
4
|
—
|
Total Rest of the World
|
239
|
6
|
—
|
6
|
245
|
2.4
|
|
|
|
|
|
|
|
As at 31.12.24
|
£m
|
£m
|
£m
|
£m
|
£m
|
%
|
Retail credit cards - US
|
277
|
—
|
—
|
—
|
277
|
—
|
Retail credit cards - Germany
|
101
|
—
|
16
|
16
|
117
|
13.7
|
Retail other - Germany
|
80
|
—
|
17
|
17
|
97
|
17.5
|
Corporate loans - US
|
5
|
—
|
—
|
—
|
5
|
—
|
Total Rest of the World
|
463
|
—
|
33
|
33
|
496
|
6.7
|
1
|
Economic uncertainty adjustment of £6m (December 2024:
£nil) reflects an adjustment introduced during the year to
provide for the elevated US macroeconomic uncertainty and reported
in Stage 2.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Half year ended 30.06.25
|
|
Half year ended 31.12.24
|
|
Half year ended 30.06.24
|
||||||
|
Average
|
High
|
Low
|
|
Average
|
High
|
Low
|
|
Average
|
High
|
Low
|
|
£m
|
£m
|
£m
|
|
£m
|
£m
|
£m
|
|
£m
|
£m
|
£m
|
Credit risk
|
16
|
20
|
13
|
|
20
|
24
|
17
|
|
22
|
27
|
19
|
Interest rate risk
|
15
|
25
|
5
|
|
14
|
22
|
7
|
|
16
|
25
|
9
|
Equity risk
|
8
|
14
|
5
|
|
5
|
12
|
2
|
|
6
|
9
|
4
|
Basis risk
|
5
|
7
|
4
|
|
5
|
6
|
4
|
|
6
|
8
|
4
|
Spread risk
|
5
|
7
|
4
|
|
4
|
7
|
3
|
|
5
|
7
|
4
|
Foreign exchange risk
|
4
|
7
|
3
|
|
4
|
7
|
3
|
|
4
|
9
|
2
|
Commodity risk
|
—
|
1
|
—
|
|
—
|
1
|
—
|
|
—
|
1
|
—
|
Inflation risk
|
5
|
8
|
3
|
|
4
|
5
|
2
|
|
4
|
5
|
2
|
Diversification effect1
|
(39)
|
n/a
|
n/a
|
|
(32)
|
n/a
|
n/a
|
|
(34)
|
n/a
|
n/a
|
Total management VaR
|
19
|
30
|
10
|
|
24
|
32
|
15
|
|
29
|
36
|
20
|
1
|
Diversification effects recognise that forecast losses from
different assets or businesses are unlikely to occur concurrently,
hence the expected aggregate loss is lower than the sum of the
expected losses from each area. Historical correlations between
losses are taken into account in making these assessments. The high
and low VaR figures reported for each category did not necessarily
occur on the same day as the high and low total management VaR.
Consequently, a diversification effect balance for the high and low
VaR figures would not be meaningful and is therefore omitted from
the above table.
|
Liquidity coverage
ratio1
|
As at 30.06.25
|
As at 31.12.24
|
|
£bn
|
£bn
|
LCR Eligible High Quality Liquid Assets (HQLA)
|
309.7
|
304.4
|
Net stress outflows
|
(174.7)
|
(176.9)
|
Surplus
|
135.0
|
127.5
|
|
|
|
Liquidity coverage ratio
|
177.7%
|
172.4%
|
1
|
Represents the average of the last 12 spot month end
ratios.
|
Net Stable Funding
Ratio2
|
As at 30.06.25
|
As at 31.12.24
|
|
£bn
|
£bn
|
Total Available Stable Funding
|
634.2
|
629.6
|
Total Required Stable Funding
|
467.6
|
466.7
|
Surplus
|
166.6
|
162.9
|
|
|
|
Net Stable Funding Ratio
|
135.6%
|
134.9%
|
2
|
Represents the average of the last four spot month end
ratios
|
Composition of the Group liquidity pool
|
|
|
|
|
|
|
|
|
|
LCR eligible1
High Quality Liquid Assets
(HQLA)
|
|
Liquidity pool
|
|||||
|
Cash
|
Level 1
|
Level 2A
|
Level 2B
|
Total
|
|
2025
|
2024
|
|
£bn
|
£bn
|
£bn
|
£bn
|
£bn
|
|
£bn
|
£bn
|
Cash and deposits with central
banks2
|
217
|
0
|
0
|
0
|
217
|
|
235
|
216
|
|
|
|
|
|
|
|
|
|
Government bonds3
|
|
|
|
|
|
|
|
|
AAA to AA-
|
|
72
|
3
|
|
75
|
|
72
|
55
|
A+ to A-
|
|
2
|
|
|
2
|
|
2
|
2
|
BBB+ to BBB-
|
|
1
|
|
|
1
|
|
1
|
1
|
Total government bonds
|
|
75
|
3
|
|
78
|
|
75
|
58
|
|
|
|
|
|
|
|
|
|
Other
|
|
|
|
|
|
|
|
|
Government Guaranteed Issuers, PSEs and GSEs
|
|
4
|
2
|
|
6
|
|
9
|
9
|
International Organisations and MDBs
|
|
9
|
|
|
9
|
|
8
|
7
|
Covered bonds
|
|
2
|
4
|
|
6
|
|
6
|
7
|
Other
|
|
|
|
2
|
2
|
|
1
|
|
Total other
|
|
15
|
6
|
2
|
23
|
|
24
|
23
|
|
|
|
|
|
|
|
|
|
Total as at 30 June 2025
|
217
|
90
|
9
|
2
|
318
|
|
334
|
|
Total as at 31 December 2024
|
196
|
74
|
9
|
2
|
281
|
|
|
297
|
1
|
The LCR eligible HQLA is adjusted under the Liquidity Coverage
Ratio (CRR) Part of the PRA Rulebook for operational restrictions
upon consolidation, such as trapped liquidity within Barclays
subsidiaries. It also reflects differences in eligibility of assets
between the LCR and Barclays’ Liquidity Pool.
|
2
|
Includes cash held at central banks and surplus cash at central
banks related to payment schemes. Over 99% (December 2024: over
98%) was placed with the Bank of England, US Federal Reserve,
European Central Bank, Bank of Japan and Swiss National
Bank.
|
3
|
Of which over 86% (December 2024: over 85%) comprised UK, US,
French, German, Japanese, Swiss and Dutch securities.
|
|
As at 30.06.25
|
|
As at 31.12.24
|
||
|
Loans and advances, debt securities at amortised cost
|
Deposits at amortised cost
|
Loan: deposit ratio1
|
|
Loan: deposit ratio1
|
Funding of loans and advances
|
£bn
|
£bn
|
%
|
|
%
|
Barclays UK
|
227
|
241
|
94
|
|
92
|
Barclays UK Corporate Bank
|
28
|
85
|
33
|
|
31
|
Barclays Private Bank and Wealth Management
|
15
|
67
|
22
|
|
21
|
Barclays Investment Bank
|
126
|
149
|
85
|
|
88
|
Barclays US consumer Bank
|
19
|
23
|
83
|
|
91
|
Head Office
|
3
|
—
|
|
|
|
Barclays Group
|
418
|
565
|
74
|
|
74
|
1
|
The loan: deposit ratio is calculated as loans and advances at
amortised cost and debt securities at amortised cost divided by
deposits at amortised cost.
|
|
As at 30.06.25
|
As at 31.12.24
|
|
|
As at 30.06.25
|
As at 31.12.24
|
Assets
|
£bn
|
£bn
|
|
Liabilities and equity
|
£bn
|
£bn
|
Loans and advances at amortised cost1
|
390
|
392
|
|
Deposits at amortised cost
|
565
|
561
|
Group liquidity pool
|
334
|
297
|
|
<1 Year wholesale funding
|
73
|
55
|
|
|
|
|
>1 Year wholesale funding
|
131
|
131
|
Reverse repurchase agreements, trading portfolio assets, cash
collateral and settlement balances
|
507
|
433
|
|
Repurchase agreements, trading portfolio liabilities, cash
collateral and settlement balances
|
430
|
358
|
Derivative financial instruments
|
280
|
294
|
|
Derivative financial instruments
|
265
|
279
|
Other assets2
|
88
|
102
|
|
Other liabilities
|
59
|
62
|
|
|
|
|
Equity
|
76
|
72
|
Total assets
|
1,599
|
1,518
|
|
Total liabilities and equity
|
1,599
|
1,518
|
1
|
Adjusted for liquidity pool debt securities reported at amortised
cost of £28bn (December 2024: £22bn).
|
2
|
Other assets include fair value assets that are not part of reverse
repurchase agreements or trading portfolio assets, and other asset
categories.
|
Maturity profile of wholesale
funding2
|
|
|
|
|
|
|
|
|
|
|
|
|
<1 month
|
1-3 months
|
3-6 months
|
6-12 months
|
<1 year
|
1-2 years
|
2-3 years
|
3-4 years
|
4-5 years
|
>5 years
|
Total
|
|
£bn
|
£bn
|
£bn
|
£bn
|
£bn
|
£bn
|
£bn
|
£bn
|
£bn
|
£bn
|
£bn
|
Barclays PLC (the Parent company)
|
|
|
|
|
|
|
|
|
|
|
|
Senior unsecured (Public benchmark)
|
—
|
—
|
—
|
3.9
|
3.9
|
5.7
|
6.7
|
6.6
|
4.7
|
26.7
|
54.3
|
Senior unsecured (Privately placed)
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
0.2
|
0.8
|
1.0
|
Subordinated liabilities
|
—
|
—
|
—
|
1.5
|
1.5
|
—
|
1.5
|
—
|
1.0
|
7.4
|
11.4
|
Barclays Bank PLC (including subsidiaries)
|
|
|
|
|
|
|
|
|
|
|
|
Senior unsecured (Privately placed)3
|
2.8
|
4.1
|
5.4
|
9.7
|
22.0
|
11.3
|
13.0
|
9.7
|
8.6
|
20.1
|
84.7
|
Certificates of deposit and commercial paper
|
3.0
|
3.1
|
11.9
|
9.8
|
27.8
|
0.3
|
—
|
—
|
—
|
—
|
28.1
|
Asset backed commercial paper
|
4.1
|
6.7
|
1.3
|
—
|
12.1
|
—
|
—
|
—
|
—
|
—
|
12.1
|
Asset backed securities
|
—
|
—
|
0.7
|
0.4
|
1.1
|
0.2
|
0.2
|
0.5
|
—
|
2.5
|
4.5
|
Subordinated liabilities
|
0.1
|
0.1
|
—
|
—
|
0.2
|
0.5
|
0.1
|
—
|
—
|
0.3
|
1.1
|
Barclays Bank UK PLC (including subsidiaries)
|
|
|
|
|
|
|
|
|
|
|
|
Senior unsecured (Privately placed)
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
0.2
|
0.2
|
Certificates of deposit and commercial paper
|
3.6
|
—
|
—
|
—
|
3.6
|
—
|
—
|
—
|
—
|
—
|
3.6
|
Covered bonds
|
—
|
—
|
—
|
—
|
—
|
—
|
0.5
|
0.7
|
0.7
|
—
|
1.9
|
Asset backed securities
|
—
|
—
|
—
|
0.6
|
0.6
|
—
|
—
|
—
|
—
|
—
|
0.6
|
Total as at 30 June 2025
|
13.6
|
14.0
|
19.3
|
25.9
|
72.8
|
18.0
|
22.0
|
17.5
|
15.2
|
58.0
|
203.5
|
Of which secured
|
4.1
|
6.7
|
2.0
|
1.0
|
13.8
|
0.2
|
0.7
|
1.2
|
0.7
|
2.5
|
19.1
|
Of which unsecured
|
9.5
|
7.3
|
17.3
|
24.9
|
59.0
|
17.8
|
21.3
|
16.3
|
14.5
|
55.5
|
184.4
|
|
|
|
|
|
|
|
|
|
|
|
|
Total as at 31 December 2024
|
7.9
|
21.3
|
11.9
|
13.9
|
55.0
|
23.0
|
17.5
|
18.6
|
15.1
|
56.8
|
186.0
|
Of which secured
|
2.4
|
8.8
|
2.1
|
0.8
|
14.1
|
1.1
|
0.5
|
0.9
|
0.6
|
3.3
|
20.5
|
Of which unsecured
|
5.5
|
12.5
|
9.8
|
13.1
|
40.9
|
21.9
|
17.0
|
17.7
|
14.5
|
53.5
|
165.5
|
1
|
Term funding comprises public benchmark and privately placed senior
unsecured notes, covered bonds, asset-backed securities and
subordinated debt where the original maturity of the instrument is
more than 1 year.
|
2
|
The composition of wholesale funds comprises the balance sheet
reported financial liabilities at fair value, debt securities in
issue and subordinated liabilities. It does not include
participation in the central bank facilities reported within
repurchase agreements and other similar secured
borrowing.
|
3
|
Includes structured notes of £71.0bn, of which £19.1bn
matures within one year.
|
Barclays Bank PLC
|
Standard & Poor's
|
Moody's
|
Fitch
|
Long-term
|
A+ / Stable
|
A1 / Stable
|
A+ / Stable
|
Short-term
|
A-1
|
P-1
|
F1
|
|
|
|
|
Barclays Bank UK PLC
|
|
|
|
Long-term
|
A+ / Stable
|
A11
/ Stable
|
A+ / Stable
|
Short-term
|
A-1
|
P-11
|
F1
|
|
|
|
|
Barclays PLC
|
|
|
|
Long-term
|
BBB+ / Stable
|
Baa1 / Stable
|
A / Stable
|
Short-term
|
A-2
|
P-2
|
F1
|
1
|
Deposit ratings.
|
Capital ratios1,2
|
As at 30.06.25
|
As at 31.03.25
|
As at 31.12.24
|
CET1
|
14.0%
|
13.9%
|
13.6%
|
T1
|
17.8%
|
17.7%
|
16.9%
|
Total regulatory capital
|
20.5%
|
20.6%
|
19.6%
|
MREL ratio as a percentage of total RWAs
|
35.4%
|
36.2%
|
34.4%
|
|
|
|
|
Own funds and eligible liabilities
|
£m
|
£m
|
£m
|
Total equity excluding non-controlling interests per the balance
sheet
|
75,906
|
74,880
|
71,821
|
Less: other equity instruments (recognised as AT1
capital)
|
(13,266)
|
(13,263)
|
(12,075)
|
Adjustment to retained earnings for foreseeable ordinary share
dividends
|
(600)
|
(1,086)
|
(786)
|
Adjustment to retained earnings for foreseeable repurchase of
shares
|
(171)
|
(664)
|
—
|
Adjustment to retained earnings for foreseeable other equity
coupons
|
(37)
|
(49)
|
(35)
|
|
|
|
|
Other regulatory adjustments and deductions
|
|
|
|
Additional value adjustments (PVA)
|
(1,887)
|
(1,795)
|
(2,051)
|
Goodwill and intangible assets
|
(8,158)
|
(8,247)
|
(8,272)
|
Deferred tax assets that rely on future profitability excluding
temporary differences
|
(1,303)
|
(1,408)
|
(1,451)
|
Fair value reserves related to gains or losses on cash flow
hedges
|
1,210
|
2,378
|
2,930
|
Excess of expected losses over impairment
|
(331)
|
(306)
|
(403)
|
Gains or losses on liabilities at fair value resulting from own
credit
|
456
|
799
|
981
|
Defined benefit pension fund assets
|
(2,177)
|
(2,326)
|
(2,367)
|
Direct and indirect holdings by an institution of own CET1
instruments
|
(5)
|
(4)
|
(1)
|
Adjustment under IFRS 9 transitional arrangements
|
—
|
—
|
138
|
Other regulatory adjustments
|
(92)
|
(115)
|
129
|
CET1 capital
|
49,545
|
48,794
|
48,558
|
|
|
|
|
AT1 capital
|
|
|
|
Capital instruments and related share premium accounts
|
13,289
|
13,289
|
12,108
|
Other regulatory adjustments and deductions
|
(23)
|
(26)
|
(32)
|
AT1 capital
|
13,266
|
13,263
|
12,076
|
|
|
|
|
T1 capital
|
62,811
|
62,057
|
60,634
|
|
|
|
|
T2 capital
|
|
|
|
Capital instruments and related share premium accounts
|
9,498
|
9,988
|
9,150
|
Qualifying T2 capital (including minority interests) issued by
subsidiaries
|
76
|
337
|
367
|
Other regulatory adjustments and deductions
|
(81)
|
(43)
|
(33)
|
Total regulatory capital
|
72,304
|
72,339
|
70,118
|
|
|
|
|
Less : Ineligible T2 capital (including minority interests) issued
by subsidiaries
|
(76)
|
(337)
|
(367)
|
Eligible liabilities
|
52,733
|
55,159
|
53,547
|
Total own funds and eligible
liabilities3
|
124,961
|
127,161
|
123,298
|
|
|
|
|
Total RWAs
|
353,043
|
351,314
|
358,127
|
1
|
2024 comparatives for Capital and RWAs have been calculated
applying the IFRS 9 transitional arrangements in accordance with
the CRR. Effective from 1 January 2025, the IFRS 9 transitional
arrangements no longer applied.
|
2
|
2024 and Q1 2025 comparatives for total capital were calculated
applying the grandfathering of certain capital instruments within
Tier 2 capital. Effective from 29 June 2025, the grandfathered
instruments no longer qualified as Tier 2 capital.
|
3
|
As at 30 June 2025, the Group's MREL requirement, excluding the
institution-specific confidential PRA buffer, was to hold
£108.3bn of own funds and eligible liabilities equating to
30.7% of RWAs. The Group remains above its MREL regulatory
requirement including the institution-specific confidential PRA
buffer.
|
Movement in CET1 capital
|
Three months ended 30.06.25
|
Six months ended 30.06.25
|
|
£m
|
£m
|
Opening CET1 capital
|
48,794
|
48,558
|
|
|
|
Profit for the period attributable to equity holders
|
1,911
|
4,007
|
Own credit relating to derivative liabilities
|
6
|
(11)
|
Ordinary share dividends paid and foreseen
|
(300)
|
(600)
|
Purchased and foreseeable share repurchase
|
—
|
(1,000)
|
Other equity coupons paid and foreseen
|
(240)
|
(486)
|
Increase in retained regulatory capital generated from
earnings
|
1,377
|
1,910
|
|
|
|
Net impact of share schemes
|
201
|
(48)
|
Fair value through other comprehensive income reserve
|
175
|
408
|
Currency translation reserve
|
(1,025)
|
(1,571)
|
Other reserves
|
(69)
|
(67)
|
Decrease in other qualifying reserves
|
(718)
|
(1,278)
|
|
|
|
Pension remeasurements within reserves
|
(152)
|
(200)
|
Defined benefit pension fund asset deduction
|
149
|
190
|
Net impact of pensions
|
(3)
|
(10)
|
|
|
|
Additional value adjustments (PVA)
|
(92)
|
164
|
Goodwill and intangible assets
|
89
|
114
|
Deferred tax assets that rely on future profitability excluding
those arising from temporary differences
|
105
|
148
|
Excess of expected loss over impairment
|
(25)
|
72
|
Direct and indirect holdings by an institution of own CET1
instruments
|
(1)
|
(4)
|
Adjustment under IFRS 9 transitional arrangements
|
—
|
(138)
|
Other regulatory adjustments
|
19
|
9
|
Increase in regulatory capital due to adjustments and
deductions
|
95
|
365
|
|
|
|
Closing CET1 capital
|
49,545
|
49,545
|
RWAs by risk type and business
|
|||||||||||||
|
Credit risk
|
|
Counterparty credit risk
|
|
Market Risk
|
|
Operational risk
|
Total RWAs
|
|||||
|
STD
|
IRB
|
|
STD
|
IRB
|
Settlement Risk
|
CVA
|
|
STD
|
IMA
|
|
|
|
As at 30.06.25
|
£m
|
£m
|
|
£m
|
£m
|
£m
|
£m
|
|
£m
|
£m
|
|
£m
|
£m
|
Barclays UK
|
16,186
|
56,362
|
|
130
|
9
|
—
|
83
|
|
145
|
—
|
|
13,196
|
86,111
|
Barclays UK Corporate Bank
|
3,993
|
16,917
|
|
134
|
387
|
—
|
12
|
|
2
|
562
|
|
3,282
|
25,289
|
Barclays Private Bank & Wealth Management
|
4,892
|
497
|
|
172
|
26
|
1
|
19
|
|
49
|
394
|
|
1,870
|
7,920
|
Barclays Investment Bank
|
38,634
|
46,858
|
|
23,025
|
22,135
|
121
|
3,779
|
|
13,257
|
24,343
|
|
24,293
|
196,445
|
Barclays US Consumer Bank
|
18,900
|
889
|
|
—
|
6
|
—
|
—
|
|
—
|
—
|
|
4,856
|
24,651
|
Head Office
|
5,622
|
5,662
|
|
1
|
6
|
—
|
2
|
|
13
|
98
|
|
1,223
|
12,627
|
Barclays Group
|
88,227
|
127,185
|
|
23,462
|
22,569
|
122
|
3,895
|
|
13,466
|
25,397
|
|
48,720
|
353,043
|
As at 31.03.25
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Barclays UK
|
15,346
|
56,050
|
|
140
|
5
|
—
|
47
|
|
184
|
—
|
|
13,196
|
84,968
|
Barclays UK Corporate Bank
|
3,780
|
16,213
|
|
105
|
348
|
—
|
11
|
|
2
|
471
|
|
3,282
|
24,212
|
Barclays Private Bank & Wealth Management
|
5,025
|
495
|
|
127
|
51
|
—
|
18
|
|
48
|
330
|
|
1,870
|
7,964
|
Barclays Investment Bank
|
40,169
|
45,915
|
|
22,924
|
22,540
|
139
|
3,190
|
|
13,458
|
23,306
|
|
24,293
|
195,934
|
Barclays US Consumer Bank
|
19,723
|
993
|
|
—
|
—
|
—
|
—
|
|
—
|
—
|
|
4,856
|
25,572
|
Head Office
|
5,516
|
5,808
|
|
1
|
13
|
—
|
2
|
|
19
|
82
|
|
1,223
|
12,664
|
Barclays Group
|
89,559
|
125,474
|
|
23,297
|
22,957
|
139
|
3,268
|
|
13,711
|
24,189
|
|
48,720
|
351,314
|
As at 31.12.24
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Barclays UK
|
15,516
|
55,301
|
|
146
|
11
|
—
|
74
|
|
228
|
—
|
|
13,181
|
84,457
|
Barclays UK Corporate Bank
|
3,932
|
15,680
|
|
106
|
336
|
—
|
12
|
|
16
|
548
|
|
3,282
|
23,912
|
Barclays Private Bank & Wealth Management
|
5,058
|
434
|
|
118
|
31
|
—
|
16
|
|
44
|
330
|
|
1,859
|
7,890
|
Barclays Investment Bank
|
40,957
|
49,231
|
|
21,889
|
24,094
|
70
|
2,913
|
|
12,442
|
23,023
|
|
24,164
|
198,783
|
Barclays US Consumer Bank
|
21,019
|
966
|
|
—
|
—
|
—
|
—
|
|
—
|
—
|
|
4,864
|
26,849
|
Head Office
|
6,580
|
8,162
|
|
1
|
20
|
—
|
4
|
|
—
|
212
|
|
1,257
|
16,236
|
Barclays Group
|
93,062
|
129,774
|
|
22,260
|
24,492
|
70
|
3,019
|
|
12,730
|
24,113
|
|
48,607
|
358,127
|
Movement analysis of RWAs
|
Credit risk
|
Counterparty credit risk
|
Market risk
|
Operational risk
|
Total RWAs
|
|
£m
|
£m
|
£m
|
£m
|
£m
|
RWAs as at 31.12.24
|
222,836
|
49,841
|
36,843
|
48,607
|
358,127
|
Book size
|
2,661
|
2,760
|
2,803
|
113
|
8,337
|
Acquisitions and disposals
|
(3,299)
|
—
|
—
|
—
|
(3,299)
|
Book quality
|
(1,121)
|
(121)
|
—
|
—
|
(1,242)
|
Model updates
|
304
|
68
|
—
|
—
|
372
|
Methodology and policy
|
(242)
|
(189)
|
—
|
—
|
(431)
|
Foreign exchange movements1
|
(5,727)
|
(2,311)
|
(783)
|
—
|
(8,821)
|
Total RWA movements
|
(7,424)
|
207
|
2,020
|
113
|
(5,084)
|
RWAs as at 30.06.25
|
215,412
|
50,048
|
38,863
|
48,720
|
353,043
|
1
|
Foreign exchange movements does not include the impact of foreign
exchange for modelled market risk or operational risk.
|
Leverage ratios1
|
As at 30.06.25
|
As at 31.03.25
|
As at 31.12.24
|
£m
|
£m
|
£m
|
|
UK leverage ratio2
|
5.0%
|
5.0%
|
5.0%
|
T1 capital
|
62,811
|
62,057
|
60,634
|
UK leverage exposure
|
1,259,772
|
1,252,827
|
1,206,502
|
Average UK leverage ratio
|
4.7%
|
4.6%
|
4.6%
|
Average T1 capital
|
61,716
|
61,641
|
60,291
|
Average UK leverage exposure
|
1,324,772
|
1,340,481
|
1,308,335
|
1
|
2024 comparatives for UK leverage ratios have been calculated
applying the IFRS 9 transitional arrangements in accordance with
the CRR. Effective from 1 January 2025, the IFRS 9 transitional
arrangements no longer applied.
|
2
|
Although the leverage ratio is expressed in terms of T1 capital,
the leverage ratio buffers and 75% of the minimum requirement must
be covered solely with CET1 capital. The CET1 capital held against
the 0.53% G-SII ALRB was £6.6bn and against the 0.4% CCLB was
£5.0bn.
|
C.S. Venkatakrishnan
|
Anna Cross
|
Group Chief Executive
|
Group Finance Director
|
Chairman
|
Executive Directors
|
Non-Executive Directors
|
Nigel Higgins
|
C.S. Venkatakrishnan
|
Robert Berry
|
|
Anna Cross
|
Dawn Fitzpatrick
|
|
|
Mary Francis CBE
|
|
|
Brian Gilvary
|
|
|
Sir John Kingman
|
|
|
Diony Lebot
|
|
|
Mary Mack
|
|
|
Marc Moses
|
|
|
Brian Shea
|
|
|
Julia Wilson
|
|
|
|
Condensed consolidated income statement (unaudited)
|
|||
|
|
Half year ended 30.06.25
|
Half year ended 30.06.24
|
|
Notes1
|
£m
|
£m
|
Interest and similar income
|
|
18,264
|
18,642
|
Interest and similar expense
|
|
(11,242)
|
(12,514)
|
Net interest income
|
|
7,022
|
6,128
|
Fee and commission income
|
3
|
5,656
|
5,429
|
Fee and commission expense
|
3
|
(1,972)
|
(1,691)
|
Net fee and commission income
|
3
|
3,684
|
3,738
|
Net trading income
|
|
4,171
|
3,228
|
Net investment (expense)/ income
|
|
(18)
|
160
|
Other income
|
|
37
|
23
|
Total income
|
|
14,896
|
13,277
|
|
|
|
|
Staff costs
|
4
|
(5,254)
|
(4,964)
|
Infrastructure, administration and general expenses
|
5
|
(3,153)
|
(3,033)
|
UK regulatory levies
|
|
(96)
|
(120)
|
Litigation and conduct
|
|
(87)
|
(64)
|
Operating expenses
|
|
(8,590)
|
(8,181)
|
|
|
|
|
Share of post-tax results of associates and joint
ventures
|
|
9
|
16
|
Profit before impairment
|
|
6,315
|
5,112
|
Credit impairment charges
|
|
(1,112)
|
(897)
|
Profit before tax
|
|
5,203
|
4,215
|
Tax charge
|
|
(1,173)
|
(892)
|
Profit after tax
|
|
4,030
|
3,323
|
|
|
|
|
Attributable to:
|
|
|
|
Shareholders of the parent
|
|
3,523
|
2,787
|
Other equity holders
|
|
484
|
510
|
Equity holders of the parent
|
|
4,007
|
3,297
|
Non-controlling interests
|
|
23
|
26
|
Profit after tax
|
|
4,030
|
3,323
|
|
|
|
|
Earnings per share
|
|
|
|
Basic earnings per ordinary share
|
6
|
24.7p
|
18.6p
|
Diluted earnings per ordinary share
|
6
|
23.8p
|
18.1p
|
|
|
|
|
1
|
For Notes to the Financial Statements see pages 69 to
89.
|
Condensed consolidated statement of comprehensive income
(unaudited)
|
|||
|
|
Half year ended 30.06.25
|
Half year ended 30.06.24
|
|
Notes1
|
£m
|
£m
|
Profit after tax
|
|
4,030
|
3,323
|
|
|
|
|
Other comprehensive income/(loss) that
may be recycled to profit or loss:2
|
|
|
|
Currency translation reserve
|
14
|
(1,571)
|
(84)
|
Fair value through other comprehensive income reserve
|
14
|
408
|
(269)
|
Cash flow hedging reserve
|
14
|
1,720
|
(90)
|
Other comprehensive income/(loss) that may be recycled to
profit
|
|
557
|
(443)
|
|
|
|
|
Other comprehensive income/(loss) not
recycled to profit or loss:2
|
|
|
|
Retirement benefit remeasurements
|
13
|
(200)
|
(97)
|
Own credit
|
14
|
516
|
(462)
|
Other comprehensive income/(loss) not recycled to
profit
|
|
316
|
(559)
|
|
|
|
|
Other comprehensive income/(loss) for the period
|
|
873
|
(1,002)
|
|
|
|
|
Total comprehensive income for the period
|
|
4,903
|
2,321
|
|
|
|
|
Attributable to:
|
|
|
|
Equity holders of the parent
|
|
4,880
|
2,295
|
Non-controlling interests
|
|
23
|
26
|
Total comprehensive income for the period
|
|
4,903
|
2,321
|
|
|
|
|
1
|
For Notes to the Financial Statements see pages 69 to
89.
|
2
|
Reported net of tax.
|
Condensed consolidated balance sheet (unaudited)
|
|||
|
|
As at 30.06.25
|
As at 31.12.24
|
Assets
|
Notes1
|
£m
|
£m
|
Cash and balances at central banks
|
|
225,723
|
210,184
|
Cash collateral and settlement balances
|
|
152,316
|
119,843
|
Debt securities at amortised cost
|
|
69,936
|
68,210
|
Loans and advances at amortised cost to banks
|
|
8,697
|
8,327
|
Loans and advances at amortised cost to customers
|
|
339,131
|
337,946
|
Reverse repurchase agreements and other similar secured lending at
amortised cost
|
|
7,917
|
4,734
|
Trading portfolio assets
|
|
187,223
|
166,453
|
Financial assets at fair value through the income
statement
|
|
218,552
|
193,734
|
Derivative financial instruments
|
8
|
280,194
|
293,530
|
Financial assets at fair value through other comprehensive
income
|
|
77,311
|
78,059
|
Investments in associates and joint ventures
|
|
913
|
891
|
Goodwill and intangible assets
|
10
|
8,186
|
8,275
|
Property, plant and equipment
|
|
3,504
|
3,604
|
Current tax assets
|
|
174
|
155
|
Deferred tax assets
|
|
5,241
|
6,321
|
Retirement benefit assets
|
13
|
2,997
|
3,263
|
Assets included in a disposal group classified as held for
sale
|
|
5,585
|
9,854
|
Other assets
|
|
5,100
|
4,819
|
Total assets
|
|
1,598,700
|
1,518,202
|
|
|
|
|
Liabilities
|
|
|
|
Deposits at amortised cost from banks
|
|
19,348
|
13,203
|
Deposits at amortised cost from customers
|
|
545,187
|
547,460
|
Cash collateral and settlement balances
|
|
140,011
|
106,229
|
Repurchase agreements and other similar secured borrowings at
amortised cost
|
|
35,469
|
39,415
|
Debt securities in issue
|
|
104,910
|
92,402
|
Subordinated liabilities
|
11
|
12,529
|
11,921
|
Trading portfolio liabilities
|
|
69,305
|
56,908
|
Financial liabilities designated at fair value
|
|
317,485
|
282,224
|
Derivative financial instruments
|
8
|
265,376
|
279,415
|
Current tax liabilities
|
|
905
|
566
|
Deferred tax liabilities
|
|
18
|
18
|
Retirement benefit liabilities
|
13
|
244
|
240
|
Provisions
|
12
|
1,364
|
1,383
|
Liabilities included in a disposal group classified as held for
sale
|
|
—
|
3,726
|
Other liabilities
|
|
10,194
|
10,611
|
Total liabilities
|
|
1,522,345
|
1,445,721
|
|
|
|
|
Equity
|
|
|
|
Called up share capital and share premium
|
|
4,201
|
4,186
|
Other reserves
|
14
|
693
|
(468)
|
Retained earnings
|
|
57,746
|
56,028
|
Shareholders' equity attributable to ordinary shareholders of the
parent
|
|
62,640
|
59,746
|
Other equity instruments
|
|
13,266
|
12,075
|
Total equity excluding non-controlling interests
|
|
75,906
|
71,821
|
Non-controlling interests2
|
|
449
|
660
|
Total equity
|
|
76,355
|
72,481
|
|
|
|
|
Total liabilities and equity
|
|
1,598,700
|
1,518,202
|
1
|
For Notes to the Financial Statements see pages 69 to
89.
|
2
|
On 16 June 2025, Barclays Bank PLC redeemed and cancelled the
outstanding 4.75% Non-Cumulative Callable Euro Preference Series 2
Shares. The principal outstanding was €319m. The movement of
£211m in non-controlling interests relates to transfer of the
share premium from the original issuance to retained
earnings.
|
Condensed consolidated statement of changes in equity
(unaudited)
|
|||||||
|
Called up share capital and share
premium1,2
|
Other equity
instruments3
|
Other reserves4
|
Retained earnings
|
Total
|
Non-controlling
interests5
|
Total equity
|
Half year ended 30.06.2025
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
Balance as at 1 January 2025
|
4,186
|
12,075
|
(468)
|
56,028
|
71,821
|
660
|
72,481
|
Profit after tax
|
—
|
484
|
—
|
3,523
|
4,007
|
23
|
4,030
|
Currency translation movements
|
—
|
—
|
(1,571)
|
—
|
(1,571)
|
—
|
(1,571)
|
Fair value through other comprehensive income reserve
|
—
|
—
|
408
|
—
|
408
|
—
|
408
|
Cash flow hedges
|
—
|
—
|
1,720
|
—
|
1,720
|
—
|
1,720
|
Retirement benefit remeasurements
|
—
|
—
|
—
|
(200)
|
(200)
|
—
|
(200)
|
Own credit
|
—
|
—
|
516
|
—
|
516
|
—
|
516
|
Total comprehensive income for the period
|
—
|
484
|
1,073
|
3,323
|
4,880
|
23
|
4,903
|
Employee share schemes and hedging thereof
|
82
|
—
|
—
|
669
|
751
|
—
|
751
|
Issue and redemption of other equity instruments
|
—
|
1,182
|
—
|
(5)
|
1,177
|
—
|
1,177
|
Other equity instruments coupon paid
|
—
|
(484)
|
—
|
—
|
(484)
|
—
|
(484)
|
Redemption of preference shares
|
—
|
—
|
—
|
(59)
|
(59)
|
(211)
|
(270)
|
Vesting of employee share schemes net of purchases
|
—
|
—
|
19
|
(585)
|
(566)
|
—
|
(566)
|
Dividends paid
|
—
|
—
|
—
|
(791)
|
(791)
|
(23)
|
(814)
|
Repurchase of shares
|
(67)
|
—
|
67
|
(834)
|
(834)
|
—
|
(834)
|
Other movements
|
—
|
9
|
2
|
—
|
11
|
—
|
11
|
Balance as at 30 June 2025
|
4,201
|
13,266
|
693
|
57,746
|
75,906
|
449
|
76,355
|
Condensed consolidated statement of changes in equity
(unaudited)
|
|||||||
|
Called up share capital and share
premium1,
2
|
Other equity
instruments3
|
Other reserves4
|
Retained earnings
|
Total
|
Non-controlling interests
|
Total equity
|
Half year ended 31.12.2024
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
Balance as at 1 July 2024
|
4,256
|
12,959
|
(882)
|
54,840
|
71,173
|
660
|
71,833
|
Profit after tax
|
—
|
481
|
—
|
2,529
|
3,010
|
23
|
3,033
|
Currency translation movements
|
—
|
—
|
38
|
—
|
38
|
—
|
38
|
Fair value through other comprehensive income reserve
|
—
|
—
|
(238)
|
—
|
(238)
|
—
|
(238)
|
Cash flow hedges
|
—
|
—
|
867
|
—
|
867
|
—
|
867
|
Retirement benefit remeasurements
|
—
|
—
|
—
|
(206)
|
(206)
|
—
|
(206)
|
Own credit
|
—
|
—
|
(360)
|
—
|
(360)
|
—
|
(360)
|
Total comprehensive income for the period
|
—
|
481
|
307
|
2,323
|
3,111
|
23
|
3,134
|
Employee share schemes and hedging thereof
|
38
|
—
|
—
|
292
|
330
|
—
|
330
|
Issue and redemption of other equity instruments
|
—
|
(892)
|
—
|
(4)
|
(896)
|
—
|
(896)
|
Other equity instruments coupon paid
|
—
|
(481)
|
—
|
—
|
(481)
|
—
|
(481)
|
Vesting of employee shares scheme net of purchases
|
—
|
—
|
(4)
|
(20)
|
(24)
|
—
|
(24)
|
Dividends paid
|
—
|
—
|
—
|
(425)
|
(425)
|
(23)
|
(448)
|
Repurchase of shares
|
(108)
|
—
|
108
|
(978)
|
(978)
|
—
|
(978)
|
Other movements
|
—
|
8
|
3
|
—
|
11
|
—
|
11
|
Balance as at 31 December 2024
|
4,186
|
12,075
|
(468)
|
56,028
|
71,821
|
660
|
72,481
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Condensed consolidated statement of changes in equity
(unaudited)
|
|||||||
|
Called up share capital and share
premium1,
2
|
Other equity
instruments3
|
Other reserves4
|
Retained earnings
|
Total
|
Non-controlling interests
|
Total equity
|
Half year ended 30.06.24
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
Balance as at 1 January 2024
|
4,288
|
13,259
|
(77)
|
53,734
|
71,204
|
660
|
71,864
|
Profit after tax
|
—
|
510
|
—
|
2,787
|
3,297
|
26
|
3,323
|
Currency translation movements
|
—
|
—
|
(84)
|
—
|
(84)
|
—
|
(84)
|
Fair value through other comprehensive income reserve
|
—
|
—
|
(269)
|
—
|
(269)
|
—
|
(269)
|
Cash flow hedges
|
—
|
—
|
(90)
|
—
|
(90)
|
—
|
(90)
|
Retirement benefit remeasurements
|
—
|
—
|
—
|
(97)
|
(97)
|
—
|
(97)
|
Own credit
|
—
|
—
|
(462)
|
—
|
(462)
|
—
|
(462)
|
Total comprehensive income for the period
|
—
|
510
|
(905)
|
2,690
|
2,295
|
26
|
2,321
|
Employee share schemes and hedging thereof
|
65
|
—
|
—
|
582
|
647
|
—
|
647
|
Issue and redemption of other equity instruments
|
—
|
(263)
|
—
|
(92)
|
(355)
|
—
|
(355)
|
Other equity instruments coupon paid
|
—
|
(510)
|
—
|
—
|
(510)
|
—
|
(510)
|
Vesting of employee shares scheme net of purchases
|
—
|
—
|
3
|
(488)
|
(485)
|
—
|
(485)
|
Dividends paid
|
—
|
—
|
—
|
(796)
|
(796)
|
(26)
|
(822)
|
Repurchase of shares
|
(97)
|
—
|
97
|
(782)
|
(782)
|
—
|
(782)
|
Other movements
|
—
|
(37)
|
—
|
(8)
|
(45)
|
—
|
(45)
|
Balance as at 30 June 2024
|
4,256
|
12,959
|
(882)
|
54,840
|
71,173
|
660
|
71,833
|
|
|
|
|
|
|
|
|
1
|
As at 30 June 2025, Called up share capital comprises 14,180m
(December 2024: 14,420m) ordinary shares of 25p each.
|
2
|
During the six months ended 30 June 2025, Barclays PLC announced,
alongside its FY24 results, a share buyback programme of
£1,000m. This programme was partially executed during the
period, with completion occurring on 24 July 2025. As part of this
buyback, 270 million shares were repurchased and cancelled in the
period. The nominal value of £67 million relating to these
shares was transferred from Share capital to the Capital redemption
reserve within Other reserves. In the year ended 31 December 2024,
Barclays PLC completed two separate share buyback programmes
totalling £1,750m. A total of 818 million shares were
repurchased and cancelled, with a nominal value of £205
million transferred from Share capital to the Capital redemption
reserve within Other reserves.
|
3
|
Other equity instruments of £13,266m (December 2024:
£12,075m) comprise AT1 securities issued by Barclays PLC.
There were two issuances in the form of Fixed Rate Resetting
Perpetual Subordinated Contingent Convertible Securities for
£2,177m (net of £9m issuance costs) and one redemption of
£995m (net of £5m issuance costs, transferred to retained
earnings on redemption) for the period ended 30 June 2025. During
the period ended 31 December 2024, there were two issuances in the
form of Fixed Rate Resetting Perpetual Subordinated Contingent
Convertible Securities, for £1,598m, which includes issuance
costs of £6m and two redemptions totalling
£2,753m.
|
4
|
Details are shown in Note 14 - Other reserves on page
81.
|
5
|
On 16 June 2025, Barclays Bank PLC redeemed and cancelled the
outstanding 4.75% Non-Cumulative Callable Euro Preference Series 2
Shares. The principal outstanding was €319m. The movement of
£211m in non-controlling interests relates to transfer of the
share premium from the original issuance to retained
earnings.
|
Condensed consolidated cash flow statement (unaudited)
|
||
|
Half year ended 30.06.25
|
Half year ended 30.06.24
|
|
£m
|
£m
|
Profit before tax
|
5,203
|
4,215
|
Adjustment for non-cash and other items
|
9,466
|
4,976
|
Net (increase)/decrease in loans and advances at amortised
cost
|
(1,950)
|
1,839
|
Net increase in deposits at amortised cost
|
3,872
|
18,663
|
Net increase/(decrease) in debt securities in issue
|
8,195
|
(1,686)
|
Changes in other operating assets and liabilities
|
(3,772)
|
10,103
|
Corporate income tax paid
|
(712)
|
(540)
|
Net cash from operating activities
|
20,302
|
37,570
|
Net cash from investing activities
|
(4,184)
|
(16,333)
|
Net cash from financing
activities1
|
3,720
|
166
|
Effect of exchange rates on cash and cash equivalents
|
(2,632)
|
(1,624)
|
Net increase in cash and cash equivalents
|
17,206
|
19,779
|
Cash and cash equivalents at beginning of the period
|
235,611
|
248,007
|
Cash and cash equivalents at end of the period
|
252,817
|
267,786
|
1
|
Issuance and redemption of debt securities included in financing
activities relate to instruments that qualify as eligible
liabilities and satisfy regulatory requirements for MREL
instruments which came into effect during 2019
|
Analysis of results by business
|
|
|
|
|
|
|
|
|
Barclays UK
|
Barclays UK Corporate Bank
|
Barclays Private Bank and Wealth Management
|
Barclays Investment Bank
|
Barclays US Consumer Bank
|
Head Office
|
Barclays Group
|
Half year ended 30.06.25
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
Net interest income
|
3,677
|
701
|
407
|
631
|
1,318
|
288
|
7,022
|
Non-interest income/(expense)
|
516
|
302
|
290
|
6,549
|
369
|
(152)
|
7,874
|
Total income
|
4,193
|
1,003
|
697
|
7,180
|
1,687
|
136
|
14,896
|
Of which inter-segmental income/(expense)
|
1
|
985
|
915
|
(1,895)
|
(3)
|
(3)
|
—
|
|
|
|
|
|
|
|
|
Operating costs
|
(2,283)
|
(474)
|
(472)
|
(3,993)
|
(803)
|
(382)
|
(8,407)
|
UK regulatory levies
|
(43)
|
(24)
|
(2)
|
(27)
|
—
|
—
|
(96)
|
Litigation and conduct
|
(29)
|
(39)
|
—
|
(11)
|
(3)
|
(5)
|
(87)
|
Total operating expenses
|
(2,355)
|
(537)
|
(474)
|
(4,031)
|
(806)
|
(387)
|
(8,590)
|
Other net income1
|
—
|
—
|
—
|
—
|
—
|
9
|
9
|
Profit/(loss) before impairment
|
1,838
|
466
|
223
|
3,149
|
881
|
(242)
|
6,315
|
Credit impairment (charges)/ releases
|
(237)
|
(31)
|
11
|
(139)
|
(711)
|
(5)
|
(1,112)
|
Profit/(loss) before tax
|
1,601
|
435
|
234
|
3,010
|
170
|
(247)
|
5,203
|
|
|
|
|
|
|
|
|
As at 30.06.25
|
£bn
|
£bn
|
£bn
|
£bn
|
£bn
|
£bn
|
£bn
|
Total assets
|
299.7
|
68.2
|
41.8
|
1,133.1
|
31.4
|
24.5
|
1,598.7
|
Total liabilities
|
282.8
|
101.9
|
76.3
|
1,026.6
|
23.6
|
11.1
|
1,522.3
|
|
Barclays UK
|
Barclays UK Corporate Bank
|
Barclays Private Bank and Wealth Management
|
Barclays Investment Bank
|
Barclays US Consumer Bank
|
Head Office
|
Barclays Group
|
Half year ended 30.06.24
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
Net interest income
|
3,146
|
573
|
362
|
465
|
1,334
|
248
|
6,128
|
Non-interest income
|
567
|
304
|
270
|
5,882
|
344
|
(218)
|
7,149
|
Total income
|
3,713
|
877
|
632
|
6,347
|
1,678
|
30
|
13,277
|
Of which inter-segmental income/(expense)
|
(23)
|
1,221
|
1,045
|
(1,951)
|
(3)
|
(289)
|
—
|
|
|
|
|
|
|
|
|
Operating costs
|
(2,048)
|
(456)
|
(434)
|
(3,858)
|
(796)
|
(406)
|
(7,997)
|
UK regulatory levies
|
(54)
|
(30)
|
(3)
|
(33)
|
—
|
—
|
(120)
|
Litigation and conduct
|
(6)
|
—
|
1
|
(11)
|
(4)
|
(43)
|
(64)
|
Total operating expenses
|
(2,108)
|
(486)
|
(436)
|
(3,902)
|
(800)
|
(449)
|
(8,181)
|
Other net income
|
—
|
—
|
—
|
—
|
—
|
16
|
16
|
Profit/(loss) before impairment
|
1,605
|
391
|
196
|
2,445
|
878
|
(403)
|
5,112
|
Credit impairment (charges)/releases
|
(66)
|
(23)
|
3
|
(34)
|
(719)
|
(58)
|
(897)
|
Profit/(loss) before tax
|
1,539
|
368
|
199
|
2,411
|
159
|
(461)
|
4,215
|
|
|
|
|
|
|
|
|
As at 31.12.24
|
£bn
|
£bn
|
£bn
|
£bn
|
£bn
|
£bn
|
£bn
|
Total assets
|
299.8
|
61.2
|
34.1
|
1,053.9
|
35.4
|
33.8
|
1,518.2
|
Total liabilities
|
284.1
|
94.4
|
75.0
|
952.1
|
24.5
|
15.6
|
1,445.7
|
1
|
Other net income/(expense) represents the share of post-tax results
of associates and joint ventures, profit (or loss) on disposal of
subsidiaries, associates and joint ventures and gains on
acquisitions.
|
|
Barclays UK
|
Barclays UK Corporate Bank
|
Barclays Private Bank and Wealth Management
|
Barclays Investment Bank
|
Barclays US consumer Bank
|
Head Office
|
Barclays Group
|
Half year ended 30.06.25
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
Fee type
|
|
|
|
|
|
|
|
Transactional
|
608
|
229
|
15
|
171
|
1,333
|
140
|
2,496
|
Advisory
|
—
|
—
|
166
|
282
|
—
|
—
|
448
|
Brokerage and execution
|
100
|
—
|
79
|
979
|
—
|
—
|
1,158
|
Underwriting and syndication
|
18
|
51
|
—
|
1,391
|
—
|
—
|
1,460
|
Other
|
6
|
—
|
—
|
—
|
—
|
9
|
15
|
Total revenue from contracts with customers
|
732
|
280
|
260
|
2,823
|
1,333
|
149
|
5,577
|
Other non-contract fee income
|
—
|
14
|
—
|
65
|
—
|
—
|
79
|
Fee and commission income
|
732
|
294
|
260
|
2,888
|
1,333
|
149
|
5,656
|
Fee and commission expense
|
(242)
|
(46)
|
(18)
|
(675)
|
(959)
|
(32)
|
(1,972)
|
Net fee and commission income
|
490
|
248
|
242
|
2,213
|
374
|
117
|
3,684
|
|
Barclays UK
|
Barclays UK Corporate Bank
|
Barclays Private Bank and Wealth Management
|
Barclays Investment Bank
|
Barclays US consumer Bank
|
Head Office
|
Barclays Group
|
Half year ended 30.06.24
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
Fee type
|
|
|
|
|
|
|
|
Transactional
|
551
|
232
|
16
|
171
|
1,320
|
171
|
2,461
|
Advisory
|
—
|
—
|
156
|
325
|
—
|
—
|
481
|
Brokerage and execution
|
107
|
—
|
62
|
776
|
—
|
—
|
945
|
Underwriting and syndication
|
17
|
46
|
—
|
1,391
|
—
|
—
|
1,454
|
Other
|
13
|
—
|
—
|
—
|
—
|
6
|
19
|
Total revenue from contracts with customers
|
688
|
278
|
234
|
2,663
|
1,320
|
177
|
5,360
|
Other non-contract fee income
|
—
|
11
|
—
|
58
|
—
|
—
|
69
|
Fee and commission income
|
688
|
289
|
234
|
2,721
|
1,320
|
177
|
5,429
|
Fee and commission expense
|
(177)
|
(43)
|
(19)
|
(516)
|
(893)
|
(43)
|
(1,691)
|
Net fee and commission income
|
511
|
246
|
215
|
2,205
|
427
|
134
|
3,738
|
|
Half year ended 30.06.25
|
Half year ended 30.06.24
|
Compensation costs
|
£m
|
£m
|
Upfront bonus charge
|
679
|
675
|
Deferred bonus charge
|
304
|
269
|
Other incentives
|
29
|
35
|
Performance costs
|
1,012
|
979
|
Salaries
|
2,549
|
2,491
|
Social security costs
|
442
|
395
|
Post-retirement benefits
|
280
|
296
|
Other compensation costs
|
354
|
282
|
Total compensation costs
|
4,637
|
4,443
|
|
|
|
Other resourcing costs
|
|
|
Outsourcing
|
437
|
299
|
Redundancy and restructuring
|
83
|
138
|
Temporary staff costs
|
33
|
31
|
Other
|
64
|
53
|
Total other resourcing costs
|
617
|
521
|
|
|
|
Total staff costs
|
5,254
|
4,964
|
|
|
|
Barclays Group compensation costs as a % of total
income
|
31.1%
|
33.5%
|
|
Half year ended 30.06.25
|
Half year ended 30.06.24
|
Infrastructure costs
|
£m
|
£m
|
Property and equipment
|
923
|
857
|
Depreciation and amortisation
|
885
|
843
|
Impairment of property, equipment and intangible
assets
|
8
|
4
|
Total infrastructure costs
|
1,816
|
1,704
|
|
|
|
Administration and general expenses
|
|
|
Consultancy, legal and professional fees
|
371
|
388
|
Marketing and advertising
|
287
|
308
|
Other administration and general expenses
|
679
|
633
|
Total administration and general expenses
|
1,337
|
1,329
|
|
|
|
Total infrastructure, administration and general
expenses
|
3,153
|
3,033
|
|
Half year ended 30.06.25
|
Half year ended 30.06.24
|
|
£m
|
£m
|
Profit attributable to ordinary equity holders of the
parent
|
3,523
|
2,787
|
|
|
|
|
m
|
m
|
Basic weighted average number of shares in issue
|
14,262
|
14,972
|
Number of potential ordinary shares
|
513
|
445
|
Diluted weighted average number of shares
|
14,775
|
15,417
|
|
|
|
|
p
|
p
|
Basic earnings per ordinary share
|
24.7
|
18.6
|
Diluted earnings per ordinary share
|
23.8
|
18.1
|
|
Half year ended 30.06.25
|
Half year ended 30.06.24
|
||
|
Per share
|
Total
|
Per share
|
Total
|
Dividends paid during the period
|
p
|
£m
|
p
|
£m
|
Full year dividend paid during period
|
5.50
|
791
|
5.30
|
796
|
|
Contract notional amount
|
|
Fair value
|
|
|
|
Assets
|
Liabilities
|
|
As at 30.06.25
|
£m
|
|
£m
|
£m
|
Foreign exchange derivatives
|
9,404,176
|
|
96,359
|
(93,246)
|
Interest rate derivatives
|
81,608,401
|
|
95,461
|
(81,613)
|
Credit derivatives
|
1,710,599
|
|
8,471
|
(8,994)
|
Equity and stock index and commodity derivatives
|
3,488,521
|
|
76,562
|
(80,909)
|
Derivative assets/(liabilities) held for trading
|
96,211,697
|
|
276,853
|
(264,762)
|
|
|
|
|
|
Derivatives in hedge accounting relationships
|
|
|
|
|
Derivatives designated as cash flow hedges
|
151,346
|
|
3,070
|
(92)
|
Derivatives designated as fair value hedges
|
161,698
|
|
71
|
(476)
|
Derivatives designated as hedges of net investments
|
4,412
|
|
200
|
(46)
|
Derivative assets/(liabilities) designated in hedge accounting
relationships
|
317,456
|
|
3,341
|
(614)
|
|
|
|
|
|
Total recognised derivative assets/(liabilities)
|
96,529,153
|
|
280,194
|
(265,376)
|
|
|
|
|
|
As at 31.12.24
|
|
|
|
|
Foreign exchange derivatives
|
8,517,266
|
|
123,724
|
(116,671)
|
Interest rate derivatives
|
70,905,836
|
|
95,631
|
(83,967)
|
Credit derivatives
|
1,537,115
|
|
6,898
|
(7,455)
|
Equity and stock index and commodity derivatives
|
3,164,854
|
|
64,738
|
(70,502)
|
Derivative assets/(liabilities) held for trading
|
84,125,071
|
|
290,991
|
(278,595)
|
|
|
|
|
|
Derivatives in hedge accounting relationships
|
|
|
|
|
Derivatives designated as cash flow hedges
|
147,180
|
|
2,338
|
(320)
|
Derivatives designated as fair value hedges
|
159,182
|
|
165
|
(434)
|
Derivatives designated as hedges of net investments
|
4,014
|
|
36
|
(66)
|
Derivative assets/(liabilities) designated in hedge accounting
relationships
|
310,376
|
|
2,539
|
(820)
|
|
|
|
|
|
Total recognised derivative assets/(liabilities)
|
84,435,447
|
|
293,530
|
(279,415)
|
|
Valuation technique using
|
|
||
|
Quoted market prices
|
Observable inputs
|
Significant unobservable inputs
|
|
|
(Level 1)
|
(Level 2)
|
(Level 3)
|
Total
|
As at 30.06.25
|
£m
|
£m
|
£m
|
£m
|
Trading portfolio assets
|
87,555
|
89,789
|
9,879
|
187,223
|
Financial assets at fair value through the income
statement
|
7,702
|
202,019
|
8,831
|
218,552
|
Derivative financial instruments
|
108
|
278,097
|
1,989
|
280,194
|
Financial assets at fair value through other comprehensive
income
|
24,755
|
49,378
|
3,178
|
77,311
|
Investment property
|
—
|
—
|
42
|
42
|
Total assets
|
120,120
|
619,283
|
23,919
|
763,322
|
Trading portfolio liabilities
|
(39,606)
|
(29,275)
|
(424)
|
(69,305)
|
Financial liabilities designated at fair value
|
(1,576)
|
(313,061)
|
(2,848)
|
(317,485)
|
Derivative financial instruments
|
(93)
|
(262,422)
|
(2,861)
|
(265,376)
|
Total liabilities
|
(41,275)
|
(604,758)
|
(6,133)
|
(652,166)
|
|
|
|
|
|
As at 31.12.24
|
|
|
|
|
Trading portfolio assets
|
77,761
|
78,577
|
10,115
|
166,453
|
Financial assets at fair value through the income
statement
|
3,526
|
181,784
|
8,424
|
193,734
|
Derivative financial instruments
|
101
|
291,352
|
2,077
|
293,530
|
Financial assets at fair value through other comprehensive
income
|
25,913
|
48,407
|
3,739
|
78,059
|
Investment property
|
—
|
—
|
9
|
9
|
Total assets
|
107,301
|
600,120
|
24,364
|
731,785
|
Trading portfolio liabilities
|
(27,694)
|
(28,819)
|
(395)
|
(56,908)
|
Financial liabilities designated at fair value
|
(181)
|
(278,785)
|
(3,258)
|
(282,224)
|
Derivative financial instruments
|
(86)
|
(276,148)
|
(3,181)
|
(279,415)
|
Total liabilities
|
(27,961)
|
(583,752)
|
(6,834)
|
(618,547)
|
As at 30.06.25
|
Loans
|
Corporate debt
|
Asset backed securities
|
Government debt
|
Private equity investments
|
Issued debt
|
Reverse repurchase and repurchase agreements
|
Interest rate derivatives
|
Equity derivatives
|
Other products1
|
Total
|
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
Trading portfolio assets
|
5,468
|
1,843
|
883
|
1,199
|
—
|
—
|
—
|
—
|
—
|
486
|
9,879
|
Financial assets at fair value through the income
statement
|
6,096
|
835
|
178
|
32
|
1,187
|
—
|
402
|
—
|
—
|
101
|
8,831
|
Derivative financial instruments
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
915
|
617
|
457
|
1,989
|
Financial assets at fair value through other comprehensive
income
|
2,350
|
67
|
757
|
—
|
4
|
—
|
—
|
—
|
—
|
—
|
3,178
|
Investment property
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
42
|
42
|
Total assets
|
13,914
|
2,745
|
1,818
|
1,231
|
1,191
|
—
|
402
|
915
|
617
|
1,086
|
23,919
|
Trading portfolio liabilities
|
—
|
(36)
|
—
|
(325)
|
—
|
—
|
—
|
—
|
—
|
(63)
|
(424)
|
Financial liabilities designated at fair value
|
—
|
—
|
—
|
—
|
(17)
|
(1,575)
|
(1,240)
|
—
|
—
|
(16)
|
(2,848)
|
Derivative financial instruments
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
(774)
|
(1,349)
|
(738)
|
(2,861)
|
Total liabilities
|
—
|
(36)
|
—
|
(325)
|
(17)
|
(1,575)
|
(1,240)
|
(774)
|
(1,349)
|
(817)
|
(6,133)
|
As at 31.12.24
|
Loans
|
Corporate debt
|
Asset backed securities
|
Government debt
|
Private equity investments
|
Issued debt
|
Reverse repurchase and repurchase agreements
|
Interest rate derivatives
|
Equity derivatives
|
Other products1
|
Total
|
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
Trading portfolio assets
|
6,146
|
1,590
|
991
|
1,018
|
—
|
—
|
—
|
—
|
—
|
370
|
10,115
|
Financial assets at fair value through the income
statement
|
5,455
|
913
|
139
|
35
|
1,166
|
—
|
539
|
—
|
—
|
177
|
8,424
|
Derivative financial instruments
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
1,193
|
481
|
403
|
2,077
|
Financial assets at fair value through other comprehensive
income
|
2,858
|
108
|
757
|
12
|
4
|
—
|
—
|
—
|
—
|
—
|
3,739
|
Investment property
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
9
|
9
|
Total assets
|
14,459
|
2,611
|
1,887
|
1,065
|
1,170
|
—
|
539
|
1,193
|
481
|
959
|
24,364
|
Trading portfolio liabilities
|
—
|
(374)
|
(6)
|
—
|
—
|
—
|
—
|
—
|
—
|
(15)
|
(395)
|
Financial liabilities designated at fair value
|
—
|
—
|
—
|
—
|
(17)
|
(1,842)
|
(1,379)
|
—
|
—
|
(20)
|
(3,258)
|
Derivative financial instruments
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
(1,013)
|
(1,219)
|
(949)
|
(3,181)
|
Total liabilities
|
—
|
(374)
|
(6)
|
—
|
(17)
|
(1,842)
|
(1,379)
|
(1,013)
|
(1,219)
|
(984)
|
(6,834)
|
1
|
Other products include funds and fund-linked products, equity cash
products, investment property, credit derivatives and foreign
exchange derivatives.
|
Analysis of movements in Level 3 assets and
liabilities
|
|
|
|
|
|
|
|||||
|
As at 01.01.25
|
|
|
|
|
Total gains and (losses) in the period recognised in the income
statement
|
Total gains and (losses) in the period recognised in
OCI
|
Transfers
|
As at 30.06.25
|
||
|
Purchases
|
Sales
|
Issues
|
Settlements
|
Trading income2
|
Other income
|
In
|
Out
|
|||
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
Trading portfolio assets
|
10,115
|
4,125
|
(3,524)
|
—
|
(1,147)
|
136
|
—
|
—
|
439
|
(265)
|
9,879
|
Financial assets at fair value through the income
statement
|
8,424
|
2,469
|
(1,200)
|
—
|
(573)
|
(75)
|
8
|
—
|
63
|
(285)
|
8,831
|
Financial assets at fair value through other comprehensive
income
|
3,739
|
566
|
(1,447)
|
—
|
(6)
|
2
|
29
|
—
|
307
|
(12)
|
3,178
|
Investment property
|
9
|
33
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
42
|
Trading portfolio liabilities
|
(395)
|
(46)
|
28
|
—
|
—
|
37
|
—
|
—
|
(57)
|
9
|
(424)
|
Financial liabilities designated at fair value
|
(3,258)
|
—
|
91
|
(617)
|
31
|
88
|
—
|
—
|
(179)
|
996
|
(2,848)
|
Net derivative financial instruments1
|
(1,104)
|
(17)
|
249
|
—
|
—
|
166
|
3
|
—
|
(34)
|
(135)
|
(872)
|
Total
|
17,530
|
7,130
|
(5,803)
|
(617)
|
(1,695)
|
354
|
40
|
—
|
539
|
308
|
17,786
|
Analysis of movements in Level 3 assets and
liabilities
|
|
|
|
|
|
|
|||||
|
As at 01.01.24
|
|
|
|
|
Total gains and (losses) in the period recognised in the income
statement
|
Total gains and (losses) in the period recognised in
OCI
|
Transfers
|
As at 30.06.24
|
||
|
Purchases
|
Sales
|
Issues
|
Settlements
|
Trading income2
|
Other income
|
In
|
Out
|
|||
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
Trading portfolio assets
|
6,509
|
3,113
|
(1,007)
|
—
|
(714)
|
(7)
|
—
|
—
|
1,046
|
(214)
|
8,726
|
Financial assets at fair value through the income
statement
|
8,249
|
2,804
|
(1,484)
|
—
|
(380)
|
(19)
|
174
|
—
|
291
|
(118)
|
9,517
|
Financial assets at fair value through other comprehensive
income
|
1,078
|
1,854
|
(42)
|
—
|
—
|
1
|
11
|
—
|
—
|
(448)
|
2,454
|
Investment property
|
2
|
—
|
(1)
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
1
|
Trading portfolio liabilities
|
(368)
|
(24)
|
17
|
—
|
—
|
18
|
—
|
—
|
(34)
|
6
|
(385)
|
Financial liabilities designated at fair value
|
(1,222)
|
(6)
|
28
|
(627)
|
16
|
(27)
|
(21)
|
—
|
(881)
|
248
|
(2,492)
|
Net derivative financial instruments1
|
(1,113)
|
(182)
|
32
|
(19)
|
(169)
|
(181)
|
—
|
—
|
21
|
109
|
(1,502)
|
Total
|
13,135
|
7,559
|
(2,457)
|
(646)
|
(1,247)
|
(215)
|
164
|
—
|
443
|
(417)
|
16,319
|
1
|
Derivative financial instruments are presented on a net basis. On a
gross basis, derivative financial assets were £1,989m (June
2024: £2,833m) and derivative financial liabilities were
£(2,861)m (June 2024: £(4,335)m).
|
2
|
Trading income represents gains and losses on Level 3 financial
instruments which in the majority are offset by losses and gains on
financial instruments disclosed in Level 2.
|
|
Half year ended 30.06.25
|
Half year ended 30.06.24
|
||||||
|
Income statement
|
Other comprehensive income
|
Total
|
Income statement
|
Other comprehensive income
|
Total
|
||
|
Trading income1
|
Other income
|
Trading income1
|
Other income
|
||||
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
Trading portfolio assets
|
21
|
—
|
—
|
21
|
(2)
|
—
|
—
|
(2)
|
Financial assets at fair value through the income
statement
|
(74)
|
7
|
—
|
(67)
|
1
|
47
|
—
|
48
|
Financial assets at fair value through other comprehensive
income
|
1
|
28
|
—
|
29
|
1
|
11
|
—
|
12
|
Investment property
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
Trading portfolio liabilities
|
34
|
—
|
—
|
34
|
17
|
—
|
—
|
17
|
Financial liabilities designated at fair value
|
87
|
—
|
—
|
87
|
(29)
|
(10)
|
—
|
(39)
|
Net derivative financial instruments
|
164
|
3
|
—
|
167
|
(180)
|
—
|
—
|
(180)
|
Total
|
233
|
38
|
—
|
271
|
(192)
|
48
|
—
|
(144)
|
1
|
Trading income represents gains and losses on Level 3 financial
instruments which in the majority are offset by losses and gains on
financial instruments disclosed in Level 2.
|
Sensitivity analysis of valuations using unobservable inputs
(Relates to Level 3 Portfolios)
|
||||||||
|
|
|
|
|
|
|
|
|
|
As at 30.06.25
|
As at 31.12.24
|
||||||
|
Favourable changes
|
Unfavourable changes
|
Favourable changes
|
Unfavourable changes
|
||||
|
Income statement
|
Equity
|
Income statement
|
Equity
|
Income statement
|
Equity
|
Income statement
|
Equity
|
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
Loans
|
306
|
38
|
(285)
|
(38)
|
653
|
43
|
(766)
|
(43)
|
Corporate debt
|
77
|
1
|
(49)
|
(1)
|
87
|
—
|
(56)
|
—
|
Asset backed securities
|
83
|
8
|
(57)
|
(8)
|
57
|
4
|
(40)
|
(4)
|
Government debt
|
54
|
—
|
(62)
|
—
|
47
|
—
|
(56)
|
—
|
Private equity investments
|
230
|
1
|
(230)
|
(1)
|
232
|
—
|
(232)
|
—
|
Interest rate derivatives
|
85
|
—
|
(158)
|
—
|
98
|
—
|
(212)
|
—
|
Equity derivatives
|
221
|
—
|
(261)
|
—
|
199
|
—
|
(269)
|
—
|
Other Products1
|
84
|
—
|
(99)
|
—
|
92
|
—
|
(104)
|
—
|
Total
|
1,140
|
48
|
(1,201)
|
(48)
|
1,465
|
47
|
(1,735)
|
(47)
|
1
|
Other products includes funds and fund linked products, equity cash
products, credit derivatives and foreign exchange
derivatives.
|
|
As at 30.06.25
|
As at 31.12.24
|
|
£m
|
£m
|
Exit price adjustments derived from market bid-offer
spreads
|
(536)
|
(542)
|
Uncollateralised derivative funding
|
28
|
19
|
Derivative credit valuation adjustments
|
(189)
|
(184)
|
Derivative debit valuation adjustments
|
117
|
108
|
|
As at 30.06.25
|
As at 31.12.24
|
||
|
Carrying amount
|
Fair value
|
Carrying amount
|
Fair value
|
Financial assets
|
£m
|
£m
|
£m
|
£m
|
Debt securities at amortised cost
|
69,936
|
69,528
|
68,210
|
67,354
|
Loans and advances at amortised cost
|
347,828
|
345,952
|
346,273
|
343,016
|
Reverse repurchase agreements and other similar secured
lending
|
7,917
|
7,917
|
4,734
|
4,734
|
|
|
|
|
|
Financial liabilities
|
|
|
|
|
Deposits at amortised cost
|
(564,535)
|
(564,669)
|
(560,663)
|
(560,393)
|
Repurchase agreements and other similar secured
borrowing
|
(35,469)
|
(35,469)
|
(39,415)
|
(39,415)
|
Debt securities in issue
|
(104,910)
|
(106,837)
|
(92,402)
|
(94,463)
|
Subordinated liabilities
|
(12,529)
|
(12,978)
|
(11,921)
|
(12,434)
|
|
Half year ended 30.06.25
|
Year ended 31.12.24
|
|
£m
|
£m
|
Opening balance as at 1 January
|
11,921
|
10,494
|
Issuances
|
1,045
|
1,870
|
Redemptions
|
(115)
|
(476)
|
Other
|
(322)
|
33
|
Closing balance
|
12,529
|
11,921
|
|
As at 30.06.25
|
As at 31.12.24
|
|
£m
|
£m
|
Customer redress
|
295
|
299
|
Legal, competition and regulatory matters
|
97
|
59
|
Redundancy and restructuring
|
183
|
213
|
Undrawn contractually committed facilities and
guarantees
|
425
|
439
|
Onerous leases
|
—
|
14
|
Sundry provisions
|
364
|
359
|
Total
|
1,364
|
1,383
|
|
As at 30.06.25
|
As at 31.12.24
|
|
£m
|
£m
|
Currency translation reserve
|
2,054
|
3,625
|
Fair value through other comprehensive income reserve
|
(1,465)
|
(1,873)
|
Cash flow hedging reserve
|
(1,210)
|
(2,930)
|
Own credit reserve
|
(541)
|
(1,059)
|
Other reserves and treasury shares
|
1,855
|
1,769
|
Total
|
693
|
(468)
|
|
As at 30.06.25
|
As at 31.12.24
|
Contingent liabilities and financial guarantees
|
£m
|
£m
|
Guarantees and letters of credit pledged as collateral
security
|
16,685
|
16,713
|
Performance guarantees, acceptances and endorsements
|
8,762
|
8,633
|
Total
|
25,447
|
25,346
|
|
|
|
Commitments
|
|
|
Documentary credits and other short-term trade related
transactions
|
1,252
|
1,433
|
Standby facilities, credit lines and other
commitments1
|
408,805
|
421,716
|
Total
|
410,057
|
423,149
|
1
|
Includes exposures relating to financial assets classified as
assets held for sale.
|
|
As at 30.06.25
|
As at 31.12.24
|
Assets included in disposal groups classified as held for
sale
|
£m
|
£m
|
Loans and advances to customers
|
5,464
|
9,544
|
Intangible assets
|
10
|
25
|
Property, plant and equipment
|
—
|
24
|
Other assets
|
111
|
261
|
Total assets classified as held for sale
|
5,585
|
9,854
|
|
|
|
Liabilities included in disposal groups classified as held for
sale
|
|
|
Deposits from customers
|
—
|
3,647
|
Other liabilities
|
—
|
77
|
Provisions
|
—
|
2
|
Total liabilities classified as held for sale
|
—
|
3,726
|
|
|
|
Net assets classified as held for sale
|
5,585
|
6,128
|
Measure
|
Definition
|
Loan: deposit ratio
|
Total loans and advances at amortised cost divided by total
deposits at amortised cost.
|
Attributable profit
|
Profit after tax attributable to ordinary shareholders of the
parent.
|
Period end tangible equity refers to:
|
|
Period end tangible shareholders' equity (for Barclays
Group)
|
Shareholders' equity attributable to ordinary shareholders of the
parent, adjusted for the deduction of goodwill and intangible
assets.
|
Period end allocated tangible equity (for businesses)
|
Allocated tangible equity is calculated as 13.5% (2024: 13.5%) of
RWAs for each business, adjusted for capital deductions, excluding
goodwill and intangible assets, reflecting the assumptions the
Barclays Group uses for capital planning purposes. Head Office
allocated tangible equity represents the difference between the
Barclays Group’s tangible shareholders’ equity and the
amounts allocated to businesses.
|
Average tangible equity refers to:
|
|
Average tangible shareholders’ equity (for Barclays
Group)
|
Calculated as the average of the previous month’s period end
tangible shareholders' equity and the current month’s period
end tangible shareholders' equity. The average tangible
shareholders’ equity for the period is the average of the
monthly averages within that period.
|
Average allocated tangible equity (for businesses)
|
Calculated as the average of the previous month’s period end
allocated tangible equity and the current month’s period end
allocated tangible equity. The average allocated tangible equity
for the period is the average of the monthly averages within that
period.
|
Return on tangible equity (RoTE) refers to:
|
|
Return on average tangible shareholders’ equity (for Barclays
Group)
|
Annualised Group attributable profit, as a proportion of average
tangible shareholders’ equity. The components of the
calculation have been included on pages 90 to 91.
|
Return on average allocated tangible equity (for
businesses)
|
Annualised business attributable profit, as a proportion of that
business's average allocated tangible equity. The components of the
calculation have been included on pages 92 to 93.
|
|
|
Operating expenses excluding litigation and conduct
|
A measure of total operating expenses excluding litigation and
conduct charges.
|
Operating costs
|
A measure of total operating expenses excluding litigation and
conduct charges and UK regulatory levies.
|
Cost: income ratio
|
Total operating expenses divided by total income.
|
Loan loss rate
|
Quoted in basis points and represents total impairment charges
divided by total gross loans and advances held at amortised cost
(including portfolios reclassified to assets held for sale) at the
balance sheet date. The components of the calculation have been
included on pages 94 to 96.
|
Net interest margin
|
Annualised net interest income divided by the sum of average
customer assets. The components of the calculation have been
included on page 25.
|
Tangible net asset value per share
|
Calculated by dividing shareholders’ equity, excluding
non-controlling interests and other equity instruments, less
goodwill and intangible assets, by the number of issued ordinary
shares. The components of the calculation have been included on
page 96.
|
Profit before impairment
|
Calculated by excluding credit impairment charges or releases from
profit before tax.
|
Structural cost actions
|
Cost actions taken to improve future financial
performance.
|
Group net interest income excluding Barclays Investment Bank and
Head Office
|
A measure of Barclays Group net interest income, excluding the net
interest income reported in Barclays Investment Bank and Head
Office.
|
|
Half year ended 30.06.25
|
|
|||||
|
Barclays UK
|
Barclays UK Corporate Bank
|
Barclays Private Bank and Wealth Management
|
Barclays Investment Bank
|
Barclays US Consumer Bank
|
Head Office
|
Barclays Group
|
Return on average tangible equity
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
Attributable profit/(loss)
|
1,090
|
284
|
184
|
2,075
|
128
|
(238)
|
3,523
|
|
|
|
|
|
|
|
|
|
£bn
|
£bn
|
£bn
|
£bn
|
£bn
|
£bn
|
£bn
|
Average equity
|
15.7
|
3.4
|
1.2
|
29.2
|
4.1
|
8.2
|
61.8
|
Average goodwill and intangibles
|
(4.0)
|
—
|
(0.1)
|
—
|
(0.6)
|
(3.6)
|
(8.3)
|
Average tangible equity
|
11.7
|
3.4
|
1.1
|
29.2
|
3.5
|
4.6
|
53.5
|
|
|
|
|
|
|
|
|
Return on average tangible equity
|
18.6%
|
16.8%
|
33.2%
|
14.2%
|
7.3%
|
n/m
|
13.2%
|
|
Half year ended 30.06.24
|
|
|||||
|
Barclays UK
|
Barclays UK Corporate Bank
|
Barclays Private Bank and Wealth Management
|
Barclays Investment Bank
|
Barclays US Consumer Bank
|
Head Office
|
Barclays Group
|
Return on average tangible equity
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
Attributable profit/(loss)
|
1,063
|
248
|
151
|
1,614
|
119
|
(408)
|
2,787
|
|
|
|
|
|
|
|
|
|
£bn
|
£bn
|
£bn
|
£bn
|
£bn
|
£bn
|
£bn
|
Average equity
|
14.3
|
3.0
|
1.1
|
30.0
|
3.6
|
6.0
|
58.0
|
Average goodwill and intangibles
|
(3.9)
|
—
|
(0.1)
|
—
|
(0.3)
|
(3.6)
|
(7.9)
|
Average tangible equity
|
10.4
|
3.0
|
1.0
|
30.0
|
3.3
|
2.4
|
50.1
|
|
|
|
|
|
|
|
|
Return on average tangible equity
|
20.4%
|
16.6%
|
29.7%
|
10.8%
|
7.2%
|
n/m
|
11.1%
|
Barclays Group
|
|
|
|
|
|
|
|
|
|
|
Return on average tangible shareholders' equity
|
Q225
|
Q125
|
|
Q424
|
Q324
|
Q224
|
Q124
|
|
Q423
|
Q323
|
£m
|
£m
|
|
£m
|
£m
|
£m
|
£m
|
|
£m
|
£m
|
|
Attributable profit/(loss)
|
1,659
|
1,864
|
|
965
|
1,564
|
1,237
|
1,550
|
|
(111)
|
1,274
|
|
|
|
|
|
|
|
|
|
|
|
|
£bn
|
£bn
|
|
£bn
|
£bn
|
£bn
|
£bn
|
|
£bn
|
£bn
|
Average shareholders' equity
|
62.1
|
61.4
|
|
59.7
|
59.1
|
57.7
|
58.3
|
|
57.1
|
55.1
|
Average goodwill and intangibles
|
(8.2)
|
(8.3)
|
|
(8.2)
|
(8.1)
|
(7.9)
|
(7.8)
|
|
(8.2)
|
(8.6)
|
Average tangible shareholders' equity
|
53.9
|
53.1
|
|
51.5
|
51.0
|
49.8
|
50.5
|
|
48.9
|
46.5
|
|
|
|
|
|
|
|
|
|
|
|
Return on average tangible shareholders' equity
|
12.3%
|
14.0%
|
|
7.5%
|
12.3%
|
9.9%
|
12.3%
|
|
(0.9)%
|
11.0%
|
Barclays UK
|
|
|
|
|
|
|
|
|
|
|
Return on average allocated tangible equity
|
Q225
|
Q125
|
|
Q424
|
Q324
|
Q224
|
Q124
|
|
Q423
|
Q323
|
£m
|
£m
|
|
£m
|
£m
|
£m
|
£m
|
|
£m
|
£m
|
|
Attributable profit
|
580
|
510
|
|
781
|
621
|
584
|
479
|
|
382
|
531
|
|
|
|
|
|
|
|
|
|
|
|
|
£bn
|
£bn
|
|
£bn
|
£bn
|
£bn
|
£bn
|
|
£bn
|
£bn
|
Average allocated equity
|
15.8
|
15.7
|
|
15.1
|
14.5
|
14.4
|
14.3
|
|
14.1
|
14.0
|
Average goodwill and intangibles
|
(4.0)
|
(4.0)
|
|
(3.9)
|
(3.9)
|
(3.9)
|
(3.9)
|
|
(3.9)
|
(3.9)
|
Average allocated tangible equity
|
11.8
|
11.7
|
|
11.2
|
10.6
|
10.5
|
10.4
|
|
10.2
|
10.1
|
|
|
|
|
|
|
|
|
|
|
|
Return on average allocated tangible equity
|
19.7%
|
17.4%
|
|
28.0%
|
23.4%
|
22.3%
|
18.5%
|
|
14.9%
|
21.0%
|
|
|
|
|
|
|
|
|
|
|
|
Barclays UK Corporate Bank
|
|
|
|
|
|
|
|
|
|
|
Return on average allocated tangible equity
|
Q225
|
Q125
|
|
Q424
|
Q324
|
Q224
|
Q124
|
|
Q423
|
Q323
|
£m
|
£m
|
|
£m
|
£m
|
£m
|
£m
|
|
£m
|
£m
|
|
Attributable profit
|
142
|
142
|
|
98
|
144
|
135
|
113
|
|
59
|
129
|
|
|
|
|
|
|
|
|
|
|
|
|
£bn
|
£bn
|
|
£bn
|
£bn
|
£bn
|
£bn
|
|
£bn
|
£bn
|
Average allocated equity
|
3.4
|
3.3
|
|
3.2
|
3.1
|
3.0
|
3.0
|
|
2.8
|
2.8
|
Average goodwill and intangibles
|
—
|
—
|
|
—
|
—
|
—
|
—
|
|
—
|
—
|
Average allocated tangible equity
|
3.4
|
3.3
|
|
3.2
|
3.1
|
3.0
|
3.0
|
|
2.8
|
2.8
|
|
|
|
|
|
|
|
|
|
|
|
Return on average allocated tangible equity
|
16.6%
|
17.1%
|
|
12.3%
|
18.8%
|
18.0%
|
15.2%
|
|
8.4%
|
18.3%
|
Barclays Private Bank and Wealth Management
|
|
|
|
|
|
|
|
|
|
|
Return on average allocated tangible equity
|
Q225
|
Q125
|
|
Q424
|
Q324
|
Q224
|
Q124
|
|
Q423
|
Q323
|
£m
|
£m
|
|
£m
|
£m
|
£m
|
£m
|
|
£m
|
£m
|
|
Attributable profit
|
88
|
96
|
|
63
|
74
|
77
|
74
|
|
47
|
102
|
|
|
|
|
|
|
|
|
|
|
|
|
£bn
|
£bn
|
|
£bn
|
£bn
|
£bn
|
£bn
|
|
£bn
|
£bn
|
Average allocated equity
|
1.2
|
1.2
|
|
1.2
|
1.1
|
1.1
|
1.1
|
|
1.1
|
1.1
|
Average goodwill and intangibles
|
(0.1)
|
(0.1)
|
|
(0.1)
|
(0.1)
|
(0.1)
|
(0.1)
|
|
(0.1)
|
(0.1)
|
Average allocated tangible equity
|
1.1
|
1.1
|
|
1.1
|
1.0
|
1.0
|
1.0
|
|
1.0
|
1.0
|
|
|
|
|
|
|
|
|
|
|
|
Return on average allocated tangible equity
|
31.9%
|
34.5%
|
|
23.9%
|
29.0%
|
30.8%
|
28.7%
|
|
19.1%
|
41.2%
|
Barclays Investment Bank
|
|
|
|
|
|
|
|
|
|
|
Return on average allocated tangible equity
|
Q225
|
Q125
|
|
Q424
|
Q324
|
Q224
|
Q124
|
|
Q423
|
Q323
|
£m
|
£m
|
|
£m
|
£m
|
£m
|
£m
|
|
£m
|
£m
|
|
Attributable profit/(loss)
|
876
|
1,199
|
|
247
|
652
|
715
|
899
|
|
(149)
|
580
|
|
|
|
|
|
|
|
|
|
|
|
|
£bn
|
£bn
|
|
£bn
|
£bn
|
£bn
|
£bn
|
|
£bn
|
£bn
|
Average allocated equity
|
28.7
|
29.6
|
|
29.3
|
29.5
|
29.9
|
30.0
|
|
28.9
|
28.8
|
Average goodwill and intangibles
|
—
|
—
|
|
—
|
—
|
—
|
—
|
|
—
|
—
|
Average allocated tangible equity
|
28.7
|
29.6
|
|
29.3
|
29.5
|
29.9
|
30.0
|
|
28.9
|
28.8
|
|
|
|
|
|
|
|
|
|
|
|
Return on average allocated tangible equity
|
12.2%
|
16.2%
|
|
3.4%
|
8.8%
|
9.6%
|
12.0%
|
|
(2.1)%
|
8.0%
|
|
|
|
|
|
|
|
|
|
|
|
Barclays US Consumer Bank
|
|
|
|
|
|
|
|
|
|
|
Return on average allocated tangible equity
|
Q225
|
Q125
|
|
Q424
|
Q324
|
Q224
|
Q124
|
|
Q423
|
Q323
|
£m
|
£m
|
|
£m
|
£m
|
£m
|
£m
|
|
£m
|
£m
|
|
Attributable profit/(loss)
|
87
|
41
|
|
94
|
89
|
75
|
44
|
|
(3)
|
3
|
|
|
|
|
|
|
|
|
|
|
|
|
£bn
|
£bn
|
|
£bn
|
£bn
|
£bn
|
£bn
|
|
£bn
|
£bn
|
Average allocated equity
|
4.0
|
4.2
|
|
4.0
|
3.8
|
3.6
|
3.6
|
|
3.6
|
3.8
|
Average goodwill and intangibles
|
(0.6)
|
(0.6)
|
|
(0.6)
|
(0.5)
|
(0.3)
|
(0.3)
|
|
(0.3)
|
(0.7)
|
Average allocated tangible equity
|
3.4
|
3.6
|
|
3.4
|
3.3
|
3.3
|
3.3
|
|
3.3
|
3.1
|
|
|
|
|
|
|
|
|
|
|
|
Return on average allocated tangible equity
|
10.2%
|
4.5%
|
|
11.2%
|
10.9%
|
9.2%
|
5.3%
|
|
(0.3)%
|
0.4%
|
|
|
|
|
|
|
|
|
|
|
|
|
Half year ended 30.06.25
|
|
|||||
|
Barclays UK
|
Barclays UK Corporate Bank
|
Barclays Private Bank and Wealth Management
|
Barclays Investment Bank
|
Barclays US Consumer Bank
|
Head Office
|
Barclays Group
|
Loan loss rate
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
Credit impairment (charges)/ releases
|
(237)
|
(31)
|
11
|
(139)
|
(711)
|
(5)
|
(1,112)
|
|
|
|
|
|
|
|
|
|
£bn
|
£bn
|
£bn
|
£bn
|
£bn
|
£bn
|
£bn
|
Gross
loans and advances held at amortised cost (including portfolios
reclassified as held for sale)1
|
228.5
|
28.2
|
14.8
|
126.8
|
27.4
|
2.7
|
428.4
|
|
|
|
|
|
|
|
|
Loan loss rate (bps)
|
21
|
22
|
(15)
|
22
|
523
|
n/m
|
52
|
|
Half year ended 30.06.24
|
|
|||||
|
Barclays UK
|
Barclays UK Corporate Bank
|
Barclays Private Bank and Wealth Management
|
Barclays Investment Bank
|
Barclays US Consumer Bank
|
Head Office
|
Barclays Group
|
Loan loss rate
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
Credit impairment (charges)/ releases
|
(66)
|
(23)
|
3
|
(34)
|
(719)
|
(58)
|
(897)
|
|
|
|
|
|
|
|
|
|
£bn
|
£bn
|
£bn
|
£bn
|
£bn
|
£bn
|
£bn
|
Gross
loans and advances held at amortised cost (including portfolios
reclassified as held for sale)1
|
217.3
|
26.0
|
14.1
|
115.5
|
32.1
|
4.0
|
409.0
|
|
|
|
|
|
|
|
|
Loan loss rate (bps)
|
6
|
18
|
(4)
|
6
|
509
|
n/m
|
45
|
1
|
Includes gross loans and advances to customers and banks, in
addition to debt securities.
|
Barclays Group
|
|
|
|
|
|
|
|
|
|
|
Loan loss rate
|
Q225
|
Q125
|
|
Q424
|
Q324
|
Q224
|
Q124
|
|
Q423
|
Q323
|
£m
|
£m
|
|
£m
|
£m
|
£m
|
£m
|
|
£m
|
£m
|
|
Credit impairment charges
|
(469)
|
(643)
|
|
(711)
|
(374)
|
(384)
|
(513)
|
|
(552)
|
(433)
|
|
|
|
|
|
|
|
|
|
|
|
|
£bn
|
£bn
|
|
£bn
|
£bn
|
£bn
|
£bn
|
|
£bn
|
£bn
|
Gross loans and advances held at amortised cost (including
portfolios reclassified as held for sale)
|
428.4
|
430.4
|
|
429.6
|
408.3
|
409.0
|
407.6
|
|
409.3
|
411.2
|
|
|
|
|
|
|
|
|
|
|
|
Loan loss rate (bps)
|
44
|
61
|
|
66
|
37
|
38
|
51
|
|
54
|
42
|
|
|
|
|
|
|
|
|
|
|
|
Barclays UK
|
|
|
|
|
|
|
|
|
|
|
Loan loss rate
|
Q225
|
Q125
|
|
Q424
|
Q324
|
Q224
|
Q124
|
|
Q423
|
Q323
|
£m
|
£m
|
|
£m
|
£m
|
£m
|
£m
|
|
£m
|
£m
|
|
Credit impairment charges
|
(79)
|
(158)
|
|
(283)
|
(16)
|
(8)
|
(58)
|
|
(37)
|
(59)
|
|
|
|
|
|
|
|
|
|
|
|
|
£bn
|
£bn
|
|
£bn
|
£bn
|
£bn
|
£bn
|
|
£bn
|
£bn
|
Gross loans and advances held at amortised cost (including
portfolios reclassified as held for sale)
|
228.5
|
227.5
|
|
227.5
|
218.4
|
217.3
|
219.4
|
|
223.3
|
225.7
|
|
|
|
|
|
|
|
|
|
|
|
Loan loss rate (bps)
|
14
|
28
|
|
49
|
3
|
1
|
11
|
|
7
|
10
|
|
|
|
|
|
|
|
|
|
|
|
Barclays UK Corporate Bank
|
|
|
|
|
|
|
|
|
|
|
Loan loss rate
|
Q225
|
Q125
|
|
Q424
|
Q324
|
Q224
|
Q124
|
|
Q423
|
Q323
|
£m
|
£m
|
|
£m
|
£m
|
£m
|
£m
|
|
£m
|
£m
|
|
Credit impairment charges
|
(12)
|
(19)
|
|
(40)
|
(13)
|
(8)
|
(15)
|
|
(18)
|
(15)
|
|
|
|
|
|
|
|
|
|
|
|
|
£bn
|
£bn
|
|
£bn
|
£bn
|
£bn
|
£bn
|
|
£bn
|
£bn
|
Gross loans and advances held at amortised cost (including
portfolios reclassified as held for sale)
|
28.2
|
27.0
|
|
25.8
|
25.2
|
26.0
|
26.1
|
|
26.6
|
27.2
|
|
|
|
|
|
|
|
|
|
|
|
Loan loss rate (bps)
|
17
|
28
|
|
62
|
21
|
12
|
23
|
|
27
|
21
|
|
|
|
|
|
|
|
|
|
|
|
Barclays Private Bank and Wealth Management
|
|
|
|
|
|
|
|
|
|
|
Loan loss rate
|
Q225
|
Q125
|
|
Q424
|
Q324
|
Q224
|
Q124
|
|
Q423
|
Q323
|
£m
|
£m
|
|
£m
|
£m
|
£m
|
£m
|
|
£m
|
£m
|
|
Credit impairment (charges)/ releases
|
2
|
9
|
|
(2)
|
(7)
|
3
|
—
|
|
4
|
2
|
|
|
|
|
|
|
|
|
|
|
|
|
£bn
|
£bn
|
|
£bn
|
£bn
|
£bn
|
£bn
|
|
£bn
|
£bn
|
Gross loans and advances held at amortised cost (including
portfolios reclassified as held for sale)
|
14.8
|
14.8
|
|
14.7
|
14.3
|
14.1
|
14.1
|
|
13.8
|
13.6
|
|
|
|
|
|
|
|
|
|
|
|
Loan loss rate (bps)
|
(5)
|
(25)
|
|
5
|
19
|
(9)
|
—
|
|
(10)
|
(7)
|
|
|
|
|
|
|
|
|
|
|
|
Barclays Investment Bank
|
|
|
|
|
|
|
|
|
|
|
Loan loss rate
|
Q225
|
Q125
|
|
Q424
|
Q324
|
Q224
|
Q124
|
|
Q423
|
Q323
|
£m
|
£m
|
|
£m
|
£m
|
£m
|
£m
|
|
£m
|
£m
|
|
Credit impairment (charges)/ releases
|
(67)
|
(72)
|
|
(46)
|
(43)
|
(44)
|
10
|
|
(23)
|
23
|
|
|
|
|
|
|
|
|
|
|
|
|
£bn
|
£bn
|
|
£bn
|
£bn
|
£bn
|
£bn
|
|
£bn
|
£bn
|
Gross loans and advances held at amortised cost (including
portfolios reclassified as held for sale)
|
126.8
|
129.6
|
|
124.9
|
116.5
|
115.5
|
113.2
|
|
109.4
|
108.6
|
|
|
|
|
|
|
|
|
|
|
|
Loan loss rate (bps)
|
21
|
23
|
|
15
|
15
|
15
|
(4)
|
|
8
|
(8)
|
|
|
|
|
|
|
|
|
|
|
|
Barclays US Consumer Bank
|
|
|
|
|
|
|
|
|
|
|
Loan loss rate
|
Q225
|
Q125
|
|
Q424
|
Q324
|
Q224
|
Q124
|
|
Q423
|
Q323
|
£m
|
£m
|
|
£m
|
£m
|
£m
|
£m
|
|
£m
|
£m
|
|
Credit impairment charges
|
(312)
|
(399)
|
|
(298)
|
(276)
|
(309)
|
(410)
|
|
(449)
|
(404)
|
|
|
|
|
|
|
|
|
|
|
|
|
£bn
|
£bn
|
|
£bn
|
£bn
|
£bn
|
£bn
|
|
£bn
|
£bn
|
Gross loans and advances held at amortised cost (including
portfolios reclassified as held for sale)
|
27.4
|
28.9
|
|
30.0
|
26.7
|
32.1
|
27.0
|
|
28.0
|
27.5
|
|
|
|
|
|
|
|
|
|
|
|
Loan loss rate (bps)
|
456
|
562
|
|
395
|
411
|
438
|
610
|
|
636
|
582
|
|
|
|
|
|
|
|
|
|
|
|
Tangible net asset value per share
|
As at 30.06.25
|
As at 31.12.24
|
As at 30.06.24
|
|
£m
|
£m
|
£m
|
Total equity excluding non-controlling interests
|
75,906
|
71,821
|
71,173
|
Other equity instruments
|
(13,266)
|
(12,075)
|
(12,959)
|
Goodwill
and intangibles
|
(8,186)
|
(8,275)
|
(7,839)
|
Tangible shareholders' equity attributable to ordinary shareholders
of the parent
|
54,454
|
51,471
|
50,375
|
|
|
|
|
|
m
|
m
|
m
|
Shares in issue
|
14,180
|
14,420
|
14,826
|
|
|
|
|
|
p
|
p
|
p
|
Tangible net asset value per share
|
384
|
357
|
340
|
Results timetable1
|
|
|
|
|
Date
|
|
|
Ex-dividend date
|
|
|
|
|
7 August 2025
|
|
|
Dividend record date
|
|
|
|
|
8 August 2025
|
|
|
DRIP last election date
|
22 August 2025
|
|
|||||
Dividend payment date
|
|
|
|
|
16 September 2025
|
|
|
Q3 2025 Results Announcement
|
|
|
|
|
22 October 2025
|
|
|
|
|
|
|
|
|
|
|
For qualifying US and Canadian resident ADR holders, the 2025 half
year dividend of 3.0p per ordinary share becomes 12.0p per ADS
(representing four shares). The ex-dividend date for ADR holders is
8 August 2025. The dividend record and dividend payment dates for
ADR holders are as shown above.
|
|||||||
A Dividend Re-Investment Plan (DRIP) is provided by Equiniti
Financial Services Limited. The DRIP enables the Company’s
shareholders to elect to have their cash dividend payments used to
purchase the Company’s shares.
More information can be found at
shareview.co.uk/info/drip
|
|||||||
DRIP participants will usually receive their additional ordinary
shares (in lieu of a cash dividend) three to four days after the
dividend payment date. Qualifying US and Canadian resident ADR
holders should contact Shareowner Services for further details
regarding the DRIP.
|
|||||||
Barclays PLC ordinary shares ISIN code: GB0031348658
|
|||||||
Barclays PLC ordinary shares TIDM Code: BARC
|
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
% Change2
|
|
|
Exchange rates
|
30.06.25
|
31.12.24
|
30.06.24
|
|
31.12.24
|
30.06.24
|
|
Period end - USD/GBP
|
1.37
|
1.25
|
1.26
|
|
10%
|
9%
|
|
6 month average - USD/GBP
|
1.30
|
1.28
|
1.26
|
|
2%
|
3%
|
|
3 month average - USD/GBP
|
1.35
|
1.28
|
1.26
|
|
5%
|
7%
|
|
Period end - EUR/GBP
|
1.17
|
1.21
|
1.18
|
|
(3)%
|
(1)%
|
|
6 month average - EUR/GBP
|
1.19
|
1.18
|
1.19
|
|
1%
|
—%
|
|
3 month average - EUR/GBP
|
1.18
|
1.20
|
1.18
|
|
(2)%
|
—%
|
|
|
|
|
|
|
|
|
|
Share price data
|
|
|
|
|
|
|
|
Barclays PLC (p)
|
337.30
|
268.15
|
208.90
|
|
|
|
|
Barclays PLC number of shares (m)3
|
14,180
|
14,420
|
14,826
|
|
|
|
|
|
|
|
|
|
|
|
|
For further information please contact
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investor relations
|
Media relations
|
|
|||||
Marina Shchukina +44 (0) 20 7116 2526
|
Tom Hoskin +44 (0) 20 7116 4755
|
|
|||||
|
|
|
|||||
More information on Barclays can be found on our
website: home.barclays
|
|
||||||
|
|
|
|
|
|
|
|
Registered office
|
|
|
|
|
|
|
|
1 Churchill Place, London, E14 5HP, United Kingdom. Tel: +44 (0) 20
7116 1000. Company number: 48839.
|
|
||||||
|
|
|
|
|
|
|
|
Registrar
|
|
|
|
|
|
|
|
Equiniti, Aspect House, Spencer Road, Lancing, West Sussex, BN99
6DA, United Kingdom.
|
|
||||||
Tel: +44 (0)371 384 2055 (UK and International telephone
number)4.
|
|
||||||
|
|
|
|
|
|
|
|
American Depositary Receipts (ADRs)
|
|
|
|
|
|
|
|
Shareowner Services
|
|
||||||
P.O. Box 64504
|
|
||||||
St. Paul, MN 55164-0504
|
|
||||||
United States of America
|
|
||||||
shareowneronline.com
|
|
||||||
Toll Free Number (US and Canada): +1 800-990-1135
|
|
|
|||||
Outside the US and Canada: +1 651-453-2128
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
Delivery of ADR certificates and overnight mail
|
|
|
|
|
|
|
|
Shareowner Services, 1110 Centre Pointe Curve, Suite 101, Mendota
Heights, MN 55120-4100, USA.
|
|
1
|
Note that these dates are provisional and subject to
change.
|
2
|
The change is the impact to GBP reported information.
|
3
|
The number of shares of 14,180m as at 30 June 2025 is different
from the 14,176m quoted in the 1 July 2025 announcement entitled
“Total Voting Rights” because the share buyback
transactions executed on 27 and 30 June 2025 did not settle until 1
and 2 July 2025 respectively.
|
4
|
Lines open 8.30am to 5.30pm (UK time), Monday to Friday, excluding
UK public holidays in England and Wales.
|